US20040101822A1 - Fluorescent silica-based nanoparticles - Google Patents

Fluorescent silica-based nanoparticles Download PDF

Info

Publication number
US20040101822A1
US20040101822A1 US10/306,614 US30661402A US2004101822A1 US 20040101822 A1 US20040101822 A1 US 20040101822A1 US 30661402 A US30661402 A US 30661402A US 2004101822 A1 US2004101822 A1 US 2004101822A1
Authority
US
United States
Prior art keywords
nanoparticle
fluorescent
ligated
cell
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/306,614
Inventor
Ulrich Wiesner
Hooisweng Ow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Priority to US10/306,614 priority Critical patent/US20040101822A1/en
Assigned to CORNELL RESEARCH FOUNDATION, INC. reassignment CORNELL RESEARCH FOUNDATION, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WIESNER, ULRICH, OW, HOOISWENG
Priority to EP20110162895 priority patent/EP2364840A1/en
Priority to PCT/US2003/037963 priority patent/WO2004074504A2/en
Priority to CNA200810170588XA priority patent/CN101387639A/en
Priority to JP2004566499A priority patent/JP4965804B2/en
Priority to EP11156074.4A priority patent/EP2369342B1/en
Priority to ES03815995T priority patent/ES2709398T3/en
Priority to AU2003303309A priority patent/AU2003303309B2/en
Priority to EP03815190.8A priority patent/EP1604031B1/en
Priority to JP2004568576A priority patent/JP2006514708A/en
Priority to CNA200380109241XA priority patent/CN1742094A/en
Priority to PCT/US2003/037793 priority patent/WO2004063387A2/en
Priority to ES11156074T priority patent/ES2753144T3/en
Priority to KR1020057009530A priority patent/KR20050109455A/en
Priority to US10/536,569 priority patent/US8298677B2/en
Priority to AU2003303290A priority patent/AU2003303290A1/en
Priority to CNB2003801092528A priority patent/CN100443295C/en
Priority to KR1020057009511A priority patent/KR20050103186A/en
Priority to EP03815995.0A priority patent/EP1572445B1/en
Publication of US20040101822A1 publication Critical patent/US20040101822A1/en
Priority to US12/579,302 priority patent/US8409876B2/en
Priority to JP2009285153A priority patent/JP2010070768A/en
Priority to JP2010262238A priority patent/JP2011052228A/en
Priority to JP2014023357A priority patent/JP2014133893A/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/02Use of particular materials as binders, particle coatings or suspension media therefor
    • C09K11/025Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00Silicon; Compounds thereof
    • C01B33/113Silicon oxides; Hydrates thereof
    • C01B33/12Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y20/00Nanooptics, e.g. quantum optics or photonic crystals
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/01Particle morphology depicted by an image
    • C01P2004/03Particle morphology depicted by an image obtained by SEM
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/64Nanometer sized, i.e. from 1-100 nanometer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24355Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.]
    • Y10T428/24372Particulate matter
    • Y10T428/2438Coated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31652Of asbestos
    • Y10T428/31663As siloxane, silicone or silane

Definitions

  • the invention generally relates to nanoparticles, and more specifically to ligated-fluorescent nanoparticles, methods of making ligated-fluorescent nanoparticles, and methods of using the ligated-fluorescent nanoparticles as biomarkers to, for example, monitor the motion or movement of cellular components on or within cell systems, and for the detection, diagnosis, or treatment of diseases or conditions, for example in intact or living cells.
  • Fluorescent and magnetic polymeric particles have known utility as markers and indicators in various biomedical assays.
  • markers for sorting cells are immunoconjugates or immunological labels which include, for example, immuno-fluorescent and immuno-magnetic labels.
  • Immunofluorescent labels typically include, for example, a fluorescent molecule joined to an antibody.
  • Immuno-magnetic labels typically include, for example, a superparamagnetic particle joined to either a primary or secondary antibody.
  • Cell labeling can be performed by, for example, attaching the antibody to a marker of interest (e.g., receptor site) on the surface of the cell, that is, a cell surface marker.
  • a marker of interest e.g., receptor site
  • the chemical and physical structure of cell surface marker and density of immunological labels attached to the cell surface have generally been difficult to accurately determine.
  • Fluorescent labels have been prepared, for example, by embedding or covalently coupling a fluorescent dye onto a polymeric particle.
  • the resulting fluorescent microparticles can be analyzed manually or by other methods known in the art but preferably using an automated technique, e.g., flow cytometry, such as disclosed in U.S. Pat. No. 4,665,024, to Mansour, et al.
  • the versatility of the fluorescent particles can be further enhanced by the incorporation of multiple fluorescent materials in a single particle.
  • Magnetic particles such as known magnetically active materials, can be bonded or attached to, for example, antibodies, such as, monoclonal antibodies that are specific to a particular cell type, antigen, or other targets.
  • the resulting magnetic-antibodies can then be mixed with a large population of many different cell types, for example, crude tissue samples, cells grown in a reactor, and the like.
  • the magnetic-antibodies therefore attach only to their pre-selected target cell type, forming a magnetic-antibody-cell conjugate.
  • the conjugate can then be separated from the rest of the cell population using a magnetic field.
  • a shortcoming of magnetic particles is the lack of specificity in magnetic labeling in that a cell or other biological target analyte may be rendered paramagnetic by a number of different routes which can confound the analysis and diagnostic information afforded by the method, for example, by binding a specific paramagnetic compound to a specific hapten on a cell or by specific or non-specific binding of a paramagnetic metal or metal complex directly to a cell, such as, a metal binding microorganism or by phagocytosis.
  • Other problems encountered with magnetic particles used in detection and diagnostics include, for example, difficulty in obtaining highly accurate quantification of a cell population's magnetic susceptibility. In addition to their magnetic properties (i.e.
  • magnetic, paramagnetic, and superparamagnetic magnetic-antibodies can be classified, for example, into three broad categories based on their relative descending particle size: magnetic particulate labels, colloidal magnetic labels, and molecular magnetic labels, see for example U.S. Pat. No. 6,412,359.
  • Latex nanoparticles having a polymeric core and a surface decorated with, for example, a ligand molecule capable of specific binding with a cell surface and optionally decorated with genetic material, such as a mutant gene, are known and may have utility in, for example, gene delivery to a cell and expression therein, for disrupting tumors, and related treatment applications, see for example, Science, 296, 2404 (2002).
  • Optically active nanoparticles such as fluorescent nanoparticles, having an electrically conducting shell and a silica core are known and have utility in, for example, modulated delivery of a chemical and treatment applications, see for example, U.S. Pat. No. 6,344,272, and 6,428,811.
  • a shortcoming of existing fluorescent probe nanoparticles is their limited brightness and their attenuated detectability as fluorescent probes in dispersed systems, particularly with single fluorescent nanoparticles.
  • the invention provides a fluorescent nanoparticle comprising: a core comprising a fluorescent silane compound; and a silica shell on the core.
  • the invention also provides a fluorescent nanoparticle comprising:
  • a core comprising a fluorescent silane compound; and a porous silica shell on the core.
  • the invention also provides a fluorescent nanoparticle which can further include a ligand, such as a antibody, conjugated with or coated on the surface of the fluorescent nanoparticle to form a ligated-fluorescent nanoparticle.
  • a ligand such as a antibody
  • the ligated- or ligand bearing-fluorescent nanoparticles of the present invention can be used, for example, as highly target specific diagnostic agents, and motion monitoring agents when combined with cells or cell components.
  • the invention also provides a pharmaceutical carrier or drug delivery vehicle comprising the fluorescent nanoparticles or the ligated-fluorescent nanoparticles of the present invention.
  • the invention also provides a fluorescent imaging agent comprising the ligated-fluorescent nanoparticles of the present invention.
  • the invention also provides ligated-fluorescent nanoparticles as pharmaceutical carrier particles.
  • the ligated-fluorescent nanoparticles can further include a therapeutic agent, which therapeutic agent is on the surface or is conjugated with the surface of the fluorescent nanoparticle to form a pharmaceutical composition.
  • the invention also provides a method of making a fluorescent nanoparticle comprising:
  • a fluorescent compound such as a reactive fluorescent dye
  • an organo-silane compound such as a co-reactive organo-silane compound
  • the invention also provides a method for monitoring movement of a cellular component of a cell comprising:
  • the invention also provides a method for treating disease comprising:
  • a ligated-fluorescent nanoparticle which nanoparticle optionally includes a therapeutic agent, the nanoparticle being adapted to selectively associate with a disease producing component of the cell, to form a selectively decorated cell with the ligated-fluorescent nanoparticle;
  • the invention also provides a method for treatment comprising:
  • the invention also provides a kit for use in the detection of an analyte, the kit comprising a ligated-fluorescent nanoparticle, as illustrated herein.
  • the invention also provides a kit for detecting and monitoring a cell surface component comprising a ligated-fluorescent nanoparticle for detecting the cell surface component, and optionally a recorder for monitoring the cell surface component.
  • the invention also provides an assay method for detecting motion or a change in the location of a cellular component in, or on the surface of, a cell when the cell is treated with a therapeutic agent comprising:
  • FIG. 1A illustrates an example of the fluorescent brightness of the fluorescent nanoparticles of the present invention compared to latex particles.
  • FIG. 2A illustrates an example of bio-molecule binding specificity of the fluorescent nanoparticles of the present invention.
  • FIG. 2B illustrates an example of bio-molecule binding specificity of comparative latex particles.
  • Applicants have discovered fluorescent nanoparticles, and linked- or ligated-fluorescent nanoparticles of the invention that are useful for labeling, detection, identification, motion monitoring, and like applications, of various biological and non-biological analytes.
  • the linked- or ligated-fluorescent nanoparticles of the invention can also be useful in therapeutic treatment, when used as a pharmaceutical carriers, for example, in combination with a suitable therapeutic agent.
  • the present invention provides nanoparticles which can have useful multifunctional architectures, for example, a fluorescent nano-sized core which can optionally contain other functionality such as a magnetic component, a silica shell which can be made to have a range of useful thicknesses and surface properties, such as a smooth monolithic surface or a highly porous surface, and which silica surface can be further physically or chemically modified with, for example, a ligand or a therapeutic agent.
  • useful multifunctional architectures for example, a fluorescent nano-sized core which can optionally contain other functionality such as a magnetic component, a silica shell which can be made to have a range of useful thicknesses and surface properties, such as a smooth monolithic surface or a highly porous surface, and which silica surface can be further physically or chemically modified with, for example, a ligand or a therapeutic agent.
  • the present invention provides for the preparation and characterizations of fluorescent nanoparticles in various sizes suitable for single particle tracking (SPT) applications. Nanoparticles of various diameters can be prepared having narrow size distributions.
  • the versatility of the preparative route allows for the incorporation of different fluorescent materials, such as dyes, depending on the intended nanoparticle application.
  • Methods for surface functionalization are also provided which enable the conjugation of specific ligands, such as antibodies or proteins, onto the fluorescent nanoparticles to form probes useful for specific SPT experiments.
  • the nanoparticle preparative procedure enables the preparation, by in situ systematic nanoparticle size-growth, of fluorescent nanoparticles in the range of, for example, from about 10 to about 500 nm, and from about 25 to about 100 nm, and narrower ranges therein as illustrated herein.
  • the fluorescent nanoparticles can be conjugated with a molecule or entity, such as an antibody ligand or linker, to provide a linked- or ligated-fluorescent nanoparticle which can be used to identify, detect, target (i.e. pinpoint or specify with a high level of certainty), monitor, or modify a disease state or condition, such as the presence or absence of particular receptors, metabolic levels of particular receptors, and like components.
  • a molecule or entity such as an antibody ligand or linker
  • the linked- or ligated-fluorescent nanoparticle can be still further conjugated or associated with, for example, a therapeutic agent and used to, for example, treat a disease state or condition, such as by delivering the therapeutic agent to a diseased site in a highly specific or localized manner and in a relatively high concentration with release of the therapeutic agent in a relatively controlled manner.
  • the ligated-fluorescent nanoparticles can be used for directed delivery of a therapeutic agent to a desired location in a variety of systems, such as on, or within, a cell or cell component, or within the body of an organism, such as a human, e.g. across the blood-brain barrier.
  • the therapeutic agent can be either or both absorbed into, such as the interstices or pores of the silica shell, or coated onto the silica shell of the fluorescent nanoparticle.
  • the therapeutic agent can be associated with the fluorescent core, such as by physical absorption or by bonding interaction.
  • the therapeutic agent can also be associated with the ligand of a ligated-fluorescent nanoparticle if desired.
  • the ligated-fluorescent nanoparticles of the present invention can be used in a variety of diagnostic and treatment applications, for example, as a pharmaceutical carrier for therapeutic agents, and as a fluorescent marker in, for example, single nucleotide polymorphorism (SNPs) experiments, such as where a DNA sample is stained with a fluorescent marker and gene activity can be detected as a colored glow of the marker when illuminated with a laser.
  • SNPs single nucleotide polymorphorism
  • the nanoparticles of the invention can be used for passive or covalent coupling of biological material, i.e. an analyte, such as haptens, antigens, antibodies, enzymes or nucleic acids, and used for various types of analyte assays such as immunoassays, nucleic acid (DNA or RNA) assays, affinity purification, cell separation, and other medical, diagnostic, environmental, and industrial applications.
  • analyte such as haptens, antigens, antibodies, enzymes or nucleic acids
  • analyte assays such as immunoassays, nucleic acid (DNA or RNA) assays, affinity purification, cell separation, and other medical, diagnostic, environmental, and industrial applications.
  • the nanoparticles incorporate known fluorescently responsive materials, such as, dyes, pigments, or combinations thereof.
  • a typical fluorophore is, for example, a fluorescent aromatic or heteroaromatic compound such as is a pyrene, an anthracene, a naphthalene, an acridine, a stilbene, an indole or benzindole, an oxazole or benzoxazole, a thiazole or benzothiazole, a 4-amino-7-nitrobenz-2-oxa-1,3-diazole (NBD), a cyanine, a carbocyanine, a carbostyryl, a porphyrin, a salicylate, an anthranilate, an azulene, a perylene, a pyridine, a quinoline, a coumarin (including hydroxycoumarins and aminocoumarins and fluorinated derivatives thereof), and like compounds, see for example U.S. Pat. Nos. 5,830,912; 4,774,339; 5,187,288; 5,248,
  • the co-reactive organosilane used for forming the fluorescent core has the general formula R (4-n) SiX n , where X can be a hydrolyzable group such as ethoxy, methoxy, or 2-methoxy-ethoxy; R can be a monovalent organic radical of from 1 to 12 carbon atoms which can optionally contains a functional organic group such as mercapto, epoxy, acrylyl, methacrylyl, or amino; and n is an integer of from 0 to 4.
  • the co-reactive organosilane used for forming the fluorescent core preferably has n equal to 3.
  • a organosilane used for forming the silica shell has n equal to 4.
  • the above mentioned organo-silane compounds and like coupling agents can be used: to make the core; to make the silica shell, to modify the surface of the resulting silica shell coated fluorescent core nanoparticles; to attach or couple a ligand to the fluorescent nanoparticles; or to modify the properties of ligand before or after attachment to fluorescent nanoparticle.
  • the organo-silane can cause gels, so it may be desirable to employ an alcohol or other known stabilizers.
  • a stabilizer can be selected that does not interfere with the polymerization.
  • An alcohol, such as methanol, is especially useful and can be employed in amounts, for example, from about twice to about ten times the amount of the organo-silane.
  • the nanoparticles can optionally incorporate known magnet or magnetically responsive materials, such as, superparamagnetic, paramagnetic, ferromagnetic metal oxide, and combinations thereof.
  • the fluorescent nanoparticles of the present invention comprise a core comprising a fluorescent silane compound; and a silica shell on the core.
  • the core of the nanoparticle can comprise, for example, the reaction product of a reactive fluorescent compound and an co-reactive organo-silane compound
  • the shell can comprise, for example, the reaction product of a silica forming compound.
  • the silica forming compound can produce, for example, one or more layers of silica, such as from 1 to about 20 layers, and depending upon the shell characteristics desired, such as shell layer thickness, the ratio of the shell thickness to the core thickness or diameter, silica shell surface coverage of the core, porosity and carrying capacity of the silica shell, and like considerations.
  • the silica shell coating on the core can cover, for example, from about 10 to about 100 percent of the surface area of the core.
  • the ligand when ligated on the surface of the fluorescent nanoparticle can cover, for example, from about 0.1 to about 100 percent of the surface area of the core.
  • the thickness or diameter of the core to the thickness of the silica shell can be in a ratio of, for example, from about 1:1 to about 1:100.
  • the diameter of the fluorescent nanoparticle can be, for example, from about 1 to about 1,000 nanometers.
  • the diameter of a ligated-fluorescent nanoparticle can be comparable to or larger than the diameter of the fluorescent nanoparticle depending upon, for example, the size and the amount of the ligand selected.
  • the diameter of the core can be, for example, from about 10 to about 300 nanometers, and preferably from about 25 to about 200 nanometers
  • the thickness of the silica shell can be, for example, from about 25 to about 800 nanometers, and preferably from about 25 to about 500 nanometers.
  • the silica shell is made porous to accommodate for example a therapeutic agent, and as illustrated herein. More preferably the nanoparticles
  • the preparative methods for fluorescent nanoparticles of the present invention can yield nanoparticles, for example, of about an order of magnitude smaller in size than those reported by van Blaaderen and Vri, Langmuir, 8, 2921-2925 (1992) (monodisperse silica sphere core particles coated with dyes and further encapsulated with silica).
  • the silica shell can be either solid, that is relatively non-porous, or meso-porous, such as semi-porous.
  • the silica shell of the fluorescent nanoparticles is preferably dielectric.
  • the silica shell of the fluorescent nanoparticles can be adapted to function as a pharmaceutical carrier nanoparticle, that is made to contain, for example, therapeutic agents, such as drugs or proteins for transport and delivery of in vivo or in vitro.
  • therapeutic agents such as drugs or proteins for transport and delivery of in vivo or in vitro.
  • the fluorescent nanoparticles of the present invention can provide a pharmaceutical carrier system which can be adapted for controlled delivery or release of therapeutic agents.
  • a ligand placed on the surface of the fluorescent nanoparticle forms a ligated-fluorescent nanoparticle.
  • the placement of the ligand can be accomplished, for example, by attachment with a covalent bond or by physical absorption.
  • the ligand on the surface of the fluorescent nanoparticle can be, for example, a biopolymer, a synthetic polymer, an antigen, an antibody, a virus or viral component, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a microorganism or a component thereof, a toxin, a surface modifier, such as a surfactant to alter the surface properties or histocompatability of the nanoparticle or of an analyte when a nanoparticle associates therewith, and combinations thereof.
  • Preferred ligands are for example, antibodies, such as monoclonal or polyclonal.
  • the present invention also provides a method of preparing analytes which are selectively labeled with ligated-fluorescent nanoparticles by, for example, coupling (e.g. covalently) or any other known method(s) of associating the ligated-fluorescent nanoparticles directly to the analyte (e.g., through ionic bonds, hydrogen bonds, by simple adsorption).
  • the resulting selectively labeled analytes having a coupled or associated ligated-fluorescent nanoparticle i.e. ligated-fluorescent nanoparticle-analyte complex
  • can be useful as an authentic or reference sample for example, in a treatment method or diagnostic kit.
  • An “analyte” of the present invention is the object or the target of the ligated-fluorescent nanoparticle for attachment or association therewith.
  • the analyte can be, for example, a microorganism or a component thereof, a virus or viral component, a cell or a component thereof, a biopolymer, a synthetic polymer, a synthetic material, such as a carbon nanotube, an antigen, an antibody, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, combinations thereof, and like substances.
  • Analytes of particular interest are microorganisms and cells, including viruses, prokaryotic and eukaryotic cells, unicellular and multi-cellular organism, e.g., fungi, bacterial, mammalian, etc., and fragments or components thereof.
  • Other analytes of particular interest are pathogens.
  • Monoclonal or polyclonal antibodies or other selective ligands which are part of the ligated-fluorescent nanoparticle can be linked to the surface of, for example, a pathogen.
  • a fluorescent nanoparticle for example, comprising:
  • a fluorescent compound such as a reactive fluorescent dye
  • an organo-silane compound such as a co-reactive organo-silane compound
  • the methods of making the nanoparticles of the present invention can further comprise combining the resulting fluorescent nanoparticle with a ligand such as a biopolymer, a synthetic polymer, an antigen, an antibody, a microorganism, a virus, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, a surface modifier, for example, to alter the surface or compatibility properties of the nanoparticle, combinations thereof, and like materials.
  • a ligand such as a biopolymer, a synthetic polymer, an antigen, an antibody, a microorganism, a virus, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, a surface modifier, for example, to alter the surface or compatibility properties of the nanoparticle, combinations thereof, and like materials.
  • the methods of making the nanoparticles can also further comprise combining the resulting nanoparticle with a therapeutic agent, with or without a ligand attached to the nanoparticle.
  • Combining the nanoparticles with a ligand or a therapeutic agent can be accomplished by, for example, coating the ligand or therapeutic agent onto the surface of the nanoparticle.
  • combining a nanoparticle with a ligand or a therapeutic agent can be accomplished by, for example, imbibing the ligand or therapeutic agent into the surface of the nanoparticle. Imbibing means to assimilate or to take in or up, for example, where a porous nanoparticle surface is imbibed with a ligand, a therapeutic agent, or both.
  • combining a nanoparticle with a ligand or a therapeutic agent can be accomplished by, for example, bonding the ligand or therapeutic agent to the surface of the resulting nanoparticle.
  • Bonding includes, for example, known covalent, ionic, hydrogen, hydrophobic, coordination, adhesive, combinations thereof, and like bonding associative methods.
  • the nanoparticles of the present invention can provide “molecular labels” which can readily associate with or be bonded to another entity, such as a ligand or a therapeutic agent, and thereafter be readily transported to and selectively attached to a target analyte.
  • the selective attachment enables useful analytical detection, diagnostic, or differentiation schemes.
  • the size of the ligated-fluorescent nanoparticles for use in embodiments of the present invention can be selected based on the number of nanoparticles to be attached to the analyte and the sensitivity of the optical or spectroscopic schemes selected.
  • the present invention provides a method for monitoring movement of a cellular component of a cell comprising:
  • the fluorescent loci can correspond to a single ligated-fluorescent nanoparticle bound to a component of the cell.
  • the fluorescent loci can correspond to two or more ligated-fluorescent nanoparticles bound to a component of the cell.
  • the monitoring method enables an operator to, for example, track the diffusion of one or more fluorescent loci, such as a receptor to which a single ligated-fluorescent nanoparticle is bound, such as, in real-time or with time-lapse techniques.
  • the ligated-fluorescent nanoparticle is preferably adapted to selectively associate with a targeted cellular component of the cell, for example, by appropriate selection of the ligand.
  • the cellular component can be, for example, a receptor, an antibody, a hapten, an enzyme, a hormone, a biopolymer, an antigen, a microorganism, a virus, a pathogen, a toxin, combinations thereof, and like components.
  • the ligated-fluorescent nanoparticle can be a fluorescent nanoparticle conjugated with an antibody.
  • the conjugated antibody can be an immunoglobin, such as IgE.
  • Suitable means for detecting, recording, measuring, or imaging in embodiments of the present invention include, for example, a flow cytometer, a laser scanning cytometer, a fluorescence micro-plate reader, a fluorescence microscope, a confocal microscope, a bright-field microscope, a high content scanning system, and like devices.
  • the recording can be accomplished, for example, with a microscopically adapted camera, such as a video-microscopy camera, a digital camera, a silver halide single exposure camera, and like devices.
  • the recording time can be any convenient and useful time period to observe notable events or phenomena, for example, intervals from about 1 microsecond to about 30 days.
  • recording for a time period can be, for example, from about 1 second to about 60 minutes, more preferably from about 1 second to about 40 minutes, and even more preferably, from about 1 minute to about 30 minutes.
  • the recording time period can often be conveniently shortened or lengthened as desired by changing the ambient temperature of the sample or system.
  • the contacting and the recording can be accomplished in vitro using conventional microscopic photography techniques.
  • the contacting and the recording can also be accomplished in vivo using, for example, a catheter adapted with a microscopic camera or fiber optic camera.
  • “recording” can be synonymous with “detecting,” since for example making a photographic recording of an illuminated specimen can also simultaneously afford detection of fluorescent loci, such as a cell or cell component selectively decorated with a ligated-fluorescent nanoparticle.
  • a pharmaceutical carrier comprising the fluorescent nanoparticle of the present invention, and optionally a ligand associated with the fluorescent nanoparticle.
  • a pharmaceutical composition comprising a ligated-fluorescent nanoparticle, and a therapeutic agent associated with the fluorescent nanoparticle.
  • an imaging agent comprising the ligated-fluorescent nanoparticle, for example, where the ligand of the ligated-fluorescent nanoparticle is on the surface of the nanoparticle.
  • the imaging agent can be used in conventional imaging processes, and preferably where, for example, a high fluorescent yield or fluorescent brightness is desired.
  • the ligated-fluorescent nanoparticles of the present invention can provide enhanced fluorescent brightness which is, for example, from about 2 to about 10 times greater compared to conventional surface decorated fluorescent particles, such as fluorescent latex particles.
  • a method for treating a disease or disorder comprising:
  • a ligated-fluorescent nanoparticle which nanoparticle optionally includes a therapeutic agent, wherein the nanoparticle is adapted to selectively associate with a disease producing component of the cell, to form a selectively decorated cell with the ligated-fluorescent nanoparticle;
  • the ligated-fluorescent nanoparticle by itself or as part of a decorated cell, when illuminated can fluoresce, heat-up, or both.
  • the selection of the reactive fluorescent compound in preparing the fluorescent nanoparticle, and the selection of the ligand can be made empirically depending upon the balance of fluorescent and non-fluorescent (heat dissipation) properties desired. Higher fluorescent properties may be desired where detection is paramount or difficult, for example in dilute systems. Higher non-fluorescent properties may be desired where high heating is needed to, for example, promote liberation of a therapeutic agent or to accomplish selective microscopic-cauterization or microscopic-heat therapy.
  • the ligated-fluorescent nanoparticles of the present invention can be used to treat a light- or heat-sensitive diseases or disorders.
  • Light therapy is known for activation of medicaments at one or more treatment sites within a living body.
  • a particular embodiment of light therapy for example, is photodynamic therapy (PDT) which is a two-step treatment process which has been found to be effective in destroying a wide variety of cancers.
  • PDT is performed by first systemically or topically administering a photosensitizer compound or like compounds, and subsequently illuminating a treatment site with light in a waveband, which corresponds to an absorption waveband of the photosensitizer.
  • the light energy activates the photosensitizer compound, causing it to destroy the diseased tissue, see for example, U.S. Pat. No. 6,454,789. It is readily evident to one skilled in the art that a fluorescent material, such as the ligated-fluorescent nanoparticles of the present invention, can be used in place of a photosensitizer compound.
  • Heat therapy methods are also known, for example, to shrink desired tissues, see U.S. Pat. No. 6,480,746, and for localized treatment of cutaneous warts, see Arch. Dermatol , (July 1992), vol. 128, p. 945-948, and to induce macrophage apoptosis, see U.S. Pat. No. 6,451,044.
  • heat therapy can be accomplished within a body or across the skin by means of, for example, irradiation or illumination, such as ultraviolet radiation, infrared radiation, microwave radiation, etc.
  • irradiation or illumination such as ultraviolet radiation, infrared radiation, microwave radiation, etc.
  • the present invention also provides a method of treatment comprising:
  • the amount and the duration of the contacting as well as the amount and the duration of irradiating can depend on, for example, the diagnostic or therapeutic objectives of the treatment method, such as fluorescent detection of a diseased state or condition, the delivery of an effect therapeutic agent, or both.
  • the amount and the duration of the contacting and irradiating can also depend on, for example, the relative concentration ligated-fluorescent nanoparticle to the target analyte, and the state of the cell for treatment, such as in vivo or in vitro whole cells, permeabilized cells, homogenized cells, sensitized cells, and like cell preparations.
  • the ligated-fluorescent nanoparticles of the present invention also have application in diagnostic kits or assays, such as immunoassays, in improved imaging agents, in purification processes, in drugs, for example, treatment regimes and therapies, such as drug delivery to specifically target and shrink tumors or to identify and separate infectious agents, and like applications.
  • the invention provides a kit for use in the detection of an analyte, the kit comprising a ligated-fluorescent nanoparticle, as illustrated herein.
  • the invention also provides a kit for detecting and monitoring a cell surface component comprising a ligated-fluorescent nanoparticle for detecting the cell surface component, and optionally a recorder for monitoring the cell surface component.
  • kits include packaging of the kit component(s) and instructions for use of the kit.
  • the invention also provides an assay method for detecting motion or a change in the location of a cellular component in, or on the surface of, a cell when the cell is treated with a therapeutic agent comprising:
  • the motion or movement of the fluorescent loci that is an analyte bound by a ligated-fluorescent nanoparticle, is representative of and can be correlated to the motion or movement of the bound analyte, such as a cellular component.
  • the assay method for detecting motion or a change in the location of a cellular component can include, for example, optionally mapping or plotting the recorded positions of ligated-fluorescent nanoparticle.
  • the assay method can further comprise determining the difference between the motion or movement of the analyte bound ligated-fluorescent nanoparticle in the presence and absence of the therapeutic agent, for example, in a tandem or control experimental design.
  • the nanoparticles materials such as the ligated-fluorescent nanoparticles, and methods of use of the present invention can be used as, for example, labeled assay reagents or reagent products made therefrom, for assaying the presence of a cell component, for example, an enzyme, a receptor, and like cell components.
  • a cell component for example, an enzyme, a receptor, and like cell components.
  • the location of the cell component can be detected and determined, for example, inside a metabolically active whole cell, in a whole cell lysate, in a permeabilized cell, in a fixed cell, or with a partially purified cell component in a cell-free environment.
  • the ligated-fluorescent nanoparticle contains an associated ligand or ligator, such as an antibody, which nanoparticle targets or associates with a specific cell component of interest.
  • the ligated-fluorescent nanoparticle also contains a fluorescent label or fluorescent component in the nanoparticle core, which fluorescent component marks or reports on the presence of the target cell component when the nanoparticle and the target cell component are associated and appropriately illuminated or irradiated.
  • the invention also provides methods for treating a disease by administration of an effective amount of a linked fluorescent nanoparticles.
  • the methods may involve administration of a linked fluorescent nanoparticles as described herein, alone, in a pharmaceutical composition, or in combination with other therapeutic agents or pharmaceutical compositions.
  • the invention also provides methods to increase the effectiveness of a therapeutic agent by linking the therapeutic agent to a fluorescent nanoparticle.
  • the fluorescent nanoparticles and pharmaceutical compositions thereof may also be used to associate therapeutic agents to increase the therapeutic efficiency of the therapeutic agent.
  • Conjugation of a fluorescent nanoparticle with a ligand to form a linked- or ligated-fluorescent nanoparticle is preferably accomplished in vitro where, for example, ligand amounts and conditions can be carefully controlled to produce a product of high purity and high quality.
  • modifying the linked fluorescent nanoparticle with a therapeutic agent is preferably accomplished in vitro.
  • the present invention provides fluorescent nanoparticles and ligated-fluorescent nanoparticle thereof, and methods for their use in, for example, immunolabeling, sub-cellular recognition procedures, diagnostics, or cell sorting.
  • the methods of the present invention provide advantages which overcome shortcomings of known methodologies and as illustrated herein.
  • the present invention provides ligated-fluorescent nanoparticles which are highly dispersible, and are useful, for example, in improved methods for chemical and biochemical analysis, such as, the detection of biological analytes including micro-organisms or sub-cellular components.
  • the ligated-fluorescent nanoparticle can provide high local concentrations of fluorescent material because of their high target selectively or affinity, and because of their enhanced brightness compared to known fluorescent particles.
  • the fluorescent material is present throughout the nanoparticle core and not simply as a surface coating material as in many conventional materials.
  • a “therapeutic agent” is a substance that may be used in the diagnosis, cure, mitigation, treatment, or prevention of disease in a human or another animal.
  • Such therapeutic agents include substances recognized in the official United States Pharmacopeia, official Homeopathic Pharmacopeia of the United States, official National Formulary, or any supplement thereof.
  • Therapeutic agents that can be incorporated with the fluorescent nanoparticles or the ligated-fluorescent nanoparticles of the invention include nucleosides, nucleoside analogs, oligopeptides, polypeptides, COX-2 inhibitors, apoptosis promoters, urinary tract agents, vaginal agents, vasodilators neurodegenerative agents (e.g., Parkinson's disease), obesity agents, ophthalmic agents, osteoporosis agents, para-sympatholytics, para-sympathometics, antianesthetics, prostaglandins, psychotherapeutic agents, respiratory agents, sedatives, hypnotics, skin and mucous membrane agents, anti-bacterials, anti-fungals, antineoplastics, cardioprotective agents, cardiovascular agents, anti-thrombotics, central nervous system stimulants, cholinesterase inhibitors, contraceptives, dopamine receptor agonists, erectile dysfunction agents, fertility agents, gastrointestinal agents, gout agents
  • Examples of specific therapeutic agents that can be linked, ligated, or associated with the fluorescent nanoparticles of the invention are flomoxef; fortimicin(s); gentamicin(s); glucosulfone solasulfone; gramicidin S; gramicidin(s); grepafloxacin; guamecycline; hetacillin; isepamicin; josamycin; kanamycin(s); flomoxef; fortimicin(s); gentamicin(s); glucosulfone solasulfone; gramicidin S; gramicidin(s); grepafloxacin; guamecycline; hetacillin; isepamicin; josamycin; kanamycin(s); bacitracin; bambermycin(s); biapenem; brodimoprim; butirosin; capreomycin; carbenicillin; carbomycin; carum
  • streptozocin doxorubicin; daunorubicin; plicamycin; idarubicin; mitomycin C; pentostatin; mitoxantrone; cytarabine; fludarabine phosphate; butorphanol; nalbuphine.
  • a “pharmaceutical composition” includes a therapeutic agent as exemplified herein in combination with a fluorescent nanoparticle of the invention, for example, where the fluorescent nanoparticle can act as the pharmaceutically acceptable carrier.
  • a pharmaceutical composition of the present invention in addition to a therapeutic agent combination with a fluorescent nanoparticle, can be formulated into or with other acceptable carriers or dosage forms, such as, a solid, gelled or liquid diluent or an ingestible capsule.
  • the pharmaceutical compositions of the invention, the salts thereof, or a mixture thereof may be administered orally in the form of a suitable pharmaceutical unit dosage form.
  • the pharmaceutical compositions of the invention may be prepared in many forms that include tablets, hard or soft gelatin capsules, aqueous solutions, suspensions, and liposomes and other slow-release formulations, such as shaped polymeric gels.
  • Oral liquid pharmaceutical compositions may be in the form of, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or may be presented as a dry product for constitution with water or other suitable vehicle before use.
  • Such liquid pharmaceutical compositions may contain conventional additives such as suspending agents, emulsifying agents, non-aqueous vehicles (which may include edible oils), or preservatives.
  • the nanoparticle pharmaceutical compositions of the invention may also be formulated for parenteral administration (e.g., by injection, for example, bolus injection or continuous infusion) and may be presented in unit dosage form in ampules, pre-filled syringes, small volume infusion containers or multi-dose containers with an added preservative.
  • the pharmaceutical compositions may take such forms as suspensions, solutions, or emulsions in oily or aqueous vehicles, and may contain formulatory agents such as suspending, stabilizing and/or dispersing agents.
  • the pharmaceutical compositions of the invention may be in powder form, obtained by aseptic isolation of sterile solid or by lyophilization from solution, for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use.
  • the pharmaceutical compositions may be formulated as ointments, creams or lotions, or as the active ingredient of a transdermal patch.
  • Suitable transdermal delivery systems are disclosed, for example, in A. Fisher et al. (U.S. Pat. No. 4,788,603), or R. Bawa et al. (U.S. Pat. Nos. 4,931,279; 4,668,506; and 4,713,224).
  • Ointments and creams may, for example, be formulated with an aqueous or oily base with the addition of suitable thickening and/or gelling agents.
  • Lotions may be formulated with an aqueous or oily base and will in general also contain one or more emulsifying agents, stabilizing agents, dispersing agents, suspending agents, thickening agents, or coloring agents.
  • the pharmaceutical compositions can also be delivered via ionophoresis, e.g., as disclosed in U.S. Pat. Nos. 4,140,122; 4,383,529; or 4,051,842.
  • compositions suitable for topical administration in the mouth include unit dosage forms such as lozenges comprising a pharmaceutical composition of the invention in a flavored base, usually sucrose and acadia or tragacanth; pastilles comprising the pharmaceutical composition in an inert base such as gelatin and glycerin or sucrose and acacia; mucoadherent gels, and mouthwashes comprising the pharmaceutical composition in a suitable liquid carrier.
  • unit dosage forms such as lozenges comprising a pharmaceutical composition of the invention in a flavored base, usually sucrose and acadia or tragacanth
  • pastilles comprising the pharmaceutical composition in an inert base such as gelatin and glycerin or sucrose and acacia
  • mucoadherent gels such as mucoadherent gels
  • mouthwashes comprising the pharmaceutical composition in a suitable liquid carrier.
  • the pharmaceutical compositions can be administered as drops, gels (S. Chrai et al., U.S. Pat. No. 4,255,415), gums (S. L. Lin et al., U.S. Pat. No. 4,136,177) or via a prolonged-release ocular insert (A. S. Michaels, U.S. Pat. No. 3,867,519 and H. M. Haddad et al., U.S. Pat. No. 3,870,791).
  • compositions can be adapted to give sustained release of a therapeutic compound employed, e.g., by combination with certain hydrophilic polymer matrices, e.g., comprising natural gels, synthetic polymer gels or mixtures thereof.
  • compositions suitable for rectal administration wherein the carrier is a solid are most preferably presented as unit dose suppositories.
  • Suitable carriers include cocoa butter and other materials commonly used in the art, and the suppositories may be conveniently formed by admixture of the pharmaceutical composition with the softened or melted carrier(s) followed by chilling and shaping in molds.
  • compositions suitable for vaginal administration may be presented as pessaries, tampons, creams, gels, pastes, foams or sprays containing, in addition to the nanoparticles and the therapeutic agent, such carriers are well known in the art.
  • the pharmaceutical compositions according to the invention are conveniently delivered from an insufflator, nebulizer or a pressurized pack or other convenient means of delivering an aerosol spray.
  • Pressurized packs may comprise a suitable propellant such as dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane, carbon dioxide or other suitable gas.
  • the dosage unit may be determined by providing a valve to deliver a metered amount.
  • the pharmaceutical compositions of the invention may take the form of a dry powder composition, for example, a powder mix of the pharmaceutical composition and a suitable powder base such as lactose or starch.
  • the powder composition may be presented in unit dosage form in, for example, capsules or cartridges or, e.g., gelatin or blister packs from which the powder may be administered with the aid of an inhalator or insufflator.
  • the pharmaceutical compositions of the invention may be administered via a liquid spray, such as via a plastic bottle atomizer.
  • a liquid spray such as via a plastic bottle atomizer.
  • mistometer® isoproterenol inhaler-Wintrop
  • Medihaler® isoproterenol inhaler—Riker.
  • compositions of the invention may also contain other adjuvants such as flavorings, colorings, anti-microbial agents, or preservatives.
  • the amount of the pharmaceutical compositions required for use in treatment will vary not only with the particular salt selected but also with the route of administration, the nature of the condition being treated and the age and condition of the patient and will be ultimately at the discretion of the attendant physician or clinician.
  • the amount of a therapeutic agent in combination with ligated-fluorescent nanoparticles of the invention which can be administered and the frequency of administration to a given human patient will depend upon a variety of variables related to the patient's psychological profile and physical condition. For evaluations of these factors, see J. F. Brien et al., Europ. J. Clin. Pharmacol., 14, 133 (1978); and Physicians' Desk Reference, Charles E. Baker, Jr., Pub., Medical Economics Co ., Oradell, N.J. (41st ed., 1987). Generally, the dosages of the therapeutic agent when used in combination with the ligated-fluorescent nanoparticles of the present can be lower than when the therapeutic agent is administered alone or in conventional pharmaceutical dosage forms.
  • the high specificity of the ligated-fluorescent nanoparticle for a target site can provide relatively high localized concentrations of a therapeutic agent, or alternatively, a sustained release of a therapeutic agent over an extended time period.
  • “Pharmaceutically acceptable salts” of the ligated-fluorescent nanoparticles and the therapeutic agents of the invention can include, but are not limited to, the nontoxic addition salts with organic and inorganic acids, such as the citrates, bicarbonates, malonates, tartrates, gluconates, hydrochlorides, sulfates, phosphates, and like salts. Additionally, in cases where the nanoparticles are sufficiently basic or acidic to form stable acid or base salts, preparation of the nanoparticles as salts may be appropriate.
  • acceptable salts are organic acid addition salts formed with acids which form a acceptable anion, for example, tosylate, methanesulfonate, acetate, citrate, malonate, tartarate, succinate, benzoate, ascorbate, ⁇ -ketoglutarate, and ⁇ -glycerophosphate.
  • Suitable inorganic salts may also be formed, including hydrochloride, sulfate, nitrate, bicarbonate, and carbonate salts.
  • Acceptable salts may be obtained using standard procedures known in the art, for example by reacting a sufficiently basic compound such as an amine with a suitable acid affording a diagnostically acceptable anion.
  • Alkali metal e.g., sodium, potassium or lithium
  • alkaline earth metal e.g. calcium
  • Receptor is any macromolecular compound or composition capable of recognizing (e.g. such as having an enhanced binding affinity to) a particular spatial and polar organization of a molecule, i.e., epitopic or determinant site.
  • Illustrative receptors include naturally occurring receptors, e.g., thyroxine binding globulin, antibodies, enzymes, immunoglobulin (Fab) fragments, lectins, various proteins found on the surface of cells (cluster of differentiation or CD molecules), and the like.
  • CD molecules denote known and unknown proteins on the surface of eukaryotic cells, for example, CD4 is the molecule that primarily defines helper T lymphocytes.
  • “Haptens” can include naturally occurring hormones, naturally occurring drugs, synthetic drugs, pollutants, allergens, affector molecules, growth factors, chemokines, cytokines, lymphokines, amino acids, oligopeptides, chemical intermediates, nucleotides, oligonucleotides, and the like.
  • the use for such compounds may be in the detection of drugs of abuse, therapeutic dosage monitoring, health status, donor matching for transplantation purposes, pregnancy (e.g., hCG or alpha-fetoprotein), detection of disease, e.g. endotoxins, cancer antigens, pathogens, and the like.
  • Immunoconjugate is a molecule formed by attachment of two different molecules or entities, such as an antibody ligated to a fluorescent nanoparticle, and a second usually biologically active molecular entity (analyte) such as an organic drug molecule, a radionuclide, an enzyme, a toxin, a protein, and like materials that can be conjugated to the antibody to form the conjugate.
  • analyte such as an organic drug molecule, a radionuclide, an enzyme, a toxin, a protein, and like materials that can be conjugated to the antibody to form the conjugate.
  • the antibody portion directs or guides the attached fluorescent nanoparticle to the target analyte enabling the fluorescent nanoparticle to efficiently produce a biological or marking effect.
  • Pathogens of interest can be, for example, viruses such as Herpesviruses, Poxviruses, Togaviruses, Orthomyxoviruses, Paramyxoviruses, Rhabdoviruses, Coronaviruses, Arenaviruses, and Retroviruses.
  • viruses such as Herpesviruses, Poxviruses, Togaviruses, Orthomyxoviruses, Paramyxoviruses, Rhabdoviruses, Coronaviruses, Arenaviruses, and Retroviruses.
  • Pathogens also include prions and bacteria including but not limited to Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Staphylococcus aureus, Enterococcus faecalis, Klebsiella pneumoniae, Salmonella typhimurium, Staphylococcus epidermidis, Serratia marcescens, Mycobacterium bovis , methicillin resistant Staphylococcus aureus and Proteus vulgaris .
  • a non-exhaustive list of these organisms and associated diseases can be found, for example, in U.S. Pat. No. 5,795,158.
  • Assays using nanoparticles of the invention can be carried out in a biological fluid, including separated or unfiltered biological fluids such as urine, cerebrospinal fluid, pleural fluid, synovial fluid, peritoneal fluid, amniotic fluid, gastric fluid, blood, serum, plasma, lymph fluid, interstitial fluid, tissue homogenate, cell extracts, saliva, sputum, stool, physiological secretions, tears, mucus, sweat, milk, semen, vaginal secretions, fluid from ulcers and other surface eruptions, blisters, abscesses, and extracts of tissues including biopsies of normal, malignant, and suspect tissues or any other constituents of the body which may contain the analyte of interest.
  • biological fluids such as urine, cerebrospinal fluid, pleural fluid, synovial fluid, peritoneal fluid, amniotic fluid, gastric fluid, blood, serum, plasma, lymph fluid, interstitial fluid, tissue homogenate, cell extracts, saliva, sputum, stool, physiological secret
  • test sample can be obtained from an environmental source, such as soil, water, or air; or from an industrial source such as taken from a waste stream, a water source, a supply line, or a production lot.
  • Industrial sources also include fermentation media, such as from a biological reactor or food fermentation process such as brewing; or foodstuff, such as meat, game, produce, or dairy products.
  • the test sample can be pre-treated prior to use, such as preparing plasma from blood, diluting viscous fluids, and the like; methods of pretreatment can involve filtration, fractionation, distillation, concentration, inactivation of interfering compounds, and addition of reagents, and like steps, or combinations thereof.
  • Methods for detecting multiple subpopulations of analytes are known, see for example, U.S. Pat. No. 5,567,627, to Lehnen, and can be adapted to the present invention.
  • Methods for detecting a nucleic acid with one or more nanoparticle having oligonucleotides attached thereto including an electrochemical assay with a probe oligonucleotide having attached a redox-active molecule, for example as in U.S. Pat. No. 6,417,340, to Mirkin, et al, can be adapted to the present invention.
  • the nanoparticle's fluorescent component should provide a signal related to the presence of analyte in the sample.
  • a ligand which includes a fluorescent nanoparticle, it should provide a fluorescent signal related to the presence of analyte in the sample and which signal can be detected as electromagnetic radiation, particularly as radiation in the ultra-violet, visible or infrared range.
  • “Optional” or “optionally” mean that the subsequently described event or condition may but need not occur, and that the description includes instances where the event or condition occurs and instances in which it does not.
  • “optionally including” means that the named component may be present but need not be present, and the description includes situations where the named component is included and situations where the named component is not included.
  • a fluorescent nanoparticle of the invention can be prepared, for example, mixing a reactive fluorescent compound, such as, a reactive fluorescent material, such as a dye (D) and a co-reactive organo-silane compound such as, a known organo-functional silane compound (OS) to form a fluorescent core particle (D-OS); and mixing the resulting core particle (D-OS) with a silica forming compound, such as a (Si(OR) 4 ), to form a silica shell on the core which product is a fluorescent nanoparticle (D-OS)(SiO 2 ).
  • a reactive fluorescent compound such as, a reactive fluorescent material, such as a dye (D) and a co-reactive organo-silane compound such as, a known organo-functional silane compound (OS)
  • OS organo-functional silane compound
  • the molar equivalent ratio of the reactive fluorescent material (D) and the co-reactive organo-silane compound (OS) can be, for example, from about 1:1 to about 1:100.
  • the molar equivalent ratio of the fluorescent core particle (D-OS) to the silica forming compound (Si(OR) 4 ) can be, for example, from about 1:1 to about 1:100.
  • the nanoparticles of the present invention can be selectively linked to either or both a ligand and analyte by, for example, any known chemical coupling reactions such as carbodiimide coupling.
  • Other coupling methods include use of carboxylates, esters, alcohols, carbamides, aldehydes, amines, sulfur oxides, nitrogen oxides, or halides, and other methods known in the art can be used.
  • Coupling a fluorescent nanoparticle to a ligand, or a ligated-fluorescent nanoparticle to an analyte, and like combinations can generally be accomplished by applying the procedures and principles disclosed in U.S. Pat. No. 6,268,222, or other procedures known in the art as applied to the present invention.
  • linked-fluorescent nanoparticle such as a surface modified fluorescent nanoparticle of the invention
  • a surface modified fluorescent nanoparticle of the invention can be prepared, for example, from a preformed fluorescent nanoparticle fluorescent nanoparticle (D-OS)(SiO 2 ) and a ligand, such as a biologically active compound (of formula X 1 -R 1 -X 2 ), and optionally a linker precursor (of formula Z 1 -L-Z 2 ), wherein X 1 , X 2 , Z 1 , and Z 2 can be selected from the values in the table below.
  • a linker precursor of formula Z 1 -L-Z 2
  • the ligand and the linker precursor can be reacted or polymerized using well known synthetic techniques (e.g. by condensation) to provide a ligated-fluorescent nanoparticle or linked product of the invention.
  • a corresponding functional group (Z 1 or Z 2 ) can be selected from the following table, to provide an ester linkage, thioester linkage, or amide linkage in the ligated-fluorescent nanoparticle or linked product.
  • suitable protecting groups can be used during the ligation reaction.
  • other functional groups present in the biologically active compound, on the nanoparticle surface, or the linker precursor can be partially or completely protected during ligation, and the protecting groups can subsequently be removed to provide the ligated-fluorescent nanoparticles of the invention.
  • Suitable protecting groups and methods for their incorporation and removal are well known in the art (see for example Greene, T. W.; Wutz, P. G. M. “Protecting Groups In Organic Synthesis” second edition, 1991, New York, John Wiley & sons, Inc.).
  • carboxylic acid when a carboxylic acid is reacted with a hydroxy group, a mercapto group, or an amine group to provide an ester linkage, thioester linkage, or an amide linkage, the carboxylic acid can be activated prior to the reaction, for example, by formation of the corresponding acid chloride.
  • Numerous methods for activating carboxylic acids, and for preparing ester linkages, thioester linkages, and amide linkages, are known in the art (see for example, Advanced Organic Chemistry: Reaction Mechanisms and Structure, 4th ed., Jerry March, John Wiley & Sons, pages 419-437 and 1281).
  • the silica shell surface of the nanoparticles can be further modified if desired by, for example, surface functionalization reactions using known cross-linking agents to afford surface functional groups and as illustrated herein.
  • Crosslinking agents are, for example, divinyl benzene, ethylene glycol dimethacrylate, trimethylol propane trimethacrylate, N,N′-methylene-bis-acrylamide, alkyl ethers, sugars, peptides, DNA fragments, or other known functionally equivalent agents. It is readily evident to one skilled in the art that many cross-linking agents can be used in combination with, or suitable for use as the ligand in forming ligated-fluorescent nanoparticles of present invention. It is readily evident to one skilled in the art in possession of the present invention that cross-linking agents can be used in surface modifying reactions to modify the surface properties of fluorescent nanoparticles, or ligated-fluorescent nanoparticles, and as illustrated herein.
  • Amounts of water, ammonia and solvent were measured in graduated cylinders. Fluorescent seed particle synthesis was carried out in 1 L Erlenmeyer flasks and stirred with magnetic TEFLON® coated stir bars at about 600 rpm. De-ionized water and ammonia solution were added to ethanol and stirred. About 2 mL of the reactive dye precursor in either ethanol or THF containing about 425 micromolar APTS, was added to the reaction vessel. The resulting mixture was stirred for about 1 to about 3 hours at room temperature with the reaction vessel covered with aluminum foil to minimize exposure to light to afford a fluorescent seed particle mixture. Tetrahydrofuran (THF) and absolute ethanol (EtOH) were distilled under nitrogen. Organic dyes were brought to room temperature from storage temperatures of about ⁇ 20° C., then placed in a glove box.
  • the silica shell coating and growth step was performed in the above mentioned fluorescent seed particle reaction mixture with regular addition of solvent, such as ethanol, methanol, or isopropanol, to prevent drastic changes in solution ionic strength while the silica forming monomer tetraethoxysilane (TEOS) was added. This prevents particle aggregation during synthesis, which can broaden the particle size distribution.
  • solvent such as ethanol, methanol, or isopropanol
  • FIG. 1A there is illustrated an example of fluorescent brightness properties of the fluorescent nanoparticles (10) of the present invention compared to polystyrene latex beads (20).
  • Fluorescence correlation spectroscopy FCS was used to obtain the count rates for the nanoparticles and beads as follows: 100 or 300 nanometer fluorescent nanoparticles had 299.1 kHz per particle; and 300 nanometer polystyrene latex beads had 69.84 kHz per bead. Fluorescence count rates indicated that the fluorescent nanoparticles (10) were about four times brighter than the polystyrene latex beads.
  • Photo-physical characterizations were performed to determine: dye content per particle content, fluorescence lifetimes, and action cross-sections.
  • the action cross-section metric is essentially the product of quantum yield and absorbance profile. Time resolved fluorescence measurements of fluorescence versus time in nanoseconds (ns) showed that a dye incorporated in a nanoparticle exhibited a longer lifetime than free dyes in solution, indicating that each dye molecule could be about 46% brighter when contained inside the core of the nanoparticles than when free in solution.
  • TRITC dyes contained within the core of the nanoparticle had a fluorescence lifetime of about 3.33 ns, compared to TRITC dyes free in solution which had a fluorescence lifetime of about 2.28 ns.
  • Alexa Fluor® 488 carboxylic acid 5 mg was dissolved in THF.
  • the molar ratio of 3-Aminopropyltriethoxysilane (APTS) to Alexa Flour® 488 carboxylic acid, succinimidyl ester was 100 to 1, with 2 ml of THF per mg of APTS.
  • APTS 3-Aminopropyltriethoxysilane
  • APTS was added to the reaction vessel and stirred for 12 hours in darkness at room temperature. Due to the minute quantities, the fluorescent dye-core adducts were not isolated from the reaction medium before the silica shell was deposited.
  • TEOS was added in small aliquots intermittently, such as 300 microliters in about 10 to 15 minute intervals, and stirred overnight at room temperature in darkness. Molar ratio of de-ionized water to monomer was kept maintained at about at least 6-fold but not more. To better monitor water content in the reaction mixture, 2.0 M ammonia was used as the catalyst source, dissolved in ethanol, methanol or isopropanol, depending on the primary solvent of the synthesis, such as 2.0 M ammonia in ethanol.
  • tetraethyl orthosilicate monomer was added intermittently, such as 300 microliters every 10 minutes to grow the siliceous shell.
  • the smaller particle size procedure for particles below about 70 nm
  • the TEOS monomer was added intermittently.
  • the alternative procedure for preparing silica shell coated fluorescent nanoparticles was devised because the size distribution of silica nanoparticles prepared by the known Stöber procedure (J. Colloid and Interface Sci., 26 62-69 (1968)) has a self-sharpening characteristic as particle size increases beyond 70 nm as more monomer is added to the reaction mixture.
  • silica nanoparticles smaller than 70 nm generally have a much broader size distribution. Therefore, the first mentioned procedure of Example 3, was modified as described thereafter to obtain nanoparticles with a narrower size distribution than what might be expected for particle sizes in the range of about 10 to about 70 nm.
  • Nanoparticle Ligation (coupling) with IgE by Adsorption Silica coated fluorescent nanoparticles of Example 3 were diluted (1: 10-1:20) with phosphate buffered saline (PBS) or Tyrodes buffer at pH 7.
  • Immunoglobulin E (IgE) (0.85 mg/mL stock concentration) was adsorbed onto the fluorescent nanoparticles by incubating with IgE for about 3 hours at room temperature to provide, for example, nanoparticle-IgE ratios of from about 1:1 to about 1:4. For nanoparticles greater than about 50 nm, unbound IgE was removed by centrifugation.
  • the unbound IgE was removed by adding 100 microliters (in a total volume of 500 microliters nanoparticles-IgE) of 0.25 wt % latex particles of size 1:2 microns. Unbound IgE stuck to the large latex particles which then settled out of suspension if undisturbed in several hours, for example, with overnight incubation at 4° C. The residual pellet mass was confirmed to be primarily latex particles bound with IgE and discarded. The resulting supernatant containing the IgE coupled-nanoparticle (IgE ligated-fluorescent nanoparticle) was carefully separated and placed in a vial.
  • the resulting IgE coupled-nanoparticle samples (i.e. IgE adsorbed onto nanoparticles) were stored at 4° C. for cell binding experiments.
  • the IgE coupled nanoparticles were diluted in Tyrodes-BSA before cell binding. The dilution was according to the IgE coupled-nanoparticle number density desired per cell.
  • Nanoparticle Surface Functionalization The surface of the nanoparticles can be further chemically modified to improve the versatility and stability of the nanoparticles, for example, introducing carboxylic acid groups or like chemical functional groups.
  • Introducing functional groups, such as carboxylic acid groups, to the surface of silica coated nanoparticles can provide attachment points to enable covalent attachment of bio-molecules, for example, proteins and antibodies, to the surface of the nanoparticles.
  • Surface functional groups, especially ionizable groups provide other desirable properties to the nanoparticles, such as charge stabilization in buffered media. Charged carboxylate surface groups can maintain the nanoparticles as single particle colloidal dispersions which avoid or minimize nanoparticle agglomeration.
  • Nanoparticle surface functionalization procedures are known and include, for example, carbodiimide modification and as illustrated herein.
  • APDMES 3-aminopropyldimethylethoxysilane
  • MSA Methyl N-succinimidyl adipate
  • Nanoparticle surface functionalization was accomplished as follows. A 20 mL suspension of nanoparticles with a diameter of 25 nm, as described in Table I, was used. The nanoparticle concentration was 4.33 mg/mL as determined by fluorescence correlation spectroscopy, and by drying and weighing known volumes of the suspension. Other nanoparticle sizes and concentrations can be surface modified according to this procedure when appropriately adapted in view of differences in particle size, surface area, concentration, and like considerations.
  • Fluorescent nanoparticles having a silica shell were cleaned by dialysis after their initial preparation described above.
  • concentration of the silica shelled nanoparticle suspension was determined by drying aliquots of the nanoparticle suspension in a vacuum oven and weighing, or by fluorescence correlation spectroscopy. Assuming a density of 2 g/mL and knowing the size of the nanoparticles, the number of particles per mL of suspension was calculated to be about 1.78 ⁇ 10 16 .
  • the density of silanol groups can be estimated as about 1.4 —OH groups per square nanometer according to literature values (e.g. R.
  • APDMES The Chemistry of Silica ), and hence there is about 7.78 ⁇ 10 ⁇ 5 moles of —OH groups available for reaction with APDMES for 100% amine coverage.
  • APDMES was added in a 2 molar excess with about 5 mg of ammonium fluoride as a catalyst, and allowed to react for about 12 hours at ambient temperature and shielded from ambient light. Excess unreacted APDMES was dialyzed away in phosphate buffer at pH 7 over 12 hours. The resulting aminated nanoparticles suspended in phosphate buffer pH 7 were then reacted with 2-molar excess of MSA dissolved in dimethyl sulfoxide at ambient temperature for about 2 to 6 hours.
  • the nanoparticle products at each functionalization step described above were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy.
  • FTIR Fourier Transform Infra-Red
  • the vibration bands of the mono-substituted amide groups at 1500-1600 cm ⁇ 1 indicated the linkage between amine groups of the silane compound APDMES and the succinimidyl ester groups of the MSA compound, as well as the carboxylic acid signature at 1700 cm ⁇ 1 .
  • the observed spectroscopic changes compared to the starting nanoparticles were indicative of successful surface functionalization reactions.
  • Nanoparticle Ligation (coupling) by Covalent Conjugation Other surface functionalization examples can be accomplished by covalent conjugation of fluorescent nanoparticles with various biomolecules as described above.
  • Confocal microscope images showed, for example, the top surface of the cells decorated with the red nanoparticles, and the antibody IgE is labeled with a green fluorophore to show co-localization of the antibody with the nanoparticles.
  • Another set of images, taken from the equitorial view of the cells showed an alternative confocal view where diffusive motions of the antibody receptors marked by the fluorescent nanoparticles can be monitored via SPT. Appropriate controls were performed to check for non-specific binding as follows. Control cells were pre-sensitized overnight using IgE, so that all the receptor sites were blocked.
  • FIGS. 2A and 2B there is illustrated an example of high biomolecular binding specificity of, for example, 100 or 300 nanometer diameter fluorescent nanoparticles of the present invention (FIG. 2A) compared to polystyrene latex beads (FIG. 2B) as measured by cell counting statistics.
  • rat basophilic leukemia (RBL) mast cells coupled with IgE coupled-nanoparticles and cells coupled with polystyrene latex beads are comparable whereas less desirable or undesired non-specific interactions (represented by the right-side of the bar pairs), such as “sticking” interactions, were greater for polystyrene latex beads and cells compared to IgE coupled-nanoparticles and cells.
  • RBL basophilic leukemia
  • IgE M refers to mouse IgE which will bind specifically to IgE receptors of rat basophilic leukemia (RBL) mast cells;
  • control: IgE H refers to human IgE which will not bind to IgE receptors of the aforementioned rat cells
  • control: particles alone refers to the respective binding of IgE coupled-fluorescent nanoparticles with cells, and binding of polystyrene latex beads with cells.
  • SPT Single fluorescent nanoparticle Tracking
  • Single particle tracking evaluates lateral diffusion of individual components on cell surfaces. This method is based on direct observation of bright fluorescent probes that are specifically conjugated to macromolecules of interest. Tracking of individual components reveals a variety of interesting and useful behaviors including confinement to a small region or movement along a track. This information enables an understanding of how components interact within cells, on cell membranes and like structures or components. However, the method is highly dependent on the quality of the probes. A significant shortcoming of the method has been nonspecific binding of the particles to cells.
  • the fluorescent nanoparticles and the ligated-fluorescent nanoparticles of the present invention provide enhanced brightness and high conjugation specificity to a component of interest. The ligated-fluorescent nanoparticles were demonstrated to be biocompatible and minimize non-specific binding interactions.
  • the HDTB serves as a templating agent around which the silica shell's formation is ordered and perturbed to enable pore formation by subsequent removal of the HDTB associated with the surface. Subsequent cleaning or removal of the HDTB from the nanoparticle provides fluorescent nanoparticles having a mesoporous silica shell.
  • a vacuum distillation was carried out to exchange ethanol solvent with dimethyl sulfoxide (DMSO). Final concentrations were determined by drying an aliquot of the suspension and weighing the solid mass. The resulting meso-porous nanoparticles in DMSO were suitable for loading therapeutic agent as illustrated below.
  • DMSO dimethyl sulfoxide
  • Sonication was done at 15% power with a pulse rate of 1.0 second on and 1.0 second off for 30 seconds of pulsing or until the solution appeared homogenous. The centrifugation was done at 25° C. at 3,000 rpm for 5 minutes. Therapeutic agent loaded particles were stored at room temperature.

Abstract

The present invention provides nanoparticle compositions comprising, for example, a core comprising a fluorescent silane compound; and a silica shell on the core. Also provided are methods for the preparation of nanoparticle compositions including fluorescent nanoparticles, ligated-fluorescent nanoparticles, ligated-fluorescent nanoparticles having therapeutic agents, and ligated-fluorescent nanoparticles coupled or associated with an analyte. Also provided are methods: for the detection of the ligated-fluorescent nanoparticles; for associating the linked-fluorescent nanoparticles with a cellular component of interest and recording or monitoring the movement of the cellular component; for improving the therapeutic properties of the therapeutic agent by combining the therapeutic agent with linked-fluorescent nanoparticles and contacting or administering the combination to a cell or organism; for making and using the fluorescent nanoparticles in, for example, diagnostic agents for the detection of various analytes, and like applications.

Description

    FIELD OF THE INVENTION
  • The invention generally relates to nanoparticles, and more specifically to ligated-fluorescent nanoparticles, methods of making ligated-fluorescent nanoparticles, and methods of using the ligated-fluorescent nanoparticles as biomarkers to, for example, monitor the motion or movement of cellular components on or within cell systems, and for the detection, diagnosis, or treatment of diseases or conditions, for example in intact or living cells. [0001]
  • BACKGROUND OF THE INVENTION
  • Fluorescent and magnetic polymeric particles have known utility as markers and indicators in various biomedical assays. Among the most commonly used markers for sorting cells are immunoconjugates or immunological labels which include, for example, immuno-fluorescent and immuno-magnetic labels. Immunofluorescent labels typically include, for example, a fluorescent molecule joined to an antibody. Immuno-magnetic labels typically include, for example, a superparamagnetic particle joined to either a primary or secondary antibody. Cell labeling can be performed by, for example, attaching the antibody to a marker of interest (e.g., receptor site) on the surface of the cell, that is, a cell surface marker. However, the chemical and physical structure of cell surface marker and density of immunological labels attached to the cell surface have generally been difficult to accurately determine. [0002]
  • Fluorescent labels have been prepared, for example, by embedding or covalently coupling a fluorescent dye onto a polymeric particle. The resulting fluorescent microparticles can be analyzed manually or by other methods known in the art but preferably using an automated technique, e.g., flow cytometry, such as disclosed in U.S. Pat. No. 4,665,024, to Mansour, et al. The versatility of the fluorescent particles can be further enhanced by the incorporation of multiple fluorescent materials in a single particle. However, while simple absorption of a single dye into a particle can be adequate for most purposes, problems can arise when more than one dye is absorbed into a particle, including: inconsistent emissions attributable to, for example, intermolecular fluorescent energy transfer; differential fluorophore uptake ratios attributable to different dye solubilities within the polymeric matrix; and substrate induced changes in either or both the absorption and emission spectrum of the intercalated fluorophore. [0003]
  • Magnetic particles, such as known magnetically active materials, can be bonded or attached to, for example, antibodies, such as, monoclonal antibodies that are specific to a particular cell type, antigen, or other targets. The resulting magnetic-antibodies can then be mixed with a large population of many different cell types, for example, crude tissue samples, cells grown in a reactor, and the like. The magnetic-antibodies therefore attach only to their pre-selected target cell type, forming a magnetic-antibody-cell conjugate. The conjugate can then be separated from the rest of the cell population using a magnetic field. A shortcoming of magnetic particles is the lack of specificity in magnetic labeling in that a cell or other biological target analyte may be rendered paramagnetic by a number of different routes which can confound the analysis and diagnostic information afforded by the method, for example, by binding a specific paramagnetic compound to a specific hapten on a cell or by specific or non-specific binding of a paramagnetic metal or metal complex directly to a cell, such as, a metal binding microorganism or by phagocytosis. Other problems encountered with magnetic particles used in detection and diagnostics include, for example, difficulty in obtaining highly accurate quantification of a cell population's magnetic susceptibility. In addition to their magnetic properties (i.e. magnetic, paramagnetic, and superparamagnetic) magnetic-antibodies can be classified, for example, into three broad categories based on their relative descending particle size: magnetic particulate labels, colloidal magnetic labels, and molecular magnetic labels, see for example U.S. Pat. No. 6,412,359. [0004]
  • Latex nanoparticles having a polymeric core and a surface decorated with, for example, a ligand molecule capable of specific binding with a cell surface and optionally decorated with genetic material, such as a mutant gene, are known and may have utility in, for example, gene delivery to a cell and expression therein, for disrupting tumors, and related treatment applications, see for example, [0005] Science, 296, 2404 (2002).
  • Optically active nanoparticles, such as fluorescent nanoparticles, having an electrically conducting shell and a silica core are known and have utility in, for example, modulated delivery of a chemical and treatment applications, see for example, U.S. Pat. No. 6,344,272, and 6,428,811. [0006]
  • A shortcoming of existing fluorescent probe nanoparticles is their limited brightness and their attenuated detectability as fluorescent probes in dispersed systems, particularly with single fluorescent nanoparticles. [0007]
  • There is currently a need for improved fluorescent nanoparticles and methods for detection and analysis therewith, including their use as fluorescent markers or probes in dispersed biological media. [0008]
  • SUMMARY OF THE INVENTION
  • The invention provides a fluorescent nanoparticle comprising: a core comprising a fluorescent silane compound; and a silica shell on the core. [0009]
  • The invention also provides a fluorescent nanoparticle comprising: [0010]
  • a core comprising a fluorescent silane compound; and a porous silica shell on the core. [0011]
  • The invention also provides a fluorescent nanoparticle which can further include a ligand, such as a antibody, conjugated with or coated on the surface of the fluorescent nanoparticle to form a ligated-fluorescent nanoparticle. The ligated- or ligand bearing-fluorescent nanoparticles of the present invention can be used, for example, as highly target specific diagnostic agents, and motion monitoring agents when combined with cells or cell components. [0012]
  • The invention also provides a pharmaceutical carrier or drug delivery vehicle comprising the fluorescent nanoparticles or the ligated-fluorescent nanoparticles of the present invention. [0013]
  • The invention also provides a fluorescent imaging agent comprising the ligated-fluorescent nanoparticles of the present invention. [0014]
  • The invention also provides ligated-fluorescent nanoparticles as pharmaceutical carrier particles. Thus, the ligated-fluorescent nanoparticles can further include a therapeutic agent, which therapeutic agent is on the surface or is conjugated with the surface of the fluorescent nanoparticle to form a pharmaceutical composition. [0015]
  • The invention also provides a method of making a fluorescent nanoparticle comprising: [0016]
  • mixing a fluorescent compound, such as a reactive fluorescent dye, and an organo-silane compound, such as a co-reactive organo-silane compound, to form a fluorescent core; and [0017]
  • mixing the resulting core with a silica forming compound, such as a tetraalkoxysilane, to form a silica shell on the core. [0018]
  • The invention also provides a method for monitoring movement of a cellular component of a cell comprising: [0019]
  • contacting the cell with a ligated-fluorescent nanoparticle to form a cell selectively decorated with the ligated-fluorescent nanoparticle; and [0020]
  • recording the motion of a fluorescent loci for a time. [0021]
  • The invention also provides a method for treating disease comprising: [0022]
  • administering to a patient in need of treatment with an effective amount of a ligated-fluorescent nanoparticle, which nanoparticle optionally includes a therapeutic agent, the nanoparticle being adapted to selectively associate with a disease producing component of the cell, to form a selectively decorated cell with the ligated-fluorescent nanoparticle; and [0023]
  • illuminating the decorated cell. [0024]
  • The invention also provides a method for treatment comprising: [0025]
  • contacting a cell with a ligated-fluorescent nanoparticle, which nanoparticle optionally includes a therapeutic agent, to form a cell selectively decorated with the ligated-fluorescent nanoparticle; and irradiating the resulting decorated cell for a time. [0026]
  • The invention also provides a kit for use in the detection of an analyte, the kit comprising a ligated-fluorescent nanoparticle, as illustrated herein. [0027]
  • The invention also provides a kit for detecting and monitoring a cell surface component comprising a ligated-fluorescent nanoparticle for detecting the cell surface component, and optionally a recorder for monitoring the cell surface component. [0028]
  • The invention also provides an assay method for detecting motion or a change in the location of a cellular component in, or on the surface of, a cell when the cell is treated with a therapeutic agent comprising: [0029]
  • contacting a cell with a ligated-fluorescent nanoparticle, wherein the nanoparticle includes a therapeutic agent, to bind the ligated-fluorescent nanoparticle to a cellular component; and [0030]
  • recording the fluorescent signal.[0031]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A illustrates an example of the fluorescent brightness of the fluorescent nanoparticles of the present invention compared to latex particles. [0032]
  • FIG. 2A illustrates an example of bio-molecule binding specificity of the fluorescent nanoparticles of the present invention. [0033]
  • FIG. 2B illustrates an example of bio-molecule binding specificity of comparative latex particles.[0034]
  • DETAILED DESCRIPTION OF THE INVENTION
  • Applicants have discovered fluorescent nanoparticles, and linked- or ligated-fluorescent nanoparticles of the invention that are useful for labeling, detection, identification, motion monitoring, and like applications, of various biological and non-biological analytes. The linked- or ligated-fluorescent nanoparticles of the invention can also be useful in therapeutic treatment, when used as a pharmaceutical carriers, for example, in combination with a suitable therapeutic agent. [0035]
  • The present invention provides nanoparticles which can have useful multifunctional architectures, for example, a fluorescent nano-sized core which can optionally contain other functionality such as a magnetic component, a silica shell which can be made to have a range of useful thicknesses and surface properties, such as a smooth monolithic surface or a highly porous surface, and which silica surface can be further physically or chemically modified with, for example, a ligand or a therapeutic agent. [0036]
  • The present invention provides for the preparation and characterizations of fluorescent nanoparticles in various sizes suitable for single particle tracking (SPT) applications. Nanoparticles of various diameters can be prepared having narrow size distributions. The versatility of the preparative route allows for the incorporation of different fluorescent materials, such as dyes, depending on the intended nanoparticle application. Methods for surface functionalization are also provided which enable the conjugation of specific ligands, such as antibodies or proteins, onto the fluorescent nanoparticles to form probes useful for specific SPT experiments. The nanoparticle preparative procedure enables the preparation, by in situ systematic nanoparticle size-growth, of fluorescent nanoparticles in the range of, for example, from about 10 to about 500 nm, and from about 25 to about 100 nm, and narrower ranges therein as illustrated herein. [0037]
  • The fluorescent nanoparticles can be conjugated with a molecule or entity, such as an antibody ligand or linker, to provide a linked- or ligated-fluorescent nanoparticle which can be used to identify, detect, target (i.e. pinpoint or specify with a high level of certainty), monitor, or modify a disease state or condition, such as the presence or absence of particular receptors, metabolic levels of particular receptors, and like components. The linked- or ligated-fluorescent nanoparticle can be still further conjugated or associated with, for example, a therapeutic agent and used to, for example, treat a disease state or condition, such as by delivering the therapeutic agent to a diseased site in a highly specific or localized manner and in a relatively high concentration with release of the therapeutic agent in a relatively controlled manner. The ligated-fluorescent nanoparticles can be used for directed delivery of a therapeutic agent to a desired location in a variety of systems, such as on, or within, a cell or cell component, or within the body of an organism, such as a human, e.g. across the blood-brain barrier. [0038]
  • In embodiments the therapeutic agent can be either or both absorbed into, such as the interstices or pores of the silica shell, or coated onto the silica shell of the fluorescent nanoparticle. In other embodiments where the silica shell is incomplete, the therapeutic agent can be associated with the fluorescent core, such as by physical absorption or by bonding interaction. The therapeutic agent can also be associated with the ligand of a ligated-fluorescent nanoparticle if desired. [0039]
  • The ligated-fluorescent nanoparticles of the present invention can be used in a variety of diagnostic and treatment applications, for example, as a pharmaceutical carrier for therapeutic agents, and as a fluorescent marker in, for example, single nucleotide polymorphorism (SNPs) experiments, such as where a DNA sample is stained with a fluorescent marker and gene activity can be detected as a colored glow of the marker when illuminated with a laser. [0040]
  • The nanoparticles of the invention, alone or in combination with a ligand, can be used for passive or covalent coupling of biological material, i.e. an analyte, such as haptens, antigens, antibodies, enzymes or nucleic acids, and used for various types of analyte assays such as immunoassays, nucleic acid (DNA or RNA) assays, affinity purification, cell separation, and other medical, diagnostic, environmental, and industrial applications. The nanoparticles incorporate known fluorescently responsive materials, such as, dyes, pigments, or combinations thereof. A wide variety of suitable chemically reactive fluorescent dyes are known, see for example MOLECULAR PROBES HANDBOOK OF FLUORESCENT PROBES AND RESEARCH CHEMICALS, 6[0041] th ed., R. P. Haugland, ed. (1996). A typical fluorophore is, for example, a fluorescent aromatic or heteroaromatic compound such as is a pyrene, an anthracene, a naphthalene, an acridine, a stilbene, an indole or benzindole, an oxazole or benzoxazole, a thiazole or benzothiazole, a 4-amino-7-nitrobenz-2-oxa-1,3-diazole (NBD), a cyanine, a carbocyanine, a carbostyryl, a porphyrin, a salicylate, an anthranilate, an azulene, a perylene, a pyridine, a quinoline, a coumarin (including hydroxycoumarins and aminocoumarins and fluorinated derivatives thereof), and like compounds, see for example U.S. Pat. Nos. 5,830,912; 4,774,339; 5,187,288; 5,248,782; 5,274,113; 5,433,896; 4,810,636; and 4,812,409.
  • The co-reactive organosilane used for forming the fluorescent core has the general formula R[0042] (4-n)SiXn, where X can be a hydrolyzable group such as ethoxy, methoxy, or 2-methoxy-ethoxy; R can be a monovalent organic radical of from 1 to 12 carbon atoms which can optionally contains a functional organic group such as mercapto, epoxy, acrylyl, methacrylyl, or amino; and n is an integer of from 0 to 4. The co-reactive organosilane used for forming the fluorescent core preferably has n equal to 3. A organosilane used for forming the silica shell has n equal to 4. The use of functional mono-, bis- and tris-alkoxysilanes for coupling and modification of co-reactive functional groups or hydroxy-functional surfaces, including glass surfaces, is also known, see Kirk-Othmer, Encyclopedia of Chemical Technology, Vol. 20, 3rd Ed., J. Wiley, N.Y. Although not desired to be limited by theory, the coupling arises as a result of hydrolysis of the alkoxysilane groups to silanol groups and as a result of condensation with hydroxyl groups of the surface, see E. Pluedemann, Silane Coupling Agents, Plenum Press, N.Y. 1982. Thus, the above mentioned organo-silane compounds and like coupling agents can be used: to make the core; to make the silica shell, to modify the surface of the resulting silica shell coated fluorescent core nanoparticles; to attach or couple a ligand to the fluorescent nanoparticles; or to modify the properties of ligand before or after attachment to fluorescent nanoparticle. The organo-silane can cause gels, so it may be desirable to employ an alcohol or other known stabilizers. When the organo-silane is to be copolymerized with another monomer such as a reactive fluorescent compound, a stabilizer can be selected that does not interfere with the polymerization. An alcohol, such as methanol, is especially useful and can be employed in amounts, for example, from about twice to about ten times the amount of the organo-silane.
  • The nanoparticles can optionally incorporate known magnet or magnetically responsive materials, such as, superparamagnetic, paramagnetic, ferromagnetic metal oxide, and combinations thereof. [0043]
  • The fluorescent nanoparticles of the present invention comprise a core comprising a fluorescent silane compound; and a silica shell on the core. The core of the nanoparticle can comprise, for example, the reaction product of a reactive fluorescent compound and an co-reactive organo-silane compound, and the shell can comprise, for example, the reaction product of a silica forming compound. The silica forming compound can produce, for example, one or more layers of silica, such as from 1 to about 20 layers, and depending upon the shell characteristics desired, such as shell layer thickness, the ratio of the shell thickness to the core thickness or diameter, silica shell surface coverage of the core, porosity and carrying capacity of the silica shell, and like considerations. [0044]
  • The silica shell coating on the core can cover, for example, from about 10 to about 100 percent of the surface area of the core. The ligand when ligated on the surface of the fluorescent nanoparticle can cover, for example, from about 0.1 to about 100 percent of the surface area of the core. The thickness or diameter of the core to the thickness of the silica shell can be in a ratio of, for example, from about 1:1 to about 1:100. The diameter of the fluorescent nanoparticle can be, for example, from about 1 to about 1,000 nanometers. The diameter of a ligated-fluorescent nanoparticle can be comparable to or larger than the diameter of the fluorescent nanoparticle depending upon, for example, the size and the amount of the ligand selected. In embodiments the diameter of the core can be, for example, from about 10 to about 300 nanometers, and preferably from about 25 to about 200 nanometers, and the thickness of the silica shell can be, for example, from about 25 to about 800 nanometers, and preferably from about 25 to about 500 nanometers. In preferred embodiments, such as when the nanoparticles are selected as a carriers, the silica shell is made porous to accommodate for example a therapeutic agent, and as illustrated herein. More preferably the nanoparticles [0045]
  • The preparative methods for fluorescent nanoparticles of the present invention can yield nanoparticles, for example, of about an order of magnitude smaller in size than those reported by van Blaaderen and Vri, [0046] Langmuir, 8, 2921-2925 (1992) (monodisperse silica sphere core particles coated with dyes and further encapsulated with silica). The silica shell can be either solid, that is relatively non-porous, or meso-porous, such as semi-porous. The silica shell of the fluorescent nanoparticles is preferably dielectric. The silica shell of the fluorescent nanoparticles can be adapted to function as a pharmaceutical carrier nanoparticle, that is made to contain, for example, therapeutic agents, such as drugs or proteins for transport and delivery of in vivo or in vitro. Thus, the fluorescent nanoparticles of the present invention can provide a pharmaceutical carrier system which can be adapted for controlled delivery or release of therapeutic agents.
  • In embodiments, a ligand placed on the surface of the fluorescent nanoparticle forms a ligated-fluorescent nanoparticle. The placement of the ligand can be accomplished, for example, by attachment with a covalent bond or by physical absorption. The ligand on the surface of the fluorescent nanoparticle can be, for example, a biopolymer, a synthetic polymer, an antigen, an antibody, a virus or viral component, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a microorganism or a component thereof, a toxin, a surface modifier, such as a surfactant to alter the surface properties or histocompatability of the nanoparticle or of an analyte when a nanoparticle associates therewith, and combinations thereof. Preferred ligands are for example, antibodies, such as monoclonal or polyclonal. [0047]
  • The present invention also provides a method of preparing analytes which are selectively labeled with ligated-fluorescent nanoparticles by, for example, coupling (e.g. covalently) or any other known method(s) of associating the ligated-fluorescent nanoparticles directly to the analyte (e.g., through ionic bonds, hydrogen bonds, by simple adsorption). The resulting selectively labeled analytes having a coupled or associated ligated-fluorescent nanoparticle (i.e. ligated-fluorescent nanoparticle-analyte complex) can be useful as an authentic or reference sample, for example, in a treatment method or diagnostic kit. [0048]
  • An “analyte” of the present invention is the object or the target of the ligated-fluorescent nanoparticle for attachment or association therewith. The analyte can be, for example, a microorganism or a component thereof, a virus or viral component, a cell or a component thereof, a biopolymer, a synthetic polymer, a synthetic material, such as a carbon nanotube, an antigen, an antibody, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, combinations thereof, and like substances. Analytes of particular interest are microorganisms and cells, including viruses, prokaryotic and eukaryotic cells, unicellular and multi-cellular organism, e.g., fungi, bacterial, mammalian, etc., and fragments or components thereof. Other analytes of particular interest are pathogens. Monoclonal or polyclonal antibodies or other selective ligands which are part of the ligated-fluorescent nanoparticle can be linked to the surface of, for example, a pathogen. [0049]
  • In embodiments of the present invention there are provided methods of making a fluorescent nanoparticle, for example, comprising: [0050]
  • mixing a fluorescent compound, such as a reactive fluorescent dye, and an organo-silane compound, such as a co-reactive organo-silane compound, to form a fluorescent core; and [0051]
  • mixing the resulting core with a silica forming compound, such as a tetraalkoxysilane, to form a silica shell on the core, to provide the fluorescent nanoparticle. [0052]
  • The methods of making the nanoparticles of the present invention can further comprise combining the resulting fluorescent nanoparticle with a ligand such as a biopolymer, a synthetic polymer, an antigen, an antibody, a microorganism, a virus, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, a surface modifier, for example, to alter the surface or compatibility properties of the nanoparticle, combinations thereof, and like materials. The resulting combination of the fluorescent nanoparticle and a ligand provides a ligated-fluorescent nanoparticle. The methods of making the nanoparticles can also further comprise combining the resulting nanoparticle with a therapeutic agent, with or without a ligand attached to the nanoparticle. Combining the nanoparticles with a ligand or a therapeutic agent can be accomplished by, for example, coating the ligand or therapeutic agent onto the surface of the nanoparticle. Alternatively or additionally, combining a nanoparticle with a ligand or a therapeutic agent can be accomplished by, for example, imbibing the ligand or therapeutic agent into the surface of the nanoparticle. Imbibing means to assimilate or to take in or up, for example, where a porous nanoparticle surface is imbibed with a ligand, a therapeutic agent, or both. Alternatively or additionally, combining a nanoparticle with a ligand or a therapeutic agent can be accomplished by, for example, bonding the ligand or therapeutic agent to the surface of the resulting nanoparticle. Bonding includes, for example, known covalent, ionic, hydrogen, hydrophobic, coordination, adhesive, combinations thereof, and like bonding associative methods. [0053]
  • Because of the small size and uniformity of the nanoparticles of the present invention and their apparent solubility or high dispersibility properties, the nanoparticles can provide “molecular labels” which can readily associate with or be bonded to another entity, such as a ligand or a therapeutic agent, and thereafter be readily transported to and selectively attached to a target analyte. The selective attachment enables useful analytical detection, diagnostic, or differentiation schemes. The size of the ligated-fluorescent nanoparticles for use in embodiments of the present invention can be selected based on the number of nanoparticles to be attached to the analyte and the sensitivity of the optical or spectroscopic schemes selected. [0054]
  • In embodiments the present invention provides a method for monitoring movement of a cellular component of a cell comprising: [0055]
  • contacting the cell with a ligated-fluorescent nanoparticle to form a cell selectively decorated with the ligated-fluorescent nanoparticle; and [0056]
  • recording the motion of a fluorescent loci for a time. [0057]
  • The fluorescent loci can correspond to a single ligated-fluorescent nanoparticle bound to a component of the cell. The fluorescent loci can correspond to two or more ligated-fluorescent nanoparticles bound to a component of the cell. The monitoring method enables an operator to, for example, track the diffusion of one or more fluorescent loci, such as a receptor to which a single ligated-fluorescent nanoparticle is bound, such as, in real-time or with time-lapse techniques. The ligated-fluorescent nanoparticle is preferably adapted to selectively associate with a targeted cellular component of the cell, for example, by appropriate selection of the ligand. [0058]
  • The cellular component can be, for example, a receptor, an antibody, a hapten, an enzyme, a hormone, a biopolymer, an antigen, a microorganism, a virus, a pathogen, a toxin, combinations thereof, and like components. In embodiments, the ligated-fluorescent nanoparticle can be a fluorescent nanoparticle conjugated with an antibody. In embodiments, the conjugated antibody can be an immunoglobin, such as IgE. [0059]
  • Suitable means for detecting, recording, measuring, or imaging in embodiments of the present invention are known in the art and include, for example, a flow cytometer, a laser scanning cytometer, a fluorescence micro-plate reader, a fluorescence microscope, a confocal microscope, a bright-field microscope, a high content scanning system, and like devices. [0060]
  • The recording can be accomplished, for example, with a microscopically adapted camera, such as a video-microscopy camera, a digital camera, a silver halide single exposure camera, and like devices. The recording time can be any convenient and useful time period to observe notable events or phenomena, for example, intervals from about 1 microsecond to about 30 days. In typical extracellular, surface-cellular, or intra-cellular events, recording for a time period can be, for example, from about 1 second to about 60 minutes, more preferably from about 1 second to about 40 minutes, and even more preferably, from about 1 minute to about 30 minutes. The recording time period can often be conveniently shortened or lengthened as desired by changing the ambient temperature of the sample or system. The contacting and the recording can be accomplished in vitro using conventional microscopic photography techniques. The contacting and the recording can also be accomplished in vivo using, for example, a catheter adapted with a microscopic camera or fiber optic camera. It will be readily evident to one of ordinary skill in the art in embodiments of the present invention that “recording” can be synonymous with “detecting,” since for example making a photographic recording of an illuminated specimen can also simultaneously afford detection of fluorescent loci, such as a cell or cell component selectively decorated with a ligated-fluorescent nanoparticle. [0061]
  • In embodiments there is provided a pharmaceutical carrier comprising the fluorescent nanoparticle of the present invention, and optionally a ligand associated with the fluorescent nanoparticle. [0062]
  • In embodiments there is also provided a pharmaceutical composition comprising a ligated-fluorescent nanoparticle, and a therapeutic agent associated with the fluorescent nanoparticle. [0063]
  • In embodiments there is provided an imaging agent comprising the ligated-fluorescent nanoparticle, for example, where the ligand of the ligated-fluorescent nanoparticle is on the surface of the nanoparticle. The imaging agent can be used in conventional imaging processes, and preferably where, for example, a high fluorescent yield or fluorescent brightness is desired. In embodiments, the ligated-fluorescent nanoparticles of the present invention can provide enhanced fluorescent brightness which is, for example, from about 2 to about 10 times greater compared to conventional surface decorated fluorescent particles, such as fluorescent latex particles. [0064]
  • In embodiments there is provided a method for treating a disease or disorder comprising: [0065]
  • administering to a patient in need of treatment an effective amount of a ligated-fluorescent nanoparticle which nanoparticle optionally includes a therapeutic agent, wherein the nanoparticle is adapted to selectively associate with a disease producing component of the cell, to form a selectively decorated cell with the ligated-fluorescent nanoparticle; and [0066]
  • illuminating the decorated cell. [0067]
  • The ligated-fluorescent nanoparticle, by itself or as part of a decorated cell, when illuminated can fluoresce, heat-up, or both. Thus, the selection of the reactive fluorescent compound in preparing the fluorescent nanoparticle, and the selection of the ligand, can be made empirically depending upon the balance of fluorescent and non-fluorescent (heat dissipation) properties desired. Higher fluorescent properties may be desired where detection is paramount or difficult, for example in dilute systems. Higher non-fluorescent properties may be desired where high heating is needed to, for example, promote liberation of a therapeutic agent or to accomplish selective microscopic-cauterization or microscopic-heat therapy. In embodiments it may be desirable to use a mixture of two or more ligated-fluorescent nanoparticles having different fluorescent and non-fluorescent properties to exploit the benefits of the different properties, for example, simultaneously or sequentially, such as in the detection and treatment of a cancerous tumor. [0068]
  • Thus, the ligated-fluorescent nanoparticles of the present invention can be used to treat a light- or heat-sensitive diseases or disorders. Light therapy is known for activation of medicaments at one or more treatment sites within a living body. A particular embodiment of light therapy, for example, is photodynamic therapy (PDT) which is a two-step treatment process which has been found to be effective in destroying a wide variety of cancers. PDT is performed by first systemically or topically administering a photosensitizer compound or like compounds, and subsequently illuminating a treatment site with light in a waveband, which corresponds to an absorption waveband of the photosensitizer. The light energy activates the photosensitizer compound, causing it to destroy the diseased tissue, see for example, U.S. Pat. No. 6,454,789. It is readily evident to one skilled in the art that a fluorescent material, such as the ligated-fluorescent nanoparticles of the present invention, can be used in place of a photosensitizer compound. [0069]
  • Heat therapy methods are also known, for example, to shrink desired tissues, see U.S. Pat. No. 6,480,746, and for localized treatment of cutaneous warts, see [0070] Arch. Dermatol, (July 1992), vol. 128, p. 945-948, and to induce macrophage apoptosis, see U.S. Pat. No. 6,451,044. In these and related applications heat therapy can be accomplished within a body or across the skin by means of, for example, irradiation or illumination, such as ultraviolet radiation, infrared radiation, microwave radiation, etc. One of ordinary skill in the art once in possession of the present invention would readily recognize how to adapt its materials and methods to accomplish light therapy or heat therapy.
  • The present invention also provides a method of treatment comprising: [0071]
  • contacting a cell with a ligated-fluorescent nanoparticle, optionally having a therapeutic agent associated with the nanoparticle, to form a cell selectively decorated with the ligated-fluorescent nanoparticle; and [0072]
  • irradiating the resulting decorated cell for a time. [0073]
  • The amount and the duration of the contacting as well as the amount and the duration of irradiating can depend on, for example, the diagnostic or therapeutic objectives of the treatment method, such as fluorescent detection of a diseased state or condition, the delivery of an effect therapeutic agent, or both. The amount and the duration of the contacting and irradiating can also depend on, for example, the relative concentration ligated-fluorescent nanoparticle to the target analyte, and the state of the cell for treatment, such as in vivo or in vitro whole cells, permeabilized cells, homogenized cells, sensitized cells, and like cell preparations. [0074]
  • The ligated-fluorescent nanoparticles of the present invention also have application in diagnostic kits or assays, such as immunoassays, in improved imaging agents, in purification processes, in drugs, for example, treatment regimes and therapies, such as drug delivery to specifically target and shrink tumors or to identify and separate infectious agents, and like applications. [0075]
  • The invention provides a kit for use in the detection of an analyte, the kit comprising a ligated-fluorescent nanoparticle, as illustrated herein. [0076]
  • The invention also provides a kit for detecting and monitoring a cell surface component comprising a ligated-fluorescent nanoparticle for detecting the cell surface component, and optionally a recorder for monitoring the cell surface component. [0077]
  • The aforementioned kits include packaging of the kit component(s) and instructions for use of the kit. [0078]
  • The invention also provides an assay method for detecting motion or a change in the location of a cellular component in, or on the surface of, a cell when the cell is treated with a therapeutic agent comprising: [0079]
  • contacting a cell with a ligated-fluorescent nanoparticle, wherein the nanoparticle includes a therapeutic agent, to bind the ligated-fluorescent nanoparticle to a cellular component; and [0080]
  • recording the fluorescent signal, such as from one or more fluorescent loci, and determining the relative motion or a change in the location of a targeted cellular component. [0081]
  • The motion or movement of the fluorescent loci, that is an analyte bound by a ligated-fluorescent nanoparticle, is representative of and can be correlated to the motion or movement of the bound analyte, such as a cellular component. [0082]
  • The assay method for detecting motion or a change in the location of a cellular component can include, for example, optionally mapping or plotting the recorded positions of ligated-fluorescent nanoparticle. The assay method can further comprise determining the difference between the motion or movement of the analyte bound ligated-fluorescent nanoparticle in the presence and absence of the therapeutic agent, for example, in a tandem or control experimental design. [0083]
  • The nanoparticles materials, such as the ligated-fluorescent nanoparticles, and methods of use of the present invention can be used as, for example, labeled assay reagents or reagent products made therefrom, for assaying the presence of a cell component, for example, an enzyme, a receptor, and like cell components. The location of the cell component can be detected and determined, for example, inside a metabolically active whole cell, in a whole cell lysate, in a permeabilized cell, in a fixed cell, or with a partially purified cell component in a cell-free environment. The ligated-fluorescent nanoparticle contains an associated ligand or ligator, such as an antibody, which nanoparticle targets or associates with a specific cell component of interest. The ligated-fluorescent nanoparticle also contains a fluorescent label or fluorescent component in the nanoparticle core, which fluorescent component marks or reports on the presence of the target cell component when the nanoparticle and the target cell component are associated and appropriately illuminated or irradiated. [0084]
  • The invention also provides methods for treating a disease by administration of an effective amount of a linked fluorescent nanoparticles. The methods may involve administration of a linked fluorescent nanoparticles as described herein, alone, in a pharmaceutical composition, or in combination with other therapeutic agents or pharmaceutical compositions. [0085]
  • The invention also provides methods to increase the effectiveness of a therapeutic agent by linking the therapeutic agent to a fluorescent nanoparticle. The fluorescent nanoparticles and pharmaceutical compositions thereof may also be used to associate therapeutic agents to increase the therapeutic efficiency of the therapeutic agent. Conjugation of a fluorescent nanoparticle with a ligand to form a linked- or ligated-fluorescent nanoparticle is preferably accomplished in vitro where, for example, ligand amounts and conditions can be carefully controlled to produce a product of high purity and high quality. Similarly, modifying the linked fluorescent nanoparticle with a therapeutic agent is preferably accomplished in vitro. [0086]
  • The present invention provides fluorescent nanoparticles and ligated-fluorescent nanoparticle thereof, and methods for their use in, for example, immunolabeling, sub-cellular recognition procedures, diagnostics, or cell sorting. The methods of the present invention provide advantages which overcome shortcomings of known methodologies and as illustrated herein. [0087]
  • The present invention provides ligated-fluorescent nanoparticles which are highly dispersible, and are useful, for example, in improved methods for chemical and biochemical analysis, such as, the detection of biological analytes including micro-organisms or sub-cellular components. The ligated-fluorescent nanoparticle can provide high local concentrations of fluorescent material because of their high target selectively or affinity, and because of their enhanced brightness compared to known fluorescent particles. The fluorescent material is present throughout the nanoparticle core and not simply as a surface coating material as in many conventional materials. [0088]
  • A “therapeutic agent” is a substance that may be used in the diagnosis, cure, mitigation, treatment, or prevention of disease in a human or another animal. Such therapeutic agents include substances recognized in the official United States Pharmacopeia, official Homeopathic Pharmacopeia of the United States, official National Formulary, or any supplement thereof. [0089]
  • Therapeutic agents that can be incorporated with the fluorescent nanoparticles or the ligated-fluorescent nanoparticles of the invention include nucleosides, nucleoside analogs, oligopeptides, polypeptides, COX-2 inhibitors, apoptosis promoters, urinary tract agents, vaginal agents, vasodilators neurodegenerative agents (e.g., Parkinson's disease), obesity agents, ophthalmic agents, osteoporosis agents, para-sympatholytics, para-sympathometics, antianesthetics, prostaglandins, psychotherapeutic agents, respiratory agents, sedatives, hypnotics, skin and mucous membrane agents, anti-bacterials, anti-fungals, antineoplastics, cardioprotective agents, cardiovascular agents, anti-thrombotics, central nervous system stimulants, cholinesterase inhibitors, contraceptives, dopamine receptor agonists, erectile dysfunction agents, fertility agents, gastrointestinal agents, gout agents, hormones, immunomodulators, suitably functionalized analgesics or general or local anesthetics, anti-convulsants, anti-diabetic agents, anti-fibrotic agents, anti-infectives, motion sickness agents, muscle relaxants, immuno-suppresives, migraine agents, non-steroidal anti-inflammatory drugs (NSAIDs), smoking cessation agents, or sympatholytics (see Physicians' Desk Reference, 55th ed., 2001, Medical Economics Company, Inc., Montvale, N.J., pages 201-202). [0090]
  • Examples of specific therapeutic agents that can be linked, ligated, or associated with the fluorescent nanoparticles of the invention are flomoxef; fortimicin(s); gentamicin(s); glucosulfone solasulfone; gramicidin S; gramicidin(s); grepafloxacin; guamecycline; hetacillin; isepamicin; josamycin; kanamycin(s); flomoxef; fortimicin(s); gentamicin(s); glucosulfone solasulfone; gramicidin S; gramicidin(s); grepafloxacin; guamecycline; hetacillin; isepamicin; josamycin; kanamycin(s); bacitracin; bambermycin(s); biapenem; brodimoprim; butirosin; capreomycin; carbenicillin; carbomycin; carumonam; cefadroxil; cefamandole; cefatrizine; cefbuperazone; cefclidin; cefdinir; cefditoren; cefepime; cefetamet; cefixime; cefinenoxime; cefininox; cladribine; apalcillin; apicycline; apramycin; arbekacin; aspoxicillin; azidamfenicol; aztreonam; cefodizime; cefonicid; cefoperazone; ceforamide; cefotaxime; cefotetan; cefotiam; cefozopran; cefpimizole; cefpiramide; cefpirome; cefprozil; cefroxadine; cefteram; ceftibuten; cefuzonam; cephalexin; cephaloglycin; cephalosporin C; cephradine; chloramphenicol; chlortetracycline; clinafloxacin; clindamycin; clomocycline; colistin; cyclacillin; dapsone; demeclocycline; diathymosulfone; dibekacin; dihydrostreptomycin; 6-mercaptopurine; thioguanine; capecitabine; docetaxel; etoposide; gemcitabine; topotecan; vinorelbine; vincristine; vinblastine; teniposide; melphalan; methotrexate; 2-p-sulfanilyanilinoethanol; 4,4′-sulfinyldianiline; 4-sulfanilamidosalicylic acid; butorphanol; nalbuphine. streptozocin; doxorubicin; daunorubicin; plicamycin; idarubicin; mitomycin C; pentostatin; mitoxantrone; cytarabine; fludarabine phosphate; butorphanol; nalbuphine. streptozocin; doxorubicin; daunorubicin; plicamycin; idarubicin; mitomycin C; pentostatin; mitoxantrone; cytarabine; fludarabine phosphate; acediasulfone; acetosulfone; amikacin; amphotericin B; ampicillin; atorvastatin; enalapril; ranitidine; ciprofloxacin; pravastatin; clarithromycin; cyclosporin; famotidine; leuprolide; acyclovir; paclitaxel; azithromycin; lamivudine; budesonide; albuterol; indinavir; metformin; alendronate; nizatidine; zidovudine; carboplatin; metoprolol; amoxicillin; diclofenac; lisinopril; ceftriaxone; captopril; salmeterol; xinafoate; imipenem; cilastatin; benazepril; cefaclor; ceftazidime; morphine; dopamine; bialamicol; fluvastatin; phenamidine; podophyllinic acid 2-ethylhydrazine; acriflavine; chloroazodin; arsphenamine; amicarbilide; aminoquinuride; quinapril; oxymorphone; buprenorphine; floxuridine; dirithromycin; doxycycline; enoxacin; enviomycin; epicillin; erythromycin; leucomycin(s); lincomycin; lomefloxacin; lucensomycin; lymecycline; meclocycline; meropenem; methacycline; micronomicin; midecamycin(s); minocycline; moxalactam; mupirocin; nadifloxacin; natamycin; neomycin; netilmicin; norfloxacin; oleandomycin; oxytetracycline; p-sulfanilylbenzylamine; panipenem; paromomycin; pazufloxacin; penicillin N; pipacycline; pipemidic acid; polymyxin; primycin; quinacillin; ribostamycin; rifamide; rifampin; rifamycin SV; rifapentine; rifaximin; ristocetin; ritipenem; rokitamycin; rolitetracycline; rosaramycin; roxithromycin; salazosulfadimidine; sancycline; sisomicin; sparfloxacin; spectinomycin; spiramycin; streptomycin; succisulfone; sulfachrysoidine; sulfaloxic acid; sulfamidochrysoidine; sulfanilic acid; sulfoxone; teicoplanin; temafloxacin; temocillin; tetroxoprim; thiamphenicol; thiazolsulfone; thiostrepton; ticarcillin; tigemonam; tobramycin; tosufloxacin; trimethoprim; trospectomycin; trovafloxacin; tuberactinomycin; vancomycin; azaserine; candicidin(s); chlorphenesin; dermostatin(s); filipin; fungichromin; mepartricin; nystatin; oligomycin(s); perimycin A; tubercidin; 6-azauridine; 6-diazo-5-oxo-L-norleucine; aclacinomycin(s); ancitabine; anthramycin; azacitadine; azaserine; bleomycin(s); ethyl biscoumacetate; ethylidene dicoumarol; iloprost; lamifiban; taprostene; tioclomarol; tirofiban; amiprilose; bucillamine; gusperimus; gentisic acid; glucamethacin; glycol salicylate; meclofenamic acid; mefenamic acid; mesalamine; niflumic acid; olsalazine; oxaceprol; S-enosylmethionine; salicylic acid; salsalate; sulfasalazine; tolfenamic acid; carubicin; carzinophillin A; chlorozotocin; chromomycin(s); denopterin; doxifluridine; edatrexate; eflornithine; elliptinium; enocitabine; epirubicin; mannomustine; menogaril; mitobronitol; mitolactol; mopidamol; mycophenolic acid; nogalamycin; olivomycin(s); peplomycin; pirarubicin; piritrexim; prednimustine; procarbazine; pteropterin; puromycin; ranimustine; streptonigrin; thiamiprine; mycophenolic acid; procodazole; romurtide; sirolimus (rapamycin); tacrolimus; butethamine; fenalcomine; hydroxytetracaine; naepaine; orthocaine; piridocaine; salicyl alcohol; 3-amino-4-hydroxybutyric acid; aceclofenac; alminoprofen; amfenac; bromfenac; bromosaligenin; bumadizon; carprofen; diclofenac; diflunisal; ditazol; enfenamic acid; etodolac; etofenamate; fendosal; fepradinol; flufenamic acid; Tomudex® (N-[[5-[[(1,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid), trimetrexate, tubercidin, ubenimex, vindesine, zorubicin; argatroban; coumetarol or dicoumarol. [0091]
  • Lists of additional therapeutic agents can be found, for example, in: Physicians' Desk Reference, 55th ed., 2001, Medical Economics Company, Inc., Montvale, N.J.; USPN Dictionary of USAN and International Drug Names, 2000, The United States Pharmacopeial Convention, Inc., Rockville, Md.; and The Merck Index, 12th ed., 1996, Merck & Co., Inc., Whitehouse Station, N.J. [0092]
  • It will be readily appreciated by those skilled in the art how to determine, for example, therapeutic activity using standard tests or other similar tests which are known in the art. [0093]
  • A “pharmaceutical composition” includes a therapeutic agent as exemplified herein in combination with a fluorescent nanoparticle of the invention, for example, where the fluorescent nanoparticle can act as the pharmaceutically acceptable carrier. A pharmaceutical composition of the present invention, in addition to a therapeutic agent combination with a fluorescent nanoparticle, can be formulated into or with other acceptable carriers or dosage forms, such as, a solid, gelled or liquid diluent or an ingestible capsule. The pharmaceutical compositions of the invention, the salts thereof, or a mixture thereof, may be administered orally in the form of a suitable pharmaceutical unit dosage form. The pharmaceutical compositions of the invention may be prepared in many forms that include tablets, hard or soft gelatin capsules, aqueous solutions, suspensions, and liposomes and other slow-release formulations, such as shaped polymeric gels. [0094]
  • Oral liquid pharmaceutical compositions may be in the form of, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or may be presented as a dry product for constitution with water or other suitable vehicle before use. Such liquid pharmaceutical compositions may contain conventional additives such as suspending agents, emulsifying agents, non-aqueous vehicles (which may include edible oils), or preservatives. [0095]
  • The nanoparticle pharmaceutical compositions of the invention may also be formulated for parenteral administration (e.g., by injection, for example, bolus injection or continuous infusion) and may be presented in unit dosage form in ampules, pre-filled syringes, small volume infusion containers or multi-dose containers with an added preservative. The pharmaceutical compositions may take such forms as suspensions, solutions, or emulsions in oily or aqueous vehicles, and may contain formulatory agents such as suspending, stabilizing and/or dispersing agents. Alternatively, the pharmaceutical compositions of the invention may be in powder form, obtained by aseptic isolation of sterile solid or by lyophilization from solution, for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use. [0096]
  • For topical administration to the epidermis, the pharmaceutical compositions may be formulated as ointments, creams or lotions, or as the active ingredient of a transdermal patch. Suitable transdermal delivery systems are disclosed, for example, in A. Fisher et al. (U.S. Pat. No. 4,788,603), or R. Bawa et al. (U.S. Pat. Nos. 4,931,279; 4,668,506; and 4,713,224). Ointments and creams may, for example, be formulated with an aqueous or oily base with the addition of suitable thickening and/or gelling agents. Lotions may be formulated with an aqueous or oily base and will in general also contain one or more emulsifying agents, stabilizing agents, dispersing agents, suspending agents, thickening agents, or coloring agents. The pharmaceutical compositions can also be delivered via ionophoresis, e.g., as disclosed in U.S. Pat. Nos. 4,140,122; 4,383,529; or 4,051,842. [0097]
  • Pharmaceutical compositions suitable for topical administration in the mouth include unit dosage forms such as lozenges comprising a pharmaceutical composition of the invention in a flavored base, usually sucrose and acadia or tragacanth; pastilles comprising the pharmaceutical composition in an inert base such as gelatin and glycerin or sucrose and acacia; mucoadherent gels, and mouthwashes comprising the pharmaceutical composition in a suitable liquid carrier. [0098]
  • For topical administration to the eye, the pharmaceutical compositions can be administered as drops, gels (S. Chrai et al., U.S. Pat. No. 4,255,415), gums (S. L. Lin et al., U.S. Pat. No. 4,136,177) or via a prolonged-release ocular insert (A. S. Michaels, U.S. Pat. No. 3,867,519 and H. M. Haddad et al., U.S. Pat. No. 3,870,791). [0099]
  • When desired, the above-described pharmaceutical compositions can be adapted to give sustained release of a therapeutic compound employed, e.g., by combination with certain hydrophilic polymer matrices, e.g., comprising natural gels, synthetic polymer gels or mixtures thereof. [0100]
  • Pharmaceutical compositions suitable for rectal administration wherein the carrier is a solid are most preferably presented as unit dose suppositories. Suitable carriers include cocoa butter and other materials commonly used in the art, and the suppositories may be conveniently formed by admixture of the pharmaceutical composition with the softened or melted carrier(s) followed by chilling and shaping in molds. [0101]
  • Pharmaceutical compositions suitable for vaginal administration may be presented as pessaries, tampons, creams, gels, pastes, foams or sprays containing, in addition to the nanoparticles and the therapeutic agent, such carriers are well known in the art. [0102]
  • For administration by inhalation, the pharmaceutical compositions according to the invention are conveniently delivered from an insufflator, nebulizer or a pressurized pack or other convenient means of delivering an aerosol spray. Pressurized packs may comprise a suitable propellant such as dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane, carbon dioxide or other suitable gas. In the case of a pressurized aerosol, the dosage unit may be determined by providing a valve to deliver a metered amount. [0103]
  • Alternatively, for administration by inhalation or insufflation, the pharmaceutical compositions of the invention may take the form of a dry powder composition, for example, a powder mix of the pharmaceutical composition and a suitable powder base such as lactose or starch. The powder composition may be presented in unit dosage form in, for example, capsules or cartridges or, e.g., gelatin or blister packs from which the powder may be administered with the aid of an inhalator or insufflator. [0104]
  • For intra-nasal administration, the pharmaceutical compositions of the invention may be administered via a liquid spray, such as via a plastic bottle atomizer. Typical of these are the Mistometer® (isoproterenol inhaler-Wintrop) and the Medihaler® (isoproterenol inhaler—Riker). [0105]
  • Pharmaceutical compositions of the invention may also contain other adjuvants such as flavorings, colorings, anti-microbial agents, or preservatives. [0106]
  • It will be further appreciated that the amount of the pharmaceutical compositions required for use in treatment will vary not only with the particular salt selected but also with the route of administration, the nature of the condition being treated and the age and condition of the patient and will be ultimately at the discretion of the attendant physician or clinician. [0107]
  • The amount of a therapeutic agent in combination with ligated-fluorescent nanoparticles of the invention which can be administered and the frequency of administration to a given human patient will depend upon a variety of variables related to the patient's psychological profile and physical condition. For evaluations of these factors, see J. F. Brien et al., [0108] Europ. J. Clin. Pharmacol., 14, 133 (1978); and Physicians' Desk Reference, Charles E. Baker, Jr., Pub., Medical Economics Co., Oradell, N.J. (41st ed., 1987). Generally, the dosages of the therapeutic agent when used in combination with the ligated-fluorescent nanoparticles of the present can be lower than when the therapeutic agent is administered alone or in conventional pharmaceutical dosage forms. The high specificity of the ligated-fluorescent nanoparticle for a target site, such as a receptor situated on a cell's surface, can provide relatively high localized concentrations of a therapeutic agent, or alternatively, a sustained release of a therapeutic agent over an extended time period.
  • “Pharmaceutically acceptable salts” of the ligated-fluorescent nanoparticles and the therapeutic agents of the invention can include, but are not limited to, the nontoxic addition salts with organic and inorganic acids, such as the citrates, bicarbonates, malonates, tartrates, gluconates, hydrochlorides, sulfates, phosphates, and like salts. Additionally, in cases where the nanoparticles are sufficiently basic or acidic to form stable acid or base salts, preparation of the nanoparticles as salts may be appropriate. Examples of acceptable salts are organic acid addition salts formed with acids which form a acceptable anion, for example, tosylate, methanesulfonate, acetate, citrate, malonate, tartarate, succinate, benzoate, ascorbate, α-ketoglutarate, and α-glycerophosphate. Suitable inorganic salts may also be formed, including hydrochloride, sulfate, nitrate, bicarbonate, and carbonate salts. Acceptable salts may be obtained using standard procedures known in the art, for example by reacting a sufficiently basic compound such as an amine with a suitable acid affording a diagnostically acceptable anion. Alkali metal (e.g., sodium, potassium or lithium) or alkaline earth metal (e.g. calcium) salts of carboxylic acids can also be made. [0109]
  • “Receptor” is any macromolecular compound or composition capable of recognizing (e.g. such as having an enhanced binding affinity to) a particular spatial and polar organization of a molecule, i.e., epitopic or determinant site. Illustrative receptors include naturally occurring receptors, e.g., thyroxine binding globulin, antibodies, enzymes, immunoglobulin (Fab) fragments, lectins, various proteins found on the surface of cells (cluster of differentiation or CD molecules), and the like. CD molecules denote known and unknown proteins on the surface of eukaryotic cells, for example, CD4 is the molecule that primarily defines helper T lymphocytes. [0110]
  • “Haptens” can include naturally occurring hormones, naturally occurring drugs, synthetic drugs, pollutants, allergens, affector molecules, growth factors, chemokines, cytokines, lymphokines, amino acids, oligopeptides, chemical intermediates, nucleotides, oligonucleotides, and the like. The use for such compounds may be in the detection of drugs of abuse, therapeutic dosage monitoring, health status, donor matching for transplantation purposes, pregnancy (e.g., hCG or alpha-fetoprotein), detection of disease, e.g. endotoxins, cancer antigens, pathogens, and the like. [0111]
  • “Immunoconjugate” is a molecule formed by attachment of two different molecules or entities, such as an antibody ligated to a fluorescent nanoparticle, and a second usually biologically active molecular entity (analyte) such as an organic drug molecule, a radionuclide, an enzyme, a toxin, a protein, and like materials that can be conjugated to the antibody to form the conjugate. The antibody portion directs or guides the attached fluorescent nanoparticle to the target analyte enabling the fluorescent nanoparticle to efficiently produce a biological or marking effect. [0112]
  • Pathogens of interest can be, for example, viruses such as Herpesviruses, Poxviruses, Togaviruses, Orthomyxoviruses, Paramyxoviruses, Rhabdoviruses, Coronaviruses, Arenaviruses, and Retroviruses. Pathogens also include prions and bacteria including but not limited to [0113] Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, Staphylococcus aureus, Enterococcus faecalis, Klebsiella pneumoniae, Salmonella typhimurium, Staphylococcus epidermidis, Serratia marcescens, Mycobacterium bovis, methicillin resistant Staphylococcus aureus and Proteus vulgaris. A non-exhaustive list of these organisms and associated diseases can be found, for example, in U.S. Pat. No. 5,795,158.
  • Assays using nanoparticles of the invention can be carried out in a biological fluid, including separated or unfiltered biological fluids such as urine, cerebrospinal fluid, pleural fluid, synovial fluid, peritoneal fluid, amniotic fluid, gastric fluid, blood, serum, plasma, lymph fluid, interstitial fluid, tissue homogenate, cell extracts, saliva, sputum, stool, physiological secretions, tears, mucus, sweat, milk, semen, vaginal secretions, fluid from ulcers and other surface eruptions, blisters, abscesses, and extracts of tissues including biopsies of normal, malignant, and suspect tissues or any other constituents of the body which may contain the analyte of interest. Other similar specimens such as cell or tissue culture or culture broth are also of interest. Alternatively, the sample can be obtained from an environmental source, such as soil, water, or air; or from an industrial source such as taken from a waste stream, a water source, a supply line, or a production lot. Industrial sources also include fermentation media, such as from a biological reactor or food fermentation process such as brewing; or foodstuff, such as meat, game, produce, or dairy products. The test sample can be pre-treated prior to use, such as preparing plasma from blood, diluting viscous fluids, and the like; methods of pretreatment can involve filtration, fractionation, distillation, concentration, inactivation of interfering compounds, and addition of reagents, and like steps, or combinations thereof. [0114]
  • Methods for detecting multiple subpopulations of analytes are known, see for example, U.S. Pat. No. 5,567,627, to Lehnen, and can be adapted to the present invention. Methods for detecting a nucleic acid with one or more nanoparticle having oligonucleotides attached thereto, including an electrochemical assay with a probe oligonucleotide having attached a redox-active molecule, for example as in U.S. Pat. No. 6,417,340, to Mirkin, et al, can be adapted to the present invention. Methods for electrochemical detection and localization of genetic point mutations and other base-stacking perturbations within oligonucleotide duplexes adsorbed onto electrodes, such as U.S. Pat. No. 6,221,586, to Barton, et al., can be adapted to the present invention. Methods for multiplexed fluorescent analysis of a plurality of analytes in a sample, such as U.S. Pat. No. 6,268,222, to Chandler, et al., can be adapted to the present invention. Other detection methods include using ultraviolet and visible spectroscopy, see for example X. Gong and E. S. Yeung, [0115] Anal. Chem., 71, 4989 (1999), “An Absorption Detection Approach for Multiplexed Capillary Electrophoresis Using a Linear Photodiode Array”. Methods for separating cells using a flow through fractional cell sorting process based on the application of a magnetic force to cells having a range of magnetic labeling densities, such as U.S. Pat. No. 5,968,820, to Zborowski, et al., can be adapted to the present invention. Methods for separating particles bound to each other via non-covalent binding and agglomeration, such as U.S. Pat. No. 4,279,617, to Masson et al., can be adapted to the present invention.
  • For the purposes of the present invention the nanoparticle's fluorescent component should provide a signal related to the presence of analyte in the sample. Similarly, when a ligand is selected, which includes a fluorescent nanoparticle, it should provide a fluorescent signal related to the presence of analyte in the sample and which signal can be detected as electromagnetic radiation, particularly as radiation in the ultra-violet, visible or infrared range. [0116]
  • “Optional” or “optionally” mean that the subsequently described event or condition may but need not occur, and that the description includes instances where the event or condition occurs and instances in which it does not. For example, “optionally including” means that the named component may be present but need not be present, and the description includes situations where the named component is included and situations where the named component is not included. [0117]
  • The terms “include”, “for example”, “such as”, and the like are used illustratively and are not intended to limit the present invention. [0118]
  • The indefinite articles “a” and “an” mean “at least one” or “one or more” when used in this application, including the claims, unless specifically indicated otherwise. [0119]
  • The following general methods were employed in preparing and evaluating nanoparticles, and conjugates or adducts, of the present invention. [0120]
  • Preparation of Fluorescent Nanoparticles [0121]
  • Processes and intermediates for preparing fluorescent nanoparticles of the invention are provided as further embodiments of the invention and are illustrated by the following procedures in which the meanings of the generic radicals are as given unless otherwise specified. [0122]
  • In embodiments, a fluorescent nanoparticle of the invention can be prepared, for example, mixing a reactive fluorescent compound, such as, a reactive fluorescent material, such as a dye (D) and a co-reactive organo-silane compound such as, a known organo-functional silane compound (OS) to form a fluorescent core particle (D-OS); and mixing the resulting core particle (D-OS) with a silica forming compound, such as a (Si(OR)[0123] 4), to form a silica shell on the core which product is a fluorescent nanoparticle (D-OS)(SiO2).
  • The molar equivalent ratio of the reactive fluorescent material (D) and the co-reactive organo-silane compound (OS) can be, for example, from about 1:1 to about 1:100. The molar equivalent ratio of the fluorescent core particle (D-OS) to the silica forming compound (Si(OR)[0124] 4) can be, for example, from about 1:1 to about 1:100.
  • The nanoparticles of the present invention can be selectively linked to either or both a ligand and analyte by, for example, any known chemical coupling reactions such as carbodiimide coupling. Other coupling methods include use of carboxylates, esters, alcohols, carbamides, aldehydes, amines, sulfur oxides, nitrogen oxides, or halides, and other methods known in the art can be used. Coupling a fluorescent nanoparticle to a ligand, or a ligated-fluorescent nanoparticle to an analyte, and like combinations, can generally be accomplished by applying the procedures and principles disclosed in U.S. Pat. No. 6,268,222, or other procedures known in the art as applied to the present invention. [0125]
  • In embodiments, linked-fluorescent nanoparticle, such as a surface modified fluorescent nanoparticle of the invention can be prepared, for example, from a preformed fluorescent nanoparticle fluorescent nanoparticle (D-OS)(SiO[0126] 2) and a ligand, such as a biologically active compound (of formula X1-R1-X2), and optionally a linker precursor (of formula Z1-L-Z2), wherein X1, X2, Z1, and Z2 can be selected from the values in the table below. In the absence of an optional linker precursor the surface silanol (Si—OH) groups of the silica shell can be used to link or associate with the ligand. The ligand and the linker precursor can be reacted or polymerized using well known synthetic techniques (e.g. by condensation) to provide a ligated-fluorescent nanoparticle or linked product of the invention. Depending on the reactive functional group (X1 or X2) of the ligand, a corresponding functional group (Z1 or Z2) can be selected from the following table, to provide an ester linkage, thioester linkage, or amide linkage in the ligated-fluorescent nanoparticle or linked product.
    Resulting Linkage
    Functional Group On in the Ligated-
    Functional Group On Linker Precursor Fluorescent
    ligand (X1 or X2) (Z1 or Z2) Nanoparticle
    —COOH —OH Ester
    —COOH —NHR Amide
    —COOH —SH Thioester
    —OH —COOH Ester
    —SH —COOH Thioester
    —NHR —COOH Amide
    —SO3H —OH Sulfate Ester
    —OH —SO3H Sulfate Ester
  • As will be clear to one skilled in the art, suitable protecting groups can be used during the ligation reaction. For example, other functional groups present in the biologically active compound, on the nanoparticle surface, or the linker precursor can be partially or completely protected during ligation, and the protecting groups can subsequently be removed to provide the ligated-fluorescent nanoparticles of the invention. Suitable protecting groups and methods for their incorporation and removal are well known in the art (see for example Greene, T. W.; Wutz, P. G. M. “Protecting Groups In Organic Synthesis” second edition, 1991, New York, John Wiley & sons, Inc.). [0127]
  • Additionally, when a carboxylic acid is reacted with a hydroxy group, a mercapto group, or an amine group to provide an ester linkage, thioester linkage, or an amide linkage, the carboxylic acid can be activated prior to the reaction, for example, by formation of the corresponding acid chloride. Numerous methods for activating carboxylic acids, and for preparing ester linkages, thioester linkages, and amide linkages, are known in the art (see for example, [0128] Advanced Organic Chemistry: Reaction Mechanisms and Structure, 4th ed., Jerry March, John Wiley & Sons, pages 419-437 and 1281).
  • The silica shell surface of the nanoparticles can be further modified if desired by, for example, surface functionalization reactions using known cross-linking agents to afford surface functional groups and as illustrated herein. Crosslinking agents are, for example, divinyl benzene, ethylene glycol dimethacrylate, trimethylol propane trimethacrylate, N,N′-methylene-bis-acrylamide, alkyl ethers, sugars, peptides, DNA fragments, or other known functionally equivalent agents. It is readily evident to one skilled in the art that many cross-linking agents can be used in combination with, or suitable for use as the ligand in forming ligated-fluorescent nanoparticles of present invention. It is readily evident to one skilled in the art in possession of the present invention that cross-linking agents can be used in surface modifying reactions to modify the surface properties of fluorescent nanoparticles, or ligated-fluorescent nanoparticles, and as illustrated herein. [0129]
  • Materials and Methods [0130]
  • All reagents were used as received without further purification and distillation. The ammonia molarity was determined by titration with methyl blue indicator before each synthesis. Glassware was cleaned by methods described in literature and dried using a heat gun before the synthetic procedure. The volume after mixing was ignored in the molarity calculations. The amount of 3-aminopropyltriethoxysilane (APTS) in the synthesis of the fluorescent core was not taken into account in the calculations of monomer molarity in Table I. [0131]
  • Nanoparticle Synthesis Materials [0132]
  • Absolute ethanol (Aldrich), Tetrahydrofuran (Aldrich), Ammonium hydroxide (Fluka, 28%), Tetraethoxysilane (Aldrich, 98%), 3-Aminopropyltriethoxysilane (Aldrich, 99%), 3-Mercaptopropyltriethoxysilane (Gelest, 99%), Tetramethylrhodamine-5-(and -6-)-isothiocyanate *mixed isomers* (TRITC) (Molecular Probes, 88%), Alexa Fluor® 488 C[0133] 5 Meleimide (Molecular Probes, 97%), Alexa Flour® 488 carboxylic acid, and succinimidyl ester (Molecular Probes, ≧50%).
  • Preparation of Core (Fluorescent Seed) Nanoparticles Generally [0134]
  • Amounts of water, ammonia and solvent were measured in graduated cylinders. Fluorescent seed particle synthesis was carried out in 1 L Erlenmeyer flasks and stirred with magnetic TEFLON® coated stir bars at about 600 rpm. De-ionized water and ammonia solution were added to ethanol and stirred. About 2 mL of the reactive dye precursor in either ethanol or THF containing about 425 micromolar APTS, was added to the reaction vessel. The resulting mixture was stirred for about 1 to about 3 hours at room temperature with the reaction vessel covered with aluminum foil to minimize exposure to light to afford a fluorescent seed particle mixture. Tetrahydrofuran (THF) and absolute ethanol (EtOH) were distilled under nitrogen. Organic dyes were brought to room temperature from storage temperatures of about −20° C., then placed in a glove box. [0135]
  • Preparation of the Silica Shell on the Core (Fluorescent Seed) Particles Generally [0136]
  • The silica shell coating and growth step was performed in the above mentioned fluorescent seed particle reaction mixture with regular addition of solvent, such as ethanol, methanol, or isopropanol, to prevent drastic changes in solution ionic strength while the silica forming monomer tetraethoxysilane (TEOS) was added. This prevents particle aggregation during synthesis, which can broaden the particle size distribution. [0137]
  • Characterization of Fluorescence Nanoparticles [0138]
  • The particle size and particle size distribution of the resulting fluorescent nanoparticles were characterized by electron microscopy (SEM) and fluorescence correlation spectroscopy (FCS). [0139]
  • Referring to FIG. 1A, there is illustrated an example of fluorescent brightness properties of the fluorescent nanoparticles (10) of the present invention compared to polystyrene latex beads (20). Fluorescence correlation spectroscopy (FCS) was used to obtain the count rates for the nanoparticles and beads as follows: 100 or 300 nanometer fluorescent nanoparticles had 299.1 kHz per particle; and 300 nanometer polystyrene latex beads had 69.84 kHz per bead. Fluorescence count rates indicated that the fluorescent nanoparticles (10) were about four times brighter than the polystyrene latex beads. [0140]
  • Photo-physical characterizations were performed to determine: dye content per particle content, fluorescence lifetimes, and action cross-sections. The action cross-section metric is essentially the product of quantum yield and absorbance profile. Time resolved fluorescence measurements of fluorescence versus time in nanoseconds (ns) showed that a dye incorporated in a nanoparticle exhibited a longer lifetime than free dyes in solution, indicating that each dye molecule could be about 46% brighter when contained inside the core of the nanoparticles than when free in solution. For example, TRITC dyes contained within the core of the nanoparticle (with a diameter of about 25 nanometers), had a fluorescence lifetime of about 3.33 ns, compared to TRITC dyes free in solution which had a fluorescence lifetime of about 2.28 ns. [0141]
  • From absorbance measurements over the range of 250 to 650 nanometers it was established that there are, for example, about 20 dye molecules per nanoparticle. For example, sample R30 had about 23 TRITC dye molecules per nanoparticle; and sample R29 had about 21 TRITC dye molecules per nanoparticle. However, action cross section measurements, σ[0142] 2p (GM) over the range of 700 to about 1,000 nm for two separate preparations of 25 nm particles (samples R29 and R30) demonstrated that R30 was almost twice as bright as R29 over the range and particularly at absorbance maxima at about 700 and about 840 nanometers, even though the dye content is almost identical. This observation suggested great complexity associated with interaction effects between the core and the shell and they may be responsible for the enhanced quantum efficiency observed. Thus, it is possible to further optimize the fluorescence properties of the nanoparticles of the present invention, for example, for use as biomarkers, by straight-forward procedures such as changing the thickness of the core or shell as disclosed herein. The invention will now be illustrated by the following non-limiting examples:
  • EXAMPLE 1
  • Preparation of Red Core Nanoparticles. 10 mg of tetramethylrhodamine-5-(and 6-)isothiocyanate (TRITC) were dissolved in ethanol. The molar ratio of 3-aminopropyltriethoxysilane (APTS) to TRITC was 50 to 1, with 2 mL of ethanol, per mg of APTS. Following complete dissolution of TRITC in ethanol, APTS was added to the reaction vessel. The reaction was stirred in the dark in the glove box for about 12 hours at room temperature. [0143]
  • EXAMPLE 2
  • Preparation of Green Core Nanoparticles. [0144]
  • 5 mg of Alexa Fluor® 488 C[0145] 5 Meleimide was dissolved in ethanol. The molar ratio of 3-mercaptopropyltriethoxysilane (MPTS) was 100 to 1, with 2 mL of ethanol per mg of MPTS. Following complete dissolution of TRITC in ethanol, MPTS was added to the reaction vessel and stirred for about 12 hours in darkness at room temperature.
  • 5 mg of Alexa Fluor® 488 carboxylic acid, succinimidyl ester was dissolved in THF. The molar ratio of 3-Aminopropyltriethoxysilane (APTS) to Alexa Flour® 488 carboxylic acid, succinimidyl ester was 100 to 1, with 2 ml of THF per mg of APTS. Following complete dissolution of Alexa Fluor® 488 carboxylic acid, succinimidyl ester in THF, APTS was added to the reaction vessel and stirred for 12 hours in darkness at room temperature. Due to the minute quantities, the fluorescent dye-core adducts were not isolated from the reaction medium before the silica shell was deposited. [0146]
  • EXAMPLE 3
  • Preparation of Sized Silica Coated Fluorescent Nanoparticles Preparation of silica coated fluorescent nanoparticles of different sizes was accomplished using different relative molar amounts of reagents as described above. The molar amounts of reagents for the synthesis of 20 nm to 200 nm particles are tabulated in Table I. All silica coating of fluorescent nanoparticle procedures were accomplished at ambient conditions, i.e. at room temperature with ethanol as the solvent. A representative procedure follows. [0147]
  • To a mixture containing fluorescent core particles there was added continuously 2 mL of TEOS in 100 mL additional solvent, dropwise such as over about 20 minutes. The remaining larger quantity of the TEOS was added at a more rapid rate, such as over about a 45 minute period with simultaneous addition of 400 mL of additional solvent. Optionally, water was added at this stage to grow particles larger than about 100 nm and to maintain the molar ratio of water to TEOS as tabulated in Table I. The resulting suspension was stirred overnight at room temperature in darkness. [0148]
    TABLE I
    Reactants (in molarity) for the Preparation and the Resulting Particle
    Size of Silica Shell Coated Fluorescent Nanoparticles
    Nominal particle Size by Size by
    size [NH3] [H2O] [TEOS] Solvent FCS SEM
    500 nm  6.127 M 16.83 M 0.1923 M i-PrOH 500 nm
    300 nm  6.127 M 16.83 M 0.1923 M EtOH 300 nm
    200 nm  3.892 M 10.80 M 0.2443 M EtOH 200 nm
    100 nm  3.892 M 10.80 M 0.2443 M i-PrOH:MeOH 125 nm
    (v:v = 3:1)
     70 nm 0.0085 M 17.60 M 0.2003 M EtOH  75 nm
     50 nm 0.0096 M 26.68 M 0.1518 M MeOH 48.6 nm
     40 nm  0.318 M 1.153 M  0.155 M EtOH 37.6 nm
     30 nm  0.150 M 1.710 M  0.155 M EtOH 28.8 nm  30 nm
     25 nm  0.200 M 1.494 M  0.155 M EtOH 24.4 nm
  • Alternatively, to produce nanoparticles having a narrow particle size range below about 70 nm, TEOS was added in small aliquots intermittently, such as 300 microliters in about 10 to 15 minute intervals, and stirred overnight at room temperature in darkness. Molar ratio of de-ionized water to monomer was kept maintained at about at least 6-fold but not more. To better monitor water content in the reaction mixture, 2.0 M ammonia was used as the catalyst source, dissolved in ethanol, methanol or isopropanol, depending on the primary solvent of the synthesis, such as 2.0 M ammonia in ethanol. After the dye-rich core/seed particle was prepared, tetraethyl orthosilicate monomer was added intermittently, such as 300 microliters every 10 minutes to grow the siliceous shell. In contrast to the larger particle procedure where monomer was added continuously via a dropping funnel, the smaller particle size procedure (for particles below about 70 nm) the TEOS monomer was added intermittently. The alternative procedure for preparing silica shell coated fluorescent nanoparticles was devised because the size distribution of silica nanoparticles prepared by the known Stöber procedure (J. Colloid and Interface Sci., 26 62-69 (1968)) has a self-sharpening characteristic as particle size increases beyond 70 nm as more monomer is added to the reaction mixture. Thus, silica nanoparticles smaller than 70 nm generally have a much broader size distribution. Therefore, the first mentioned procedure of Example 3, was modified as described thereafter to obtain nanoparticles with a narrower size distribution than what might be expected for particle sizes in the range of about 10 to about 70 nm. [0149]
  • EXAMPLE 4
  • Nanoparticle Ligation (coupling) with IgE by Adsorption Silica coated fluorescent nanoparticles of Example 3 were diluted (1: 10-1:20) with phosphate buffered saline (PBS) or Tyrodes buffer at [0150] pH 7. Immunoglobulin E (IgE) (0.85 mg/mL stock concentration) was adsorbed onto the fluorescent nanoparticles by incubating with IgE for about 3 hours at room temperature to provide, for example, nanoparticle-IgE ratios of from about 1:1 to about 1:4. For nanoparticles greater than about 50 nm, unbound IgE was removed by centrifugation. For nanoparticles of size of 50 nm or smaller, the unbound IgE was removed by adding 100 microliters (in a total volume of 500 microliters nanoparticles-IgE) of 0.25 wt % latex particles of size 1:2 microns. Unbound IgE stuck to the large latex particles which then settled out of suspension if undisturbed in several hours, for example, with overnight incubation at 4° C. The residual pellet mass was confirmed to be primarily latex particles bound with IgE and discarded. The resulting supernatant containing the IgE coupled-nanoparticle (IgE ligated-fluorescent nanoparticle) was carefully separated and placed in a vial. The resulting IgE coupled-nanoparticle samples (i.e. IgE adsorbed onto nanoparticles) were stored at 4° C. for cell binding experiments. The IgE coupled nanoparticles were diluted in Tyrodes-BSA before cell binding. The dilution was according to the IgE coupled-nanoparticle number density desired per cell.
  • EXAMPLE 5
  • Nanoparticle Surface Functionalization The surface of the nanoparticles can be further chemically modified to improve the versatility and stability of the nanoparticles, for example, introducing carboxylic acid groups or like chemical functional groups. Introducing functional groups, such as carboxylic acid groups, to the surface of silica coated nanoparticles can provide attachment points to enable covalent attachment of bio-molecules, for example, proteins and antibodies, to the surface of the nanoparticles. Surface functional groups, especially ionizable groups, provide other desirable properties to the nanoparticles, such as charge stabilization in buffered media. Charged carboxylate surface groups can maintain the nanoparticles as single particle colloidal dispersions which avoid or minimize nanoparticle agglomeration. Nanoparticle surface functionalization procedures are known and include, for example, carbodiimide modification and as illustrated herein. [0151]
  • Materials [0152]
  • 3-aminopropyldimethylethoxysilane (APDMES) (Gelest Inc.); Bifunctional Crosslinking Reagent (Pierce Endogen Inc.): Methyl N-succinimidyl adipate (MSA). [0153]
  • Nanoparticle surface functionalization was accomplished as follows. A 20 mL suspension of nanoparticles with a diameter of 25 nm, as described in Table I, was used. The nanoparticle concentration was 4.33 mg/mL as determined by fluorescence correlation spectroscopy, and by drying and weighing known volumes of the suspension. Other nanoparticle sizes and concentrations can be surface modified according to this procedure when appropriately adapted in view of differences in particle size, surface area, concentration, and like considerations. [0154]
  • Fluorescent nanoparticles having a silica shell were cleaned by dialysis after their initial preparation described above. The concentration of the silica shelled nanoparticle suspension was determined by drying aliquots of the nanoparticle suspension in a vacuum oven and weighing, or by fluorescence correlation spectroscopy. Assuming a density of 2 g/mL and knowing the size of the nanoparticles, the number of particles per mL of suspension was calculated to be about 1.78·×10[0155] 16. The total nanoparticle surface area, assuming solid particles, was for example, about 3.35·×1019 nm2. The density of silanol groups can be estimated as about 1.4 —OH groups per square nanometer according to literature values (e.g. R. Iler, The Chemistry of Silica), and hence there is about 7.78·10−5 moles of —OH groups available for reaction with APDMES for 100% amine coverage. APDMES was added in a 2 molar excess with about 5 mg of ammonium fluoride as a catalyst, and allowed to react for about 12 hours at ambient temperature and shielded from ambient light. Excess unreacted APDMES was dialyzed away in phosphate buffer at pH 7 over 12 hours. The resulting aminated nanoparticles suspended in phosphate buffer pH 7 were then reacted with 2-molar excess of MSA dissolved in dimethyl sulfoxide at ambient temperature for about 2 to 6 hours. Excess unreacted MSA was dialyzed away in phosphate buffer at pH 9.5 for about 6 to 12 hours, which also hydrolyzes the ester group in the MSA, to afford carboxylic acid groups covalently attached to the surface of the nanoparticle.
  • Nanoparticle Characterization by FTIR [0156]
  • The nanoparticle products at each functionalization step described above were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy. The vibration bands of the mono-substituted amide groups at 1500-1600 cm[0157] −1 indicated the linkage between amine groups of the silane compound APDMES and the succinimidyl ester groups of the MSA compound, as well as the carboxylic acid signature at 1700 cm−1. The observed spectroscopic changes compared to the starting nanoparticles were indicative of successful surface functionalization reactions.
  • EXAMPLE 6
  • Nanoparticle Ligation (coupling) by Covalent Conjugation Other surface functionalization examples can be accomplished by covalent conjugation of fluorescent nanoparticles with various biomolecules as described above. [0158]
  • EXAMPLE 7
  • Cell Binding with IgE Coupled-Fluorescent Nanoparticles Specificity binding experiments using a rat basophilic leukemia (RBL) mast cell model system demonstrated specific binding characteristics of the fluorescent silica-based nanoparticles. Cells (e.g. rat basophilic leukemia (RBL) mast cells) were harvested using Trypsin-EDTA. The cells were then counted to determine the cell concentration (number of cells per mL). The appropriate number of cells was incubated with IgE coupled-nanoparticles, for example, around 2×10[0159] 5 IgE coupled-nanoparticles per cell, for about 1 hour on ice to avoid any internalization. The resulting nanoparticle-IgE bound cells, i.e. IgE coupled-nanoparticles bound to cells, were washed with Tyrodes-BSA, and the cells were viewed under a confocal microscope for specific binding.
  • Confocal microscope images showed, for example, the top surface of the cells decorated with the red nanoparticles, and the antibody IgE is labeled with a green fluorophore to show co-localization of the antibody with the nanoparticles. Another set of images, taken from the equitorial view of the cells showed an alternative confocal view where diffusive motions of the antibody receptors marked by the fluorescent nanoparticles can be monitored via SPT. Appropriate controls were performed to check for non-specific binding as follows. Control cells were pre-sensitized overnight using IgE, so that all the receptor sites were blocked. These blocked cells were then harvested in the same manner as above using Trypsin-EDTA, labeled with same IgE coupled-nanoparticles per cell concentration. These cells were then viewed under the confocal microscope for any non-specific binding (or sticking). [0160]
  • Referring to FIGS. 2A and 2B, there is illustrated an example of high biomolecular binding specificity of, for example, 100 or 300 nanometer diameter fluorescent nanoparticles of the present invention (FIG. 2A) compared to polystyrene latex beads (FIG. 2B) as measured by cell counting statistics. The result indicate that specific interactions (represented by the left-side of the bar pairs) of rat basophilic leukemia (RBL) mast cells coupled with IgE coupled-nanoparticles and cells coupled with polystyrene latex beads are comparable whereas less desirable or undesired non-specific interactions (represented by the right-side of the bar pairs), such as “sticking” interactions, were greater for polystyrene latex beads and cells compared to IgE coupled-nanoparticles and cells. A comparable result is expected for fluorescent nanoparticles of the present invention with diameters between 25 and 100 nanometers. [0161]
  • In FIGS. 2A and 2B, the legends: [0162]
  • “IgE[0163] M” refers to mouse IgE which will bind specifically to IgE receptors of rat basophilic leukemia (RBL) mast cells;
  • “control: IgE[0164] H” refers to human IgE which will not bind to IgE receptors of the aforementioned rat cells; and
  • “control: particles alone” refers to the respective binding of IgE coupled-fluorescent nanoparticles with cells, and binding of polystyrene latex beads with cells. [0165]
  • EXAMPLE 8
  • Single Particle Tracking (SPT) Single fluorescent nanoparticle tracking experiments were performed by confocally following the motion of a selected single bright fluorescent spot (corresponding to a single receptor bound particle) for about 20-30 minutes to track the diffusion of the receptor to which the single particle was bound. Alternatively, a plurality of selected single bright fluorescent spots could be tracked. [0166]
  • Single particle tracking evaluates lateral diffusion of individual components on cell surfaces. This method is based on direct observation of bright fluorescent probes that are specifically conjugated to macromolecules of interest. Tracking of individual components reveals a variety of interesting and useful behaviors including confinement to a small region or movement along a track. This information enables an understanding of how components interact within cells, on cell membranes and like structures or components. However, the method is highly dependent on the quality of the probes. A significant shortcoming of the method has been nonspecific binding of the particles to cells. The fluorescent nanoparticles and the ligated-fluorescent nanoparticles of the present invention provide enhanced brightness and high conjugation specificity to a component of interest. The ligated-fluorescent nanoparticles were demonstrated to be biocompatible and minimize non-specific binding interactions. [0167]
  • EXAMPLE 9
  • Mesoporous Silica Nanoparticles for Targeted Delivery and Controlled Release of a Therapeutic Agent Fluorescent core nanoparticles were prepared according to, for example, Examples 1 and 2, and in accord with the general core preparative procedure above. [0168]
  • Mesoporous Shell [0169]
  • A surface substantive agent, N-hexadecyltrimethylammonium bromide (2.4 g, 6.6 mmol, HDTB), was dissolved in the reaction mixture containing fluorescent seed core nanoparticles. The mixture was stirred (450 rpm) until the HDTB was fully dissolved and then 3.4 g TEOS (16 mmol) was added all at once. The HDTB serves as a templating agent around which the silica shell's formation is ordered and perturbed to enable pore formation by subsequent removal of the HDTB associated with the surface. Subsequent cleaning or removal of the HDTB from the nanoparticle provides fluorescent nanoparticles having a mesoporous silica shell. [0170]
  • Cleaning Procedure [0171]
  • After about 5 hours of reaction with TEOS, a solid was recovered from three centrifugation washes at 6,000 rpm. At each centrifugation step the supernatant was refreshed with absolute ethanol. Two washes by filtration in de-ionized water followed the centrifugation procedure. The centrifugation and filtration steps removed approximately 90% of the HDTB surfactant. The recovered nanoparticles containing solid was finally suspended in absolute ethanol. The suspension was homogenized by ultrasonic agitation. [0172]
  • A vacuum distillation was carried out to exchange ethanol solvent with dimethyl sulfoxide (DMSO). Final concentrations were determined by drying an aliquot of the suspension and weighing the solid mass. The resulting meso-porous nanoparticles in DMSO were suitable for loading therapeutic agent as illustrated below. [0173]
  • Loading Mesoporous Nanoparticles with a Therapeutic Agent [0174]
  • The above mesoporous nanoparticles suspended in DMSO were stirred and transferred to a 50 mL Falcon tube. The solution was centrifuged at 3,000 rpm for about 5 minutes and the volume of DMSO was reduced to 4 mL by pouring off 6 mL of the supernatant fluid. A 16 mg sample of a therapeutic agent, camptothecin (CPT), was added to the solution. After 5 hours, the solution was centrifuged, and two washes with phosphate buffer saline (PBS) were done. For each wash, 20 mL of PBS was added, and the particles were sonicated and centrifuged. Sonication was done at 15% power with a pulse rate of 1.0 second on and 1.0 second off for 30 seconds of pulsing or until the solution appeared homogenous. The centrifugation was done at 25° C. at 3,000 rpm for 5 minutes. Therapeutic agent loaded particles were stored at room temperature. [0175]
  • All publications, patents, and patent documents are incorporated by reference herein, as though individually incorporated by reference. The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention. [0176]

Claims (58)

What is claimed is:
1. A fluorescent nanoparticle comprising:
a core comprising a fluorescent silane compound; and
a silica shell on the core.
2. The nanoparticle of claim 1 wherein the core comprises the reaction product of a reactive fluorescent compound and an organo-silane, and the shell comprises the reaction product of a silica forming compound.
3. The nanoparticle of claim 1 further comprising a ligand on the surface of the fluorescent nanoparticle to form a ligated-fluorescent nanoparticle.
4. The nanoparticle of claim 3 wherein the ligand on the surface of the fluorescent nanoparticle is attached by a covalent bond or by physical absorption.
5. The nanoparticle of claim 3 wherein the ligand on the surface of the fluorescent nanoparticle is selected from the group consisting of a biopolymer, a synthetic polymer, an antigen, an antibody, a microorganism, a virus, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, a surface modifier, and combinations thereof.
6. The nanoparticle of claim 1 wherein the silica shell coating on the core covers from about 10 to about 100 percent of the surface area of the core.
7. The nanoparticle of claim 3 wherein the ligand on the surface of the fluorescent nanoparticle covers from about 10 to about 100 percent of the surface area of the core.
8. The nanoparticle of claim 1 wherein the thickness of the core to the silica shell is in a ratio of from about 1:1 to about 1:100.
9. The nanoparticle of claim 1 wherein the diameter of the nanoparticle is from about 1 to about 1,000 nanometers.
10. The nanoparticle of claim 1 further comprising a therapeutic agent.
11. The nanoparticle of claim 3 further comprising a therapeutic agent.
12. The nanoparticle of claim 10 or 11 wherein the therapeutic agent is selected from the group consisting of a drug, a biomolecule, a surface modifier, and combinations thereof.
13. The nanoparticle of claim 10 or 11 wherein the therapeutic agent is absorbed into the silica shell of the nanoparticle.
14. The nanoparticle of claim 10 or 11 wherein the therapeutic agent is coated onto the silica shell of the nanoparticle.
15. The nanoparticle of claim 3 wherein the therapeutic agent is associated with the ligand of the nanoparticle.
16. A method of making a fluorescent nanoparticle comprising:
mixing a fluorescent compound and an organo-silane compound to form a fluorescent core; and
mixing the resulting core with a silica forming compound to form a silica shell on the core, to provide the fluorescent nanoparticle.
17. The method of claim 16 further comprising combining the resulting nanoparticle with a ligand selected from the group consisting of a biopolymer, a synthetic polymer, an antigen, an antibody, a microorganism, a virus, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, a surface modifier, and combinations thereof.
18. The method of claim 16 further comprising combining the resulting fluorescent nanoparticle with a therapeutic agent selected from the group consisting of a drug, a biomolecule, a surface modifier, and combinations thereof.
19. The method of any one of claim 17 or 18 wherein combining comprises coating the ligand or therapeutic agent onto the surface of the nanoparticle.
20. The method of any one of claim 17 or 18 wherein combining comprises imbibing the ligand or therapeutic agent into the surface of the nanoparticle.
21. The method of any one of claim 17 or 18 wherein combining comprises bonding the ligand or therapeutic agent to the surface of the resulting nanoparticle.
22. A method for monitoring movement of a cellular component of a cell comprising:
contacting the cell with a ligated-fluorescent nanoparticle to form a cell selectively decorated with the ligated-fluorescent nanoparticle and to form a fluorescent loci; and
recording the motion of the fluorescent loci for a time, to monitor the movement of a cellular component.
23. The method of claim 22 wherein the fluorescent loci corresponds to one or more ligated-fluorescent nanoparticle bound to a component of the cell.
24. The method of claim 22 wherein the fluorescent loci corresponds to a single ligated-fluorescent nanoparticle bound to a component of the cell.
25. The method of claim 22 wherein the ligated-fluorescent nanoparticle is adapted to selectively associate with a cellular component of the cell.
26. The method of claim 22 wherein the cellular component is a receptor, an antibody, a hapten, an enzyme, a hormone, a biopolymer, an antigen, a microorganism, a virus, a pathogen, a toxin, and combinations thereof.
27. The method of claim 22 wherein the ligated-fluorescent nanoparticle is a fluorescent nanoparticle conjugated with an antibody.
28. The method of claim 27 wherein the antibody is an immunoglobin.
29. The method of claim 28 wherein the antibody is IgE.
30. The method of claim 22 wherein recording is accomplished with a microscopically adapted camera.
31. The method of claim 22 wherein recording for a time is from about 1 microsecond to about 30 days
32. The method of claim 22 wherein recording for a time is from about 1 second to about 60 minutes.
33. The method of claim 22 wherein the contacting and the recording are accomplished in vitro.
34. The method of claim 22 wherein the contacting and the recording are accomplished in vivo.
35. A pharmaceutical carrier comprising the fluorescent nanoparticle of claim 1, and optionally a ligand.
36. A pharmaceutical composition comprising the ligated-fluorescent nanoparticle of claim 3 and optionally a therapeutic agent.
37. An imaging agent comprising the ligated-fluorescent nanoparticle of claim 3.
38. A method for treating disease or disorder comprising:
administering to a patient in need of treatment an effective amount of a ligated-fluorescent nanoparticle optionally including a therapeutic agent, the nanoparticle being adapted to selectively associate with a disease producing component of the cell, to form a selectively decorated cell with the ligated-fluorescent nanoparticle; and
illuminating the decorated cell to treat disease or disorder.
39. The method of claim 38 wherein the ligated-fluorescent nanoparticle fluoresces and heats-up when illuminated.
40. The method of claim 38 wherein the ligated-fluorescent nanoparticle is an antibody ligated to a fluorescent nanoparticle.
41. The method of claim 38 wherein the disease is cancerous tumor.
42. The method of claim 38 wherein the disease in sensitive to fluorescence, heat, or both.
43. A method of treating a disease or disorder comprising:
contacting a cell with a ligated-fluorescent nanoparticle to form a cell selectively decorated with the ligated-fluorescent nanoparticle; and
irradiating the resulting decorated cell for a time to treat the disease or disorder.
44. A kit for use in the detection of an analyte, the kit comprising packaging material containing a ligated-fluorescent nanoparticle.
45. A kit for detecting and monitoring a cell surface component, the kit comprising packaging material containing a ligated-fluorescent nanoparticle for detecting the cell surface component, and optionally a recorder for monitoring the cell surface component.
46. An assay method for detecting motion or a change in the location of a cellular component of a cell when the cell is treated with a therapeutic agent comprising:
contacting a cell with a ligated-fluorescent nanoparticle, the nanoparticle having a therapeutic agent, to bind the ligated-fluorescent nanoparticle to a cellular component; and
recording the fluorescent signal, to detect the motion or location change of the component.
47. The method of claim 46 further comprising determining the difference between the motion or movement of the bound ligated-fluorescent nanoparticle in the presence and absence of the therapeutic agent.
48. A method for detecting the presence of an analyte comprising:
contacting a sample which may contain an analyte with a ligated-fluorescent nanoparticle adapted to associate with the analyte, if present, to form a ligated-fluorescent nanoparticle-analyte complex;
optionally separating uncomplexed ligated-fluorescent nanoparticle; and
detecting the fluorescent signal of ligated-fluorescent nanoparticle-analyte complex to establish the presence of the analyte.
49. The method of claim 48 wherein the ligated-fluorescent nanoparticle-analyte comprises:
a ligated-fluorescent nanoparticle where the ligand is selected from the group consisting of a cell component, a biopolymer, a synthetic polymer, an antigen, an antibody, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, and combinations thereof; and
an analyte selected from the group consisting of a microorganism, a virus, a cell, a cell component, a biopolymer, a synthetic polymer, an antigen, an antibody, a receptor, a hapten, an enzyme, a hormone, a chemical compound, a pathogen, a toxin, and combinations thereof.
50. A fluorescent nanoparticle comprising:
a core comprising a fluorescent silane compound; and
a porous silica shell on the core.
51. The nanoparticle of claim 50 further comprising a therapeutic agent, a ligand, or mixtures thereof, on the surface of the fluorescent nanoparticle.
52. The nanoparticle of claim 51 further comprising a ligand on the surface of the fluorescent nanoparticle.
53. The nanoparticle of claim 51 further comprising a therapeutic agent on the surface of the fluorescent nanoparticle.
54. The nanoparticle of claim 51 further comprising a magnetic component in the core of the fluorescent nanoparticle.
55. The method of claim 16 further comprising treating the fluorescent core with a templating agent prior to forming a silica shell on the core.
56. The method of claim 55 wherein the templating agent is a quaternary ammonium salt.
57. The method of claim 55 further comprising removing the templating agent after forming a silica shell on the core to afford a porous silica shell.
58. The method of claim 57 further comprising treating the porous silica shell with a ligand, a therapeutic, or mixtures thereof.
US10/306,614 2002-11-26 2002-11-26 Fluorescent silica-based nanoparticles Abandoned US20040101822A1 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
US10/306,614 US20040101822A1 (en) 2002-11-26 2002-11-26 Fluorescent silica-based nanoparticles
EP03815995.0A EP1572445B1 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
CNA200380109241XA CN1742094A (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
ES11156074T ES2753144T3 (en) 2002-11-26 2003-11-26 Silica-based fluorescent nanoparticles
CNA200810170588XA CN101387639A (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
JP2004566499A JP4965804B2 (en) 2002-11-26 2003-11-26 Silica-based fluorescent nanoparticles
EP11156074.4A EP2369342B1 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
ES03815995T ES2709398T3 (en) 2002-11-26 2003-11-26 Fluorescent nanoparticles based on silica
AU2003303309A AU2003303309B2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
EP03815190.8A EP1604031B1 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
JP2004568576A JP2006514708A (en) 2002-11-26 2003-11-26 Silica-based fluorescent nanoparticles
EP20110162895 EP2364840A1 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
PCT/US2003/037793 WO2004063387A2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
PCT/US2003/037963 WO2004074504A2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
KR1020057009530A KR20050109455A (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
US10/536,569 US8298677B2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
AU2003303290A AU2003303290A1 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
CNB2003801092528A CN100443295C (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
KR1020057009511A KR20050103186A (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
US12/579,302 US8409876B2 (en) 2002-11-26 2009-10-14 Fluorescent silica-based nanoparticles
JP2009285153A JP2010070768A (en) 2002-11-26 2009-12-16 Fluorescent silica-based nanoparticle
JP2010262238A JP2011052228A (en) 2002-11-26 2010-11-25 Fluorescent silica-based nanoparticle
JP2014023357A JP2014133893A (en) 2002-11-26 2014-02-10 Fluorescent silica-based nanoparticle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/306,614 US20040101822A1 (en) 2002-11-26 2002-11-26 Fluorescent silica-based nanoparticles

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US10/536,569 Continuation US8298677B2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
US11/536,569 Continuation US20070026044A1 (en) 2002-05-06 2006-09-28 Use of VEGF For Treating Bone Defects
US12/579,302 Continuation US8409876B2 (en) 2002-11-26 2009-10-14 Fluorescent silica-based nanoparticles

Publications (1)

Publication Number Publication Date
US20040101822A1 true US20040101822A1 (en) 2004-05-27

Family

ID=32325737

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/306,614 Abandoned US20040101822A1 (en) 2002-11-26 2002-11-26 Fluorescent silica-based nanoparticles
US10/536,569 Active 2026-11-07 US8298677B2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
US12/579,302 Expired - Fee Related US8409876B2 (en) 2002-11-26 2009-10-14 Fluorescent silica-based nanoparticles

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/536,569 Active 2026-11-07 US8298677B2 (en) 2002-11-26 2003-11-26 Fluorescent silica-based nanoparticles
US12/579,302 Expired - Fee Related US8409876B2 (en) 2002-11-26 2009-10-14 Fluorescent silica-based nanoparticles

Country Status (8)

Country Link
US (3) US20040101822A1 (en)
EP (4) EP2369342B1 (en)
JP (5) JP2006514708A (en)
KR (2) KR20050109455A (en)
CN (3) CN101387639A (en)
AU (2) AU2003303290A1 (en)
ES (2) ES2709398T3 (en)
WO (2) WO2004063387A2 (en)

Cited By (603)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050025820A1 (en) * 2003-04-25 2005-02-03 Mark Kester Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
FR2873021A1 (en) * 2004-07-16 2006-01-20 Oreal Cosmetic composition, used as a make-up and/or skin care (particularly face, lips and/or keratinous fibers) product, comprises a photo luminescent mineral nanoparticles in a medium
WO2006011014A1 (en) * 2004-07-16 2006-02-02 L'oreal Cosmetic composition containing photoluminescent particles
US20060115917A1 (en) * 2004-11-30 2006-06-01 Linden Kurt J Precision synthesis of quantum dot nanostructures for fluorescent and optoelectronic devices
US20060113557A1 (en) * 2004-11-30 2006-06-01 Spire Corporation Nanophotovoltaic devices
US20060216239A1 (en) * 2005-03-18 2006-09-28 Washington, University Of Magnetic nanoparticle compositions and methods
US20060222286A1 (en) * 2005-03-31 2006-10-05 Eastman Kodak Company Polarized light emitting source with an electro-optical addressing architecture
US20060222292A1 (en) * 2005-03-31 2006-10-05 Eastman Kodak Company Placement of lumiphores within a light emitting resonator in a visual display with electro-optical addressing architecture
US20060227840A1 (en) * 2005-03-31 2006-10-12 Eastman Kodak Company Visual display with electro-optical addressing architecture
US20060245971A1 (en) * 2005-05-02 2006-11-02 Burns Andrew A Photoluminescent silica-based sensors and methods of use
US20060291769A1 (en) * 2005-05-27 2006-12-28 Eastman Kodak Company Light emitting source incorporating vertical cavity lasers and other MEMS devices within an electro-optical addressing architecture
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers
US20070051674A1 (en) * 2000-02-04 2007-03-08 Bratten Jack R Lift station and method
WO2007029980A1 (en) * 2005-09-08 2007-03-15 Biterials Co., Ltd. Magnetic nanoparticle having fluorescent and preparation method thereof and use thereof
US20070154965A1 (en) * 2005-04-22 2007-07-05 Miqin Zhang Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumors
US20070203584A1 (en) * 2006-02-14 2007-08-30 Amit Bandyopadhyay Bone replacement materials
US20070262116A1 (en) * 2005-08-31 2007-11-15 Hueil Joseph C Surgical stapling device with multiple stacked actuator wedge cams for driving staple drivers
EP1862794A1 (en) * 2006-05-31 2007-12-05 Carl Zeiss MicroImaging GmbH Method for high resolution spatial images
EP1883676A1 (en) * 2005-05-27 2008-02-06 Ciba Specialty Chemicals Holding Inc. Functionalized nanoparticles
US20080073163A1 (en) * 2006-09-22 2008-03-27 Weir Michael P Micro-electromechanical device
US20080086051A1 (en) * 2006-09-20 2008-04-10 Ethicon Endo-Surgery, Inc. System, storage medium for a computer program, and method for displaying medical images
KR100821192B1 (en) * 2005-09-08 2008-04-11 주식회사바이테리얼즈 Magnetic nanoparticle having fluorescent and preparation method thereof
WO2008071772A2 (en) * 2006-12-13 2008-06-19 L'oreal Use of coloured or fluorescent hybrid particles for treating keratin fibres
FR2909869A1 (en) * 2006-12-13 2008-06-20 Oreal Use of hybrid particles for dyeing keratinous fibers, obtained from an organosilane compound carrying a colored species
US20080167521A1 (en) * 2007-01-09 2008-07-10 Sheetz Jane A Method of in vivo monitoring using an imaging system including scanned beam imaging unit
US20080221434A1 (en) * 2007-03-09 2008-09-11 Voegele James W Displaying an internal image of a body lumen of a patient
US20080226034A1 (en) * 2007-03-12 2008-09-18 Weir Michael P Power modulation of a scanning beam for imaging, therapy, and/or diagnosis
US20080232656A1 (en) * 2007-03-22 2008-09-25 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in image data of a patient
US20080234544A1 (en) * 2007-03-20 2008-09-25 Ethicon Endo-Sugery, Inc. Displaying images interior and exterior to a body lumen of a patient
US20080234566A1 (en) * 2007-03-21 2008-09-25 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in a patient image data
US20080242967A1 (en) * 2007-03-27 2008-10-02 Ethicon Endo-Surgery, Inc. Medical imaging and therapy utilizing a scanned beam system operating at multiple wavelengths
US20080255460A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Nanoparticle tissue based identification and illumination
US20080255458A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. System and method using fluorescence to examine within a patient's anatomy
US20080252778A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Combined SBI and conventional image processor
US20080275305A1 (en) * 2007-05-01 2008-11-06 Ethicon Endo-Surgery, Inc. Medical scanned beam imager and components associated therewith
US20080274463A1 (en) * 2007-05-04 2008-11-06 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
US20080286371A1 (en) * 2005-09-12 2008-11-20 Cristalia Produtos Quimicos Farmaceuticos Ltda Immunogenical Complex Formed by Vaccinal Antigens Encapsulated by Nanostructured Mesoporous Silica
US20080293584A1 (en) * 2005-12-27 2008-11-27 The Furukawa Electric Co., Ltd. Fluorescent silica nano-particle, fluorescent nano-material, and biochip and assay using the same
US20080312490A1 (en) * 2007-06-18 2008-12-18 Ethicon Endo-Surgery, Inc. Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly
US20090001128A1 (en) * 2007-03-15 2009-01-01 Weisenburgh Ii William B Washer for use with a surgical stapling instrument
WO2009017695A1 (en) * 2007-07-26 2009-02-05 The Regents Of The University Of California A single cell surgery tool and a cell transfection device utilizing the photothermal properties of thin films and/or metal nanoparticles
US20090035802A1 (en) * 2007-07-31 2009-02-05 Digital Bio Technology, Co., Ltd. Method for detection and enumeration of cell surface markers
US20090043109A1 (en) * 2007-08-07 2009-02-12 Spangler Brenda D Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source
US20090054761A1 (en) * 2007-08-22 2009-02-26 Ethicon Endo-Surgery, Inc. Medical system, method, and storage medium concerning a natural orifice transluminal medical procedure
US20090062659A1 (en) * 2007-08-28 2009-03-05 Weir Michael P Medical device including scanned beam unit with operational control features
US20090060381A1 (en) * 2007-08-31 2009-03-05 Ethicon Endo-Surgery, Inc. Dynamic range and amplitude control for imaging
US20090062658A1 (en) * 2007-08-27 2009-03-05 Dunki-Jacobs Robert J Position tracking and control for a scanning assembly
US20090068272A1 (en) * 2006-04-25 2009-03-12 Washington State University Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents
WO2009059677A1 (en) * 2007-11-08 2009-05-14 Merck Patent Gmbh Method for the production of coated luminescent substances
US20090137060A1 (en) * 2005-07-11 2009-05-28 Rikshospitalet Hf Multicolored particles
WO2009073193A2 (en) * 2007-12-03 2009-06-11 The Johns Hopkins University Methods of synthesis and use of chemospheres
US7558455B2 (en) 2007-06-29 2009-07-07 Ethicon Endo-Surgery, Inc Receiver aperture broadening for scanned beam imaging
US20090202816A1 (en) * 2006-06-06 2009-08-13 Florida State University Research Foundation, Inc. Stabilized silica colloid
US20090217932A1 (en) * 2008-03-03 2009-09-03 Ethicon Endo-Surgery, Inc. Intraluminal tissue markers
US20090226371A1 (en) * 2005-11-16 2009-09-10 Signalomics Gmbh Fluorescent nanoparticles
US20090276056A1 (en) * 2006-04-25 2009-11-05 Washington State University Resorbable ceramics with controlled strength loss rates
US20090289225A1 (en) * 2007-04-19 2009-11-26 Naiyong Jing Reducing fluorescent self-quenching with nanoparticles
US20100040693A1 (en) * 2006-08-09 2010-02-18 Korea Research Institute Of Bioscience And Biotech Silica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same
US7665647B2 (en) 2006-09-29 2010-02-23 Ethicon Endo-Surgery, Inc. Surgical cutting and stapling device with closure apparatus for limiting maximum tissue compression force
WO2010021512A2 (en) * 2008-08-22 2010-02-25 Snu R&Db Foundation Silica-based fluorescent nanoparticles
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US7673781B2 (en) 2005-08-31 2010-03-09 Ethicon Endo-Surgery, Inc. Surgical stapling device with staple driver that supports multiple wire diameter staples
US20100089970A1 (en) * 2008-10-10 2010-04-15 Ethicon Endo-Surgery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
US7713265B2 (en) 2006-12-22 2010-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for medically treating a tattoo
US20100119500A1 (en) * 2007-02-28 2010-05-13 Mika Jokinen Method for preparing silica compositions, silica compositions and uses thereof
US20100184087A1 (en) * 2006-11-01 2010-07-22 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US20100260686A1 (en) * 2009-04-09 2010-10-14 Washington, University Of Nanoparticles for brain tumor imaging
US20100310872A1 (en) * 2007-12-06 2010-12-09 The University Of Tokushima Nanofunctional silica particles and manufacturing method thereof
US20100311871A1 (en) * 2008-02-12 2010-12-09 Nissan Chemical Industries, Ltd. Colloidal silica particles, process for producing the same, and organic solvent-dispersed silica sol, polymerizable compound-dispersed silica sol, and dicarboxylic anhydride-dispersed silica sol each obtained from the same
US20100317537A1 (en) * 2008-02-15 2010-12-16 University Of Florida Research Foundation, Inc. Biophysical parameters for systems biology
US20100330366A1 (en) * 2009-06-30 2010-12-30 Keiser Bruce A Silica-based particle composition
US20100327482A1 (en) * 2005-12-20 2010-12-30 University Of Hawaii Polymer matrix composites with nano-scale reinforcements
US20110028662A1 (en) * 2007-08-31 2011-02-03 Hybrid Silica Technologies, Inc. Peg-coated core-shell silica nanoparticles and methods of manufacture and use
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US20110110858A1 (en) * 2009-11-11 2011-05-12 Omer Aras Gold nanoparticle imaging agents and uses thereof
US20110111233A1 (en) * 2008-07-07 2011-05-12 Kazuya Tsukada Inorganic nanoparticle labeling agent
US7982776B2 (en) 2007-07-13 2011-07-19 Ethicon Endo-Surgery, Inc. SBI motion artifact removal apparatus and method
US20110174860A1 (en) * 2006-01-31 2011-07-21 Ethicon Endo-Surgery, Inc. Surgical instrument with force-feedback capabilities
US20110203023P1 (en) * 2010-02-16 2011-08-18 Menachem Bronstein Gypsophila Plant Named 'Pearl Blossom''
US20110214488A1 (en) * 2010-03-04 2011-09-08 Rose Peter E Colloidal-crystal quantum dots as tracers in underground formations
US8050520B2 (en) 2008-03-27 2011-11-01 Ethicon Endo-Surgery, Inc. Method for creating a pixel image from sampled data of a scanned beam imager
US20110288234A1 (en) * 2008-02-19 2011-11-24 The Research Foundation on State University of NY Silica nanoparticles postloaded with photosensitizers for drug delivery in photodynamic therapy
US20110300222A1 (en) * 2009-02-20 2011-12-08 The Regents Of The University Of California Luminescent porous silicon nanoparticles, methods of making and using same
US8113410B2 (en) 2008-02-14 2012-02-14 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features
US8161977B2 (en) 2006-01-31 2012-04-24 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US8196795B2 (en) 2008-02-14 2012-06-12 Ethicon Endo-Surgery, Inc. Disposable motor-driven loading unit for use with a surgical cutting and stapling apparatus
US8196796B2 (en) 2007-06-04 2012-06-12 Ethicon Endo-Surgery, Inc. Shaft based rotary drive system for surgical instruments
CN101457139B (en) * 2008-08-22 2012-06-13 吉林大学 High quantum production rate luminescent silicon ball with controllable structure and preparation method thereof
US8273015B2 (en) 2007-01-09 2012-09-25 Ethicon Endo-Surgery, Inc. Methods for imaging the anatomy with an anatomically secured scanner assembly
US20120252140A1 (en) * 2009-12-25 2012-10-04 Konica Minolta Medical & Graphic, Inc. Fluorescent substance-containing silica nanoparticles and biosubstance labeling agent
US8332014B2 (en) 2008-04-25 2012-12-11 Ethicon Endo-Surgery, Inc. Scanned beam device and method using same which measures the reflectance of patient tissue
CN102921014A (en) * 2012-11-15 2013-02-13 中国科学院化学研究所 Biocompatible nano composite drug carrier with synergistic anti-tumor effect, drug with synergistic anti-tumor effect and preparation methods of biocompatible nano composite drug carrier and drug
US20130064776A1 (en) * 2009-10-09 2013-03-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US8397971B2 (en) 2009-02-05 2013-03-19 Ethicon Endo-Surgery, Inc. Sterilizable surgical instrument
CN103013016A (en) * 2011-09-28 2013-04-03 国家纳米科学中心 Medical carrier and medical composition and preparation method thereof
US20130084643A1 (en) * 2009-12-24 2013-04-04 Total Sa Use of nanoparticles for labelling oil field injection waters
US8414577B2 (en) 2009-02-05 2013-04-09 Ethicon Endo-Surgery, Inc. Surgical instruments and components for use in sterile environments
US8424740B2 (en) 2007-06-04 2013-04-23 Ethicon Endo-Surgery, Inc. Surgical instrument having a directional switching mechanism
US8445191B2 (en) 2007-05-23 2013-05-21 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US8459525B2 (en) 2008-02-14 2013-06-11 Ethicon Endo-Sugery, Inc. Motorized surgical cutting and fastening instrument having a magnetic drive train torque limiting device
US8459520B2 (en) 2007-01-10 2013-06-11 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and remote sensor
US8479969B2 (en) 2007-01-10 2013-07-09 Ethicon Endo-Surgery, Inc. Drive interface for operably coupling a manipulatable surgical tool to a robot
US8534528B2 (en) 2007-06-04 2013-09-17 Ethicon Endo-Surgery, Inc. Surgical instrument having a multiple rate directional switching mechanism
US8540128B2 (en) 2007-01-11 2013-09-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with a curved end effector
US8573465B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical end effector system with rotary actuated closure systems
US8573461B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with cam-driven staple deployment arrangements
US8584919B2 (en) 2008-02-14 2013-11-19 Ethicon Endo-Sugery, Inc. Surgical stapling apparatus with load-sensitive firing mechanism
US8602288B2 (en) 2008-09-23 2013-12-10 Ethicon Endo-Surgery. Inc. Robotically-controlled motorized surgical end effector system with rotary actuated closure systems having variable actuation speeds
US8602287B2 (en) 2008-09-23 2013-12-10 Ethicon Endo-Surgery, Inc. Motor driven surgical cutting instrument
US8616431B2 (en) 2007-06-04 2013-12-31 Ethicon Endo-Surgery, Inc. Shiftable drive interface for robotically-controlled surgical tool
US8622274B2 (en) 2008-02-14 2014-01-07 Ethicon Endo-Surgery, Inc. Motorized cutting and fastening instrument having control circuit for optimizing battery usage
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US8657174B2 (en) 2008-02-14 2014-02-25 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument having handle based power source
WO2014052875A1 (en) 2012-09-27 2014-04-03 Cynvenio Biosystems, Inc. Stimulus-sensitive microparticles and methods of use
US8703490B2 (en) 2008-06-05 2014-04-22 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US8747238B2 (en) 2012-06-28 2014-06-10 Ethicon Endo-Surgery, Inc. Rotary drive shaft assemblies for surgical instruments with articulatable end effectors
US8752749B2 (en) 2008-02-14 2014-06-17 Ethicon Endo-Surgery, Inc. Robotically-controlled disposable motor-driven loading unit
US8763879B2 (en) 2006-01-31 2014-07-01 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of surgical instrument
US8783541B2 (en) 2003-05-20 2014-07-22 Frederick E. Shelton, IV Robotically-controlled surgical end effector system
US8789741B2 (en) 2010-09-24 2014-07-29 Ethicon Endo-Surgery, Inc. Surgical instrument with trigger assembly for generating multiple actuation motions
US20140220598A1 (en) * 2011-09-09 2014-08-07 Tohoku University Biological substance detection method
US8800838B2 (en) 2005-08-31 2014-08-12 Ethicon Endo-Surgery, Inc. Robotically-controlled cable-based surgical end effectors
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
WO2014153051A1 (en) 2013-03-14 2014-09-25 University Of Washington Through Its Center For Commercialization Polymer dot compositions and related methods
US8844789B2 (en) 2006-01-31 2014-09-30 Ethicon Endo-Surgery, Inc. Automated end effector component reloading system for use with a robotic system
US8873041B1 (en) 2013-01-29 2014-10-28 Bayspec, Inc. Raman spectroscopy using multiple excitation wavelengths
US8893949B2 (en) 2010-09-30 2014-11-25 Ethicon Endo-Surgery, Inc. Surgical stapler with floating anvil
US8911471B2 (en) 2006-03-23 2014-12-16 Ethicon Endo-Surgery, Inc. Articulatable surgical device
US8961825B2 (en) 2009-04-15 2015-02-24 Cornell University Fluorescent silica nanoparticles through silica densification
US8978954B2 (en) 2010-09-30 2015-03-17 Ethicon Endo-Surgery, Inc. Staple cartridge comprising an adjustable distal portion
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US9018347B2 (en) 2010-02-04 2015-04-28 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
US9023595B2 (en) 2008-05-15 2015-05-05 Morphotek, Inc. Treatment of metastatic tumors
US9028494B2 (en) 2012-06-28 2015-05-12 Ethicon Endo-Surgery, Inc. Interchangeable end effector coupling arrangement
US9028519B2 (en) 2008-09-23 2015-05-12 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US9042765B2 (en) 2012-01-16 2015-05-26 Samsung Electronics Co., Ltd. Image forming apparatus with improved heat transmission
US9044230B2 (en) 2012-02-13 2015-06-02 Ethicon Endo-Surgery, Inc. Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
US9050084B2 (en) 2011-09-23 2015-06-09 Ethicon Endo-Surgery, Inc. Staple cartridge including collapsible deck arrangement
US9055941B2 (en) 2011-09-23 2015-06-16 Ethicon Endo-Surgery, Inc. Staple cartridge including collapsible deck
US20150177153A1 (en) * 2013-12-20 2015-06-25 Sicpa Holding Sa Thermoluminescent composite particle and marking comprising same
US9068084B2 (en) 2010-01-19 2015-06-30 Wuxi Zodolabs Biotech Co., Ltd. Silica nanoparticles doped with dye having negative charge and preparing method thereof
US9072536B2 (en) 2012-06-28 2015-07-07 Ethicon Endo-Surgery, Inc. Differential locking arrangements for rotary powered surgical instruments
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
US20150202848A1 (en) * 2014-01-22 2015-07-23 Samsung Display Co., Ltd. Display device
US9101385B2 (en) 2012-06-28 2015-08-11 Ethicon Endo-Surgery, Inc. Electrode connections for rotary driven surgical tools
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
EP2833144A4 (en) * 2012-03-28 2015-08-26 Konica Minolta Inc Method for detection biological substance
US9119657B2 (en) 2012-06-28 2015-09-01 Ethicon Endo-Surgery, Inc. Rotary actuatable closure arrangement for surgical end effector
US9125552B2 (en) 2007-07-31 2015-09-08 Ethicon Endo-Surgery, Inc. Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy
US9125662B2 (en) 2012-06-28 2015-09-08 Ethicon Endo-Surgery, Inc. Multi-axis articulating and rotating surgical tools
US9138225B2 (en) 2007-06-22 2015-09-22 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with an articulatable end effector
US9198662B2 (en) 2012-03-28 2015-12-01 Ethicon Endo-Surgery, Inc. Tissue thickness compensator having improved visibility
US9204880B2 (en) 2012-03-28 2015-12-08 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising capsules defining a low pressure environment
US9204878B2 (en) 2008-02-14 2015-12-08 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US9204879B2 (en) 2012-06-28 2015-12-08 Ethicon Endo-Surgery, Inc. Flexible drive member
US9211120B2 (en) 2011-04-29 2015-12-15 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a plurality of medicaments
US9220500B2 (en) 2010-09-30 2015-12-29 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising structure to produce a resilient load
US9220501B2 (en) 2010-09-30 2015-12-29 Ethicon Endo-Surgery, Inc. Tissue thickness compensators
US9226751B2 (en) 2012-06-28 2016-01-05 Ethicon Endo-Surgery, Inc. Surgical instrument system including replaceable end effectors
US9232941B2 (en) 2010-09-30 2016-01-12 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a reservoir
JP2016501286A (en) * 2012-11-16 2016-01-18 エスエヌユー アールアンドディービー ファウンデーショ Coded polymer particles
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US9272406B2 (en) 2010-09-30 2016-03-01 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a cutting member for releasing a tissue thickness compensator
US9282966B2 (en) 2004-07-28 2016-03-15 Ethicon Endo-Surgery, Inc. Surgical stapling instrument
US9282974B2 (en) 2012-06-28 2016-03-15 Ethicon Endo-Surgery, Llc Empty clip cartridge lockout
US9283054B2 (en) 2013-08-23 2016-03-15 Ethicon Endo-Surgery, Llc Interactive displays
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
US9301752B2 (en) 2010-09-30 2016-04-05 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising a plurality of capsules
US9307989B2 (en) 2012-03-28 2016-04-12 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorportating a hydrophobic agent
US9307986B2 (en) 2013-03-01 2016-04-12 Ethicon Endo-Surgery, Llc Surgical instrument soft stop
US9314246B2 (en) 2010-09-30 2016-04-19 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent
US9320521B2 (en) 2006-06-27 2016-04-26 Ethicon Endo-Surgery, Llc Surgical instrument
US9320523B2 (en) 2012-03-28 2016-04-26 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising tissue ingrowth features
US9332987B2 (en) 2013-03-14 2016-05-10 Ethicon Endo-Surgery, Llc Control arrangements for a drive member of a surgical instrument
US9332974B2 (en) 2010-09-30 2016-05-10 Ethicon Endo-Surgery, Llc Layered tissue thickness compensator
US9332984B2 (en) 2013-03-27 2016-05-10 Ethicon Endo-Surgery, Llc Fastener cartridge assemblies
US9345481B2 (en) 2013-03-13 2016-05-24 Ethicon Endo-Surgery, Llc Staple cartridge tissue thickness sensor system
US9358005B2 (en) 2010-09-30 2016-06-07 Ethicon Endo-Surgery, Llc End effector layer including holding features
US9364233B2 (en) 2010-09-30 2016-06-14 Ethicon Endo-Surgery, Llc Tissue thickness compensators for circular surgical staplers
US9386984B2 (en) 2013-02-08 2016-07-12 Ethicon Endo-Surgery, Llc Staple cartridge comprising a releasable cover
US9393015B2 (en) 2009-02-06 2016-07-19 Ethicon Endo-Surgery, Llc Motor driven surgical fastener device with cutting member reversing mechanism
US9486214B2 (en) 2009-02-06 2016-11-08 Ethicon Endo-Surgery, Llc Motor driven surgical fastener device with switching system configured to prevent firing initiation until activated
US9532949B2 (en) 2011-07-19 2017-01-03 Stc.Unm Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
US9561038B2 (en) 2012-06-28 2017-02-07 Ethicon Endo-Surgery, Llc Interchangeable clip applier
US9572577B2 (en) 2013-03-27 2017-02-21 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a tissue thickness compensator including openings therein
US9574644B2 (en) 2013-05-30 2017-02-21 Ethicon Endo-Surgery, Llc Power module for use with a surgical instrument
US9579283B2 (en) 2011-04-28 2017-02-28 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
US9585657B2 (en) 2008-02-15 2017-03-07 Ethicon Endo-Surgery, Llc Actuator for releasing a layer of material from a surgical end effector
US9625456B2 (en) 2009-07-02 2017-04-18 Sloan-Kettering Institute For Cancer Research Fluorescent silica-based nanoparticles
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
US9649110B2 (en) 2013-04-16 2017-05-16 Ethicon Llc Surgical instrument comprising a closing drive and a firing drive operated from the same rotatable output
US9690362B2 (en) 2014-03-26 2017-06-27 Ethicon Llc Surgical instrument control circuit having a safety processor
US9693777B2 (en) 2014-02-24 2017-07-04 Ethicon Llc Implantable layers comprising a pressed region
US9724098B2 (en) 2012-03-28 2017-08-08 Ethicon Endo-Surgery, Llc Staple cartridge comprising an implantable layer
US9724094B2 (en) 2014-09-05 2017-08-08 Ethicon Llc Adjunct with integrated sensors to quantify tissue compression
US9743928B2 (en) 2006-01-31 2017-08-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US9743929B2 (en) 2014-03-26 2017-08-29 Ethicon Llc Modular powered surgical instrument with detachable shaft assemblies
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
US9795384B2 (en) 2013-03-27 2017-10-24 Ethicon Llc Fastener cartridge comprising a tissue thickness compensator and a gap setting element
US9795382B2 (en) 2005-08-31 2017-10-24 Ethicon Llc Fastener cartridge assembly comprising a cam and driver arrangement
US9801627B2 (en) 2014-09-26 2017-10-31 Ethicon Llc Fastener cartridge for creating a flexible staple line
US9808246B2 (en) 2015-03-06 2017-11-07 Ethicon Endo-Surgery, Llc Method of operating a powered surgical instrument
US9814462B2 (en) 2010-09-30 2017-11-14 Ethicon Llc Assembly for fastening tissue comprising a compressible layer
US9820738B2 (en) 2014-03-26 2017-11-21 Ethicon Llc Surgical instrument comprising interactive systems
US9826978B2 (en) 2010-09-30 2017-11-28 Ethicon Llc End effectors with same side closure and firing motions
US9833241B2 (en) 2014-04-16 2017-12-05 Ethicon Llc Surgical fastener cartridges with driver stabilizing arrangements
WO2017210754A1 (en) * 2016-06-10 2017-12-14 The University Of Queensland Detecting an analyte
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
WO2018005595A1 (en) * 2016-06-28 2018-01-04 The Trustees Of The University Of Pennsylvania Superoleophobic membranes for oil/water separation
US9861359B2 (en) 2006-01-31 2018-01-09 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US9895148B2 (en) 2015-03-06 2018-02-20 Ethicon Endo-Surgery, Llc Monitoring speed control and precision incrementing of motor for powered surgical instruments
US9895147B2 (en) 2005-11-09 2018-02-20 Ethicon Llc End effectors for surgical staplers
US9901342B2 (en) 2015-03-06 2018-02-27 Ethicon Endo-Surgery, Llc Signal and power communication system positioned on a rotatable shaft
US9913642B2 (en) 2014-03-26 2018-03-13 Ethicon Llc Surgical instrument comprising a sensor system
US9924961B2 (en) 2015-03-06 2018-03-27 Ethicon Endo-Surgery, Llc Interactive feedback system for powered surgical instruments
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US9931118B2 (en) 2015-02-27 2018-04-03 Ethicon Endo-Surgery, Llc Reinforced battery for a surgical instrument
WO2018060722A1 (en) * 2016-09-30 2018-04-05 Sumitomo Chemical Company Limited Composite particle
US9937129B2 (en) 2007-04-16 2018-04-10 The Regents Of The University Of California Materials and methods for delivering compositions to selected tissues
US9943309B2 (en) 2014-12-18 2018-04-17 Ethicon Llc Surgical instruments with articulatable end effectors and movable firing beam support arrangements
US9944683B2 (en) 2010-05-11 2018-04-17 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
US9962161B2 (en) 2014-02-12 2018-05-08 Ethicon Llc Deliverable surgical instrument
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US20180155564A1 (en) * 2015-06-18 2018-06-07 Sicpa Holding Sa Thermoluminescent and superparamagnetic composite particle and marking comprising same
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US9993258B2 (en) 2015-02-27 2018-06-12 Ethicon Llc Adaptable surgical instrument handle
US9999694B2 (en) 2009-07-02 2018-06-19 Sloan-Kettering Institute For Cancer Research Multimodal silica-based nanoparticles
US10004498B2 (en) 2006-01-31 2018-06-26 Ethicon Llc Surgical instrument comprising a plurality of articulation joints
US10045776B2 (en) 2015-03-06 2018-08-14 Ethicon Llc Control techniques and sub-processor contained within modular shaft with select control processing from handle
US10045781B2 (en) 2014-06-13 2018-08-14 Ethicon Llc Closure lockout systems for surgical instruments
US10052102B2 (en) 2015-06-18 2018-08-21 Ethicon Llc Surgical end effectors with dual cam actuated jaw closing features
US10052044B2 (en) 2015-03-06 2018-08-21 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US10076326B2 (en) 2015-09-23 2018-09-18 Ethicon Llc Surgical stapler having current mirror-based motor control
US10076325B2 (en) 2014-10-13 2018-09-18 Ethicon Llc Surgical stapling apparatus comprising a tissue stop
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US10085751B2 (en) 2015-09-23 2018-10-02 Ethicon Llc Surgical stapler having temperature-based motor control
US10092292B2 (en) 2013-02-28 2018-10-09 Ethicon Llc Staple forming features for surgical stapling instrument
US10098642B2 (en) 2015-08-26 2018-10-16 Ethicon Llc Surgical staples comprising features for improved fastening of tissue
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US10111963B2 (en) 2014-05-29 2018-10-30 Memorial Sloan Kettering Cancer Center Nanoparticle drug conjugates
US10117649B2 (en) 2014-12-18 2018-11-06 Ethicon Llc Surgical instrument assembly comprising a lockable articulation system
US10130359B2 (en) 2006-09-29 2018-11-20 Ethicon Llc Method for forming a staple
US10156559B2 (en) 2012-12-10 2018-12-18 Fred Hutchinson Cancer Research Center Lipocalin fusion partners
US10172619B2 (en) 2015-09-02 2019-01-08 Ethicon Llc Surgical staple driver arrays
US10172620B2 (en) 2015-09-30 2019-01-08 Ethicon Llc Compressible adjuncts with bonding nodes
US10180463B2 (en) 2015-02-27 2019-01-15 Ethicon Llc Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band
US10188385B2 (en) 2014-12-18 2019-01-29 Ethicon Llc Surgical instrument system comprising lockable systems
US10191060B2 (en) 2009-11-09 2019-01-29 University Of Washington Functionalized chromophoric polymer dots and bioconjugates thereof
US10203326B2 (en) 2003-10-02 2019-02-12 Furukawa Electric Co., Ltd. Method of detecting target substance
US10206676B2 (en) 2008-02-14 2019-02-19 Ethicon Llc Surgical cutting and fastening instrument
US10211586B2 (en) 2017-06-28 2019-02-19 Ethicon Llc Surgical shaft assemblies with watertight housings
US10213201B2 (en) 2015-03-31 2019-02-26 Ethicon Llc Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw
US10226249B2 (en) 2013-03-01 2019-03-12 Ethicon Llc Articulatable surgical instruments with conductive pathways for signal communication
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
US10245029B2 (en) 2016-02-09 2019-04-02 Ethicon Llc Surgical instrument with articulating and axially translatable end effector
US10258418B2 (en) 2017-06-29 2019-04-16 Ethicon Llc System for controlling articulation forces
US10258336B2 (en) 2008-09-19 2019-04-16 Ethicon Llc Stapling system configured to produce different formed staple heights
US10258331B2 (en) 2016-02-12 2019-04-16 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US10265065B2 (en) 2013-12-23 2019-04-23 Ethicon Llc Surgical staples and staple cartridges
US10271849B2 (en) 2015-09-30 2019-04-30 Ethicon Llc Woven constructs with interlocked standing fibers
USD847989S1 (en) 2016-06-24 2019-05-07 Ethicon Llc Surgical fastener cartridge
US10293100B2 (en) 2004-07-28 2019-05-21 Ethicon Llc Surgical stapling instrument having a medical substance dispenser
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
USD850617S1 (en) 2016-06-24 2019-06-04 Ethicon Llc Surgical fastener cartridge
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
USD851762S1 (en) 2017-06-28 2019-06-18 Ethicon Llc Anvil
US10327769B2 (en) 2015-09-23 2019-06-25 Ethicon Llc Surgical stapler having motor control based on a drive system component
US10327767B2 (en) 2017-06-20 2019-06-25 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
WO2019123156A1 (en) * 2017-12-19 2019-06-27 3M Innovative Properties Company Compositions and methods to detect microorganisms
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
USD854151S1 (en) 2017-06-28 2019-07-16 Ethicon Llc Surgical instrument shaft
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10363036B2 (en) 2015-09-23 2019-07-30 Ethicon Llc Surgical stapler having force-based motor control
US10363037B2 (en) 2016-04-18 2019-07-30 Ethicon Llc Surgical instrument system comprising a magnetic lockout
US10368864B2 (en) 2017-06-20 2019-08-06 Ethicon Llc Systems and methods for controlling displaying motor velocity for a surgical instrument
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10376263B2 (en) 2016-04-01 2019-08-13 Ethicon Llc Anvil modification members for surgical staplers
US10390841B2 (en) 2017-06-20 2019-08-27 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US10398433B2 (en) 2007-03-28 2019-09-03 Ethicon Llc Laparoscopic clamp load measuring devices
US10398434B2 (en) 2017-06-29 2019-09-03 Ethicon Llc Closed loop velocity control of closure member for robotic surgical instrument
JP2019525379A (en) * 2016-06-06 2019-09-05 ダウ グローバル テクノロジーズ エルエルシー LIGHT EMITTING DEVICE AND ELECTRONIC DEVICE EQUIPPED WITH THE SAME
US10405859B2 (en) 2016-04-15 2019-09-10 Ethicon Llc Surgical instrument with adjustable stop/start control during a firing motion
US10413294B2 (en) 2012-06-28 2019-09-17 Ethicon Llc Shaft assembly arrangements for surgical instruments
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10426481B2 (en) 2014-02-24 2019-10-01 Ethicon Llc Implantable layer assemblies
US10426471B2 (en) 2016-12-21 2019-10-01 Ethicon Llc Surgical instrument with multiple failure response modes
US10435661B2 (en) 2011-05-13 2019-10-08 The Regents Of The University Of California Photothermal substrates for selective transfection of cells
US10448950B2 (en) 2016-12-21 2019-10-22 Ethicon Llc Surgical staplers with independently actuatable closing and firing systems
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US10472651B2 (en) 2014-03-28 2019-11-12 The Regents Of The University Of California Efficient delivery of large cargos into cells on a porous substrate
US10485543B2 (en) 2016-12-21 2019-11-26 Ethicon Llc Anvil having a knife slot width
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US10492785B2 (en) 2016-12-21 2019-12-03 Ethicon Llc Shaft assembly comprising a lockout
USD869655S1 (en) 2017-06-28 2019-12-10 Ethicon Llc Surgical fastener cartridge
US10499890B2 (en) 2006-01-31 2019-12-10 Ethicon Llc Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US10499914B2 (en) 2016-12-21 2019-12-10 Ethicon Llc Staple forming pocket arrangements
US10517595B2 (en) 2016-12-21 2019-12-31 Ethicon Llc Jaw actuated lock arrangements for preventing advancement of a firing member in a surgical end effector unless an unfired cartridge is installed in the end effector
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US10537325B2 (en) 2016-12-21 2020-01-21 Ethicon Llc Staple forming pocket arrangement to accommodate different types of staples
US10537324B2 (en) 2016-12-21 2020-01-21 Ethicon Llc Stepped staple cartridge with asymmetrical staples
US20200024592A1 (en) * 2015-05-28 2020-01-23 Bioneer Corporation Highly active silica magnetic nanoparticles for purifying biomaterial and preparation method thereof
US10542979B2 (en) 2016-06-24 2020-01-28 Ethicon Llc Stamped staples and staple cartridges using the same
US10548989B2 (en) * 2015-04-07 2020-02-04 Memorial Sloan Kettering Cancer Center Nanoparticle immunoconjugates
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US10568626B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaw opening features for increasing a jaw opening distance
US10568625B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Staple cartridges and arrangements of staples and staple cavities therein
US10575868B2 (en) 2013-03-01 2020-03-03 Ethicon Llc Surgical instrument with coupler assembly
US10588632B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical end effectors and firing members thereof
US10588633B2 (en) 2017-06-28 2020-03-17 Ethicon Llc Surgical instruments with open and closable jaws and axially movable firing member that is initially parked in close proximity to the jaws prior to firing
USD879809S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with changeable graphical user interface
USD879808S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
US10617413B2 (en) 2016-04-01 2020-04-14 Ethicon Llc Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts
US10617418B2 (en) 2015-08-17 2020-04-14 Ethicon Llc Implantable layers for a surgical instrument
US10617412B2 (en) 2015-03-06 2020-04-14 Ethicon Llc System for detecting the mis-insertion of a staple cartridge into a surgical stapler
US10624633B2 (en) 2017-06-20 2020-04-21 Ethicon Llc Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument
US10631859B2 (en) 2017-06-27 2020-04-28 Ethicon Llc Articulation systems for surgical instruments
US10646220B2 (en) 2017-06-20 2020-05-12 Ethicon Llc Systems and methods for controlling displacement member velocity for a surgical instrument
US10667809B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Staple cartridge and staple cartridge channel comprising windows defined therein
US10675028B2 (en) 2006-01-31 2020-06-09 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US10682134B2 (en) 2017-12-21 2020-06-16 Ethicon Llc Continuous use self-propelled stapling instrument
US10687810B2 (en) 2016-12-21 2020-06-23 Ethicon Llc Stepped staple cartridge with tissue retention and gap setting features
US10687813B2 (en) 2017-12-15 2020-06-23 Ethicon Llc Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments
US10687806B2 (en) 2015-03-06 2020-06-23 Ethicon Llc Adaptive tissue compression techniques to adjust closure rates for multiple tissue types
US10695062B2 (en) 2010-10-01 2020-06-30 Ethicon Llc Surgical instrument including a retractable firing member
US10716614B2 (en) 2017-06-28 2020-07-21 Ethicon Llc Surgical shaft assemblies with slip ring assemblies with increased contact pressure
US10716565B2 (en) 2017-12-19 2020-07-21 Ethicon Llc Surgical instruments with dual articulation drivers
USD890784S1 (en) 2017-06-20 2020-07-21 Ethicon Llc Display panel with changeable graphical user interface
US10729509B2 (en) 2017-12-19 2020-08-04 Ethicon Llc Surgical instrument comprising closure and firing locking mechanism
US10736972B2 (en) 2015-05-29 2020-08-11 Memorial Sloan Kettering Cancer Center Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
US10743875B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member
US10743872B2 (en) 2017-09-29 2020-08-18 Ethicon Llc System and methods for controlling a display of a surgical instrument
US10743874B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Sealed adapters for use with electromechanical surgical instruments
US10743851B2 (en) 2008-02-14 2020-08-18 Ethicon Llc Interchangeable tools for surgical instruments
US10751076B2 (en) 2009-12-24 2020-08-25 Ethicon Llc Motor-driven surgical cutting instrument with electric actuator directional control assembly
USD894389S1 (en) 2016-06-24 2020-08-25 Ethicon Llc Surgical fastener
US10758230B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument with primary and safety processors
US10758229B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument comprising improved jaw control
US10758233B2 (en) 2009-02-05 2020-09-01 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
US10765424B2 (en) 2008-02-13 2020-09-08 Ethicon Llc Surgical stapling instrument
US10765429B2 (en) 2017-09-29 2020-09-08 Ethicon Llc Systems and methods for providing alerts according to the operational state of a surgical instrument
US10772629B2 (en) 2017-06-27 2020-09-15 Ethicon Llc Surgical anvil arrangements
US10779825B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments
US10779903B2 (en) 2017-10-31 2020-09-22 Ethicon Llc Positive shaft rotation lock activated by jaw closure
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US10779824B2 (en) 2017-06-28 2020-09-22 Ethicon Llc Surgical instrument comprising an articulation system lockable by a closure system
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US10779821B2 (en) 2018-08-20 2020-09-22 Ethicon Llc Surgical stapler anvils with tissue stop features configured to avoid tissue pinch
US10796471B2 (en) 2017-09-29 2020-10-06 Ethicon Llc Systems and methods of displaying a knife position for a surgical instrument
US10813639B2 (en) 2017-06-20 2020-10-27 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10828033B2 (en) 2017-12-15 2020-11-10 Ethicon Llc Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US10842492B2 (en) 2018-08-20 2020-11-24 Ethicon Llc Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system
US10856869B2 (en) 2017-06-27 2020-12-08 Ethicon Llc Surgical anvil arrangements
US10856870B2 (en) 2018-08-20 2020-12-08 Ethicon Llc Switching arrangements for motor powered articulatable surgical instruments
US10869666B2 (en) 2017-12-15 2020-12-22 Ethicon Llc Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US10881396B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Surgical instrument with variable duration trigger arrangement
USD907647S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US10888321B2 (en) 2017-06-20 2021-01-12 Ethicon Llc Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument
USD907648S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US10903685B2 (en) 2017-06-28 2021-01-26 Ethicon Llc Surgical shaft assemblies with slip ring assemblies forming capacitive channels
US10898183B2 (en) 2017-06-29 2021-01-26 Ethicon Llc Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing
US10912559B2 (en) 2018-08-20 2021-02-09 Ethicon Llc Reinforced deformable anvil tip for surgical stapler anvil
USD910847S1 (en) 2017-12-19 2021-02-16 Ethicon Llc Surgical instrument assembly
US10925599B2 (en) 2013-12-23 2021-02-23 Ethicon Llc Modular surgical instruments
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US10945727B2 (en) 2016-12-21 2021-03-16 Ethicon Llc Staple cartridge with deformable driver retention features
USD914878S1 (en) 2018-08-20 2021-03-30 Ethicon Llc Surgical instrument anvil
US10966718B2 (en) 2017-12-15 2021-04-06 Ethicon Llc Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments
US10982217B2 (en) 2013-03-15 2021-04-20 The Regents Of The University Of California High-throughput cargo delivery into live cells using photothermal platforms
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
US10980537B2 (en) 2017-06-20 2021-04-20 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations
USD917500S1 (en) 2017-09-29 2021-04-27 Ethicon Llc Display screen or portion thereof with graphical user interface
US10987102B2 (en) 2010-09-30 2021-04-27 Ethicon Llc Tissue thickness compensator comprising a plurality of layers
US10986997B2 (en) 2013-12-31 2021-04-27 Memorial Sloan Kettering Cancer Center Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time
US10993715B2 (en) 2016-12-21 2021-05-04 Ethicon Llc Staple cartridge comprising staples with different clamping breadths
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US11006955B2 (en) 2017-12-15 2021-05-18 Ethicon Llc End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments
US11007022B2 (en) 2017-06-29 2021-05-18 Ethicon Llc Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument
US11013511B2 (en) 2007-06-22 2021-05-25 Ethicon Llc Surgical stapling instrument with an articulatable end effector
US11020109B2 (en) 2013-12-23 2021-06-01 Ethicon Llc Surgical stapling assembly for use with a powered surgical interface
US11020112B2 (en) 2017-12-19 2021-06-01 Ethicon Llc Surgical tools configured for interchangeable use with different controller interfaces
US11033267B2 (en) 2017-12-15 2021-06-15 Ethicon Llc Systems and methods of controlling a clamping member firing rate of a surgical instrument
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US11045270B2 (en) 2017-12-19 2021-06-29 Cilag Gmbh International Robotic attachment comprising exterior drive actuator
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11051813B2 (en) 2006-01-31 2021-07-06 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US11071545B2 (en) 2014-09-05 2021-07-27 Cilag Gmbh International Smart cartridge wake up operation and data retention
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US11123065B2 (en) 2013-12-23 2021-09-21 Cilag Gmbh International Surgical cutting and stapling instruments with independent jaw control features
US11129680B2 (en) 2017-12-21 2021-09-28 Cilag Gmbh International Surgical instrument comprising a projector
US11133106B2 (en) 2013-08-23 2021-09-28 Cilag Gmbh International Surgical instrument assembly comprising a retraction assembly
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
WO2021173629A3 (en) * 2020-02-28 2021-11-04 NanoBio Designs, LLC Molecular detection via assembly of particle complexes
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US11197671B2 (en) 2012-06-28 2021-12-14 Cilag Gmbh International Stapling assembly comprising a lockout
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US11202633B2 (en) 2014-09-26 2021-12-21 Cilag Gmbh International Surgical stapling buttresses and adjunct materials
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
US11213295B2 (en) 2015-09-02 2022-01-04 Cilag Gmbh International Surgical staple configurations with camming surfaces located between portions supporting surgical staples
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11219456B2 (en) 2015-08-26 2022-01-11 Cilag Gmbh International Surgical staple strips for permitting varying staple properties and enabling easy cartridge loading
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US11224428B2 (en) 2016-12-21 2022-01-18 Cilag Gmbh International Surgical stapling systems
US11229437B2 (en) 2019-06-28 2022-01-25 Cilag Gmbh International Method for authenticating the compatibility of a staple cartridge with a surgical instrument
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11241230B2 (en) 2012-06-28 2022-02-08 Cilag Gmbh International Clip applier tool for use with a robotic surgical system
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US11259799B2 (en) 2014-03-26 2022-03-01 Cilag Gmbh International Interface systems for use with surgical instruments
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11266409B2 (en) 2014-04-16 2022-03-08 Cilag Gmbh International Fastener cartridge comprising a sled including longitudinally-staggered ramps
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US11272927B2 (en) 2008-02-15 2022-03-15 Cilag Gmbh International Layer arrangements for surgical staple cartridges
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US11284898B2 (en) 2014-09-18 2022-03-29 Cilag Gmbh International Surgical instrument including a deployable knife
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
US11291449B2 (en) 2009-12-24 2022-04-05 Cilag Gmbh International Surgical cutting instrument that analyzes tissue thickness
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
US11317913B2 (en) 2016-12-21 2022-05-03 Cilag Gmbh International Lockout arrangements for surgical end effectors and replaceable tool assemblies
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US11350928B2 (en) 2016-04-18 2022-06-07 Cilag Gmbh International Surgical instrument comprising a tissue thickness lockout and speed control system
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US11382627B2 (en) 2014-04-16 2022-07-12 Cilag Gmbh International Surgical stapling assembly comprising a firing member including a lateral extension
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11464513B2 (en) 2012-06-28 2022-10-11 Cilag Gmbh International Surgical instrument system including replaceable end effectors
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
US11478247B2 (en) 2010-07-30 2022-10-25 Cilag Gmbh International Tissue acquisition arrangements and methods for surgical stapling devices
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
US11523823B2 (en) 2016-02-09 2022-12-13 Cilag Gmbh International Surgical instruments with non-symmetrical articulation arrangements
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
US11559591B2 (en) 2017-05-25 2023-01-24 Memorial Sloan Kettering Cancer Center Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
US11564682B2 (en) 2007-06-04 2023-01-31 Cilag Gmbh International Surgical stapler device
US11571215B2 (en) 2010-09-30 2023-02-07 Cilag Gmbh International Layer of material for a surgical end effector
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
US11622763B2 (en) 2013-04-16 2023-04-11 Cilag Gmbh International Stapling assembly comprising a shiftable drive
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
US11638582B2 (en) 2020-07-28 2023-05-02 Cilag Gmbh International Surgical instruments with torsion spine drive arrangements
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11678877B2 (en) 2014-12-18 2023-06-20 Cilag Gmbh International Surgical instrument including a flexible support configured to support a flexible firing member
US11684367B2 (en) 2016-12-21 2023-06-27 Cilag Gmbh International Stepped assembly having and end-of-life indicator
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11690619B2 (en) 2016-06-24 2023-07-04 Cilag Gmbh International Staple cartridge comprising staples having different geometries
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11697713B2 (en) 2011-12-30 2023-07-11 University Of Washington Through Its Center For Commercialization Chromophoric polymer dots with narrow-band emission
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11717294B2 (en) 2014-04-16 2023-08-08 Cilag Gmbh International End effector arrangements comprising indicators
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11723662B2 (en) 2021-05-28 2023-08-15 Cilag Gmbh International Stapling instrument comprising an articulation control display
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11766260B2 (en) 2016-12-21 2023-09-26 Cilag Gmbh International Methods of stapling tissue
US11766259B2 (en) 2016-12-21 2023-09-26 Cilag Gmbh International Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11793522B2 (en) 2015-09-30 2023-10-24 Cilag Gmbh International Staple cartridge assembly including a compressible adjunct
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11826048B2 (en) 2017-06-28 2023-11-28 Cilag Gmbh International Surgical instrument comprising selectively actuatable rotatable couplers
US11826132B2 (en) 2015-03-06 2023-11-28 Cilag Gmbh International Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
US11849952B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11883026B2 (en) 2014-04-16 2024-01-30 Cilag Gmbh International Fastener cartridge assemblies and staple retainer cover arrangements
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11925349B2 (en) 2021-02-26 2024-03-12 Cilag Gmbh International Adjustment to transfer parameters to improve available power
US11931425B2 (en) 2021-12-30 2024-03-19 Memorial Sloan Kettering Cancer Center Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101822A1 (en) * 2002-11-26 2004-05-27 Ulrich Wiesner Fluorescent silica-based nanoparticles
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0400235D0 (en) * 2004-01-07 2004-02-11 Univ Sunderland Nanoparticles as agents for imaging finger prints
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
CA2598558C (en) * 2005-02-14 2013-04-02 Australian Nuclear Science & Technology Organisation Layered nanoparticles
WO2006102377A2 (en) * 2005-03-21 2006-09-28 The Regents Of The University Of California Functionalized magnetic nanoparticles and methods of use thereof
JP4774507B2 (en) * 2005-03-22 2011-09-14 国立大学法人徳島大学 Color material composition and colored or luminescent product containing the same
CN100586482C (en) * 2005-04-29 2010-02-03 同济大学 Lymph dye with silicon dioxide microparticle as supporter and its preparation method
JP2006328032A (en) * 2005-05-30 2006-12-07 Fujifilm Holdings Corp Nucleic acid probe and method for fluorescence detection of multiple-stranded nucleic acid
JP5330828B2 (en) 2005-08-09 2013-10-30 ユニヴァーシティ・オヴ・サンダーランド Hydrophobic silica particles and method for producing them
JP4931015B2 (en) * 2005-08-30 2012-05-16 学校法人東京電機大学 Nanosilicon-containing dissolving tablet and method for producing the same
EP1760467A1 (en) * 2005-09-02 2007-03-07 Schering AG Optically fluorescent nanoparticles
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
JP2007197382A (en) * 2006-01-27 2007-08-09 Konica Minolta Medical & Graphic Inc Semiconductor nanoparticle
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
FR2910632B1 (en) * 2006-12-22 2010-08-27 Commissariat Energie Atomique OPTICAL PLASMON ENCODING DEVICE AND AUTHENTICATION METHOD EMPLOYING THE SAME
DE602008003565D1 (en) 2007-05-11 2010-12-30 Basf Se FUNCTIONALIZED NANOPARTICLES
KR100845010B1 (en) * 2007-08-29 2008-07-08 한국생명공학연구원 Polymer particles for nir/mr bimodal molecular imaging and method for preparing thereof
WO2009032994A2 (en) * 2007-09-06 2009-03-12 Emory University Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb
CN101343538B (en) * 2008-08-25 2011-03-23 华东理工大学 Fluorescence silica gel particle and uses thereof
JP5419199B2 (en) * 2008-12-08 2014-02-19 積水化学工業株式会社 Magnetic inclusion particles, method for producing magnetic inclusion particles, immunoassay particles, and immunochromatography method
EP2383322A1 (en) * 2008-12-25 2011-11-02 Nippon Sheet Glass Company Limited Fluorescent dye-containing particles and manufacturing method thereof
CN101463252B (en) * 2009-01-08 2012-01-04 东南大学 Preparation of dye doped silicon dioxide fluorescent nanoparticle
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US20120077279A1 (en) * 2009-04-15 2012-03-29 Cornell University Silica Nanoparticles Incorporating Chemiluminescent And Absorbing Active Molecules
DE102009019411A1 (en) 2009-04-29 2010-11-04 Bayer Technology Services Gmbh Process for the UV stabilization of organic substances
DE102009024685A1 (en) 2009-06-12 2010-12-16 Gmbu E.V., Fachsektion Dresden Luminescent composite particle, useful e.g. as marking agent in polymeric films and articles for forgery-proof product identification, comprises organic optical brightener, which is homogeneously embedded in microspherical inorganic oxide
JP5620154B2 (en) * 2009-10-15 2014-11-05 公益財団法人神奈川科学技術アカデミー Hollow micro object and method for producing the same
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011109214A2 (en) * 2010-03-01 2011-09-09 University Of Florida Research Foundation, Inc. Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same
IT1399551B1 (en) 2010-04-13 2013-04-19 Univ Palermo NANO SILICATE NANO-EMITTERS FOR IN-VIVO APPLICATIONS AND RELATIVE PRODUCTION PROCESS.
KR101218204B1 (en) * 2010-07-09 2013-01-03 한국과학기술원 Fluorescence hollow silica nanoparticle and preparation method thereof
CN101993693B (en) * 2010-09-28 2013-08-07 华东理工大学 Preparation method of mesoporous silica fluorescent nanoparticles for pH ratio probes
EP3447155A1 (en) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwich assays in droplets
US9525092B2 (en) 2010-11-05 2016-12-20 Pacific Light Technologies Corp. Solar module employing quantum luminescent lateral transfer concentrator
EP2646818A4 (en) * 2010-11-30 2016-09-21 Univ Illinois Silica nanoparticle agent conjugates
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012133306A1 (en) * 2011-03-25 2012-10-04 株式会社Tasプロジェクト Method for quantitatively detecting 8-oxo-2'-deoxyguanosine in aqueous sample solution with high sensitivity
WO2012147774A1 (en) * 2011-04-26 2012-11-01 古河電気工業株式会社 Method for producing silica nanoparticles containing functional molecules to which biomolecules are bonded
CN102320612A (en) * 2011-05-26 2012-01-18 东北师范大学 Preparation method and application of fluorescence mesoporous silica nano-particle
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US20120323112A1 (en) * 2011-06-17 2012-12-20 The Board Of Trustees Of The Leland Stanford Junior University Nanoparticles for accoustic imaging, methods of making, and methods of accoustic imaging
WO2013020714A2 (en) * 2011-08-11 2013-02-14 Qiagen Gmbh Cell- or virus simulating means comprising encapsulated marker molecules
GB201117675D0 (en) 2011-10-13 2011-11-23 Univ St Andrews Nanocolloids for local temperature monitoring
US20130112942A1 (en) 2011-11-09 2013-05-09 Juanita Kurtin Composite having semiconductor structures embedded in a matrix
US20130112941A1 (en) 2011-11-09 2013-05-09 Juanita Kurtin Semiconductor structure having nanocrystalline core and nanocrystalline shell with insulator coating
WO2013192609A1 (en) * 2012-06-22 2013-12-27 Cornell University Mesoporous oxide nanoparticles and methods of making and using same
ITBO20120444A1 (en) 2012-08-10 2014-02-11 R D Pharmadvice S R L METHOD FOR THE PRODUCTION OF THERMOCHEMALUMINESCENT SILICA NANOPARTICLES AND THEIR USE AS MARKERS IN BIOANALYTICAL METHODS
US9425365B2 (en) 2012-08-20 2016-08-23 Pacific Light Technologies Corp. Lighting device having highly luminescent quantum dots
KR101445596B1 (en) * 2012-09-27 2014-10-07 단국대학교 산학협력단 Measurement method and measurement kit of antibiotics concentration
US8889457B2 (en) 2012-12-13 2014-11-18 Pacific Light Technologies Corp. Composition having dispersion of nano-particles therein and methods of fabricating same
US11366061B2 (en) 2013-01-24 2022-06-21 Grace Bio-Labs, Inc. Protein microarray assay imager
US9119875B2 (en) 2013-03-14 2015-09-01 International Business Machines Corporation Matrix incorporated fluorescent porous and non-porous silica particles for medical imaging
US9371237B2 (en) 2013-04-22 2016-06-21 American Talc Company Methods and systems for controlled conversion of minerals to pigmenting elements
WO2015026663A1 (en) 2013-08-19 2015-02-26 University Of Houston Phosphorescent reporters
JP6080164B2 (en) * 2013-10-02 2017-02-15 古河電気工業株式会社 Fluorescently labeled particles
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
EP3090063B1 (en) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Method for detection of latent retrovirus
WO2015160794A1 (en) * 2014-04-14 2015-10-22 Ecosynthetix Ltd. Bio-based nanoparticle and composite materials derived therefrom
WO2015168439A1 (en) 2014-04-30 2015-11-05 Nitto Denko Corporation Inorganic oxide coated fluorescent chromophores for use in highly photostable wavelength conversion films
WO2016012433A1 (en) * 2014-07-22 2016-01-28 Koninklijke Philips N.V. Siloxane ligands to be used for dispersing quantum dots in silicone hosts to obtain color converters for led lighting
JP6751715B2 (en) 2014-12-15 2020-09-09 メモリアル スローン ケタリング キャンサー センター Cyclic peptide with enhanced neural binding selectivity, nanoparticles bound to the cyclic peptide, and use of the cyclic peptide for real-time in vivo neural tissue imaging.
CN106281305A (en) * 2015-06-10 2017-01-04 南开大学 A kind of life-span adjustable fluorescence nano core-shell material and preparation method thereof
KR101938284B1 (en) * 2015-06-15 2019-01-15 주식회사 엘지화학 Fluorescent complex, light conversion film, light conversioni device and display appratus comprising the same
US9716211B2 (en) * 2015-07-22 2017-07-25 Sharp Kabushiki Kaisha Semiconductor phosphor nanoparticle, semiconductor phosphor nanoparticle-containing glass, light emitting device, and light emitting element
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
JP2018536734A (en) * 2015-11-11 2018-12-13 ダウ グローバル テクノロジーズ エルエルシー Luminescent nanoparticles and manufacturing process thereof
JP2017155069A (en) * 2016-02-29 2017-09-07 古河電気工業株式会社 Silica nanoparticles, manufacturing method of silica nanoparticles, fluid dispersion of silica nanoparticles
US20210220494A1 (en) 2016-04-29 2021-07-22 Memorial Sloan Kettering Cancer Center Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors
WO2017196789A1 (en) * 2016-05-09 2017-11-16 The Trustees Of The University Of Pennsylvania Omni-transparent and superhydrophobic coatings assembled from chain-like nanoparticles
CN105999296B (en) * 2016-06-07 2019-02-05 上海纳米技术及应用国家工程研究中心有限公司 A kind of preparation method of across the blood-brain barrier film fluorescent silicon dioxide nano particle of different-grain diameter
JP7137841B2 (en) * 2016-06-14 2022-09-15 ユニバーシティ オブ ワシントン Polymer-Silica Hybrid Pdots and Methods of Using Them
KR20190028723A (en) 2016-07-07 2019-03-19 메모리얼 슬로안 케터링 캔서 센터 Imaging systems and methods for particle-driven, knowledge-based, and predictive cancer radiation radiation genomics
EP3548096A1 (en) 2016-11-30 2019-10-09 Memorial Sloan Kettering Cancer Center Inhibitor-functionalized ultrasmall nanoparticles and methods thereof
CN106596482B (en) * 2016-12-08 2019-04-30 哈尔滨师范大学 Fluorescence silicon nano particles and its application in mercury ion detecting and fingerprint manifestation
WO2018191316A1 (en) * 2017-04-10 2018-10-18 Cornell University Sulfur- or heavy atom-containing nanoparticles, methods of making same, and uses thereof
WO2018237253A1 (en) 2017-06-23 2018-12-27 Memorial Sloan Kettering Cancer Center Method of imaging in vivo tissues using nanoparticles comprising a reference dye and a sensor dye.
US10729501B2 (en) 2017-09-29 2020-08-04 Ethicon Llc Systems and methods for language selection of a surgical instrument
CN107871677B (en) * 2017-10-31 2020-08-25 合肥京东方光电科技有限公司 Display panel, packaging monitoring device and packaging monitoring method thereof
WO2019113004A1 (en) 2017-12-04 2019-06-13 Memorial Sloan Kettering Cancer Center Methods of cancer treatment via regulated ferroptosis
TW201936896A (en) * 2018-02-20 2019-09-16 國立大學法人九州大學 Method for producing luminescent particles, luminescent particles, and bioimaging material
US11045555B2 (en) * 2018-04-20 2021-06-29 The Regents Of The University Of California Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles
WO2019213456A1 (en) * 2018-05-02 2019-11-07 Cornell University Ultrasmall nanoparticles and methods of making, using and analyzing same
EP3787684A1 (en) 2018-05-02 2021-03-10 Memorial Sloan Kettering Cancer Center Nanotherapeutic systems and methods using particle-driven photodynamic therapy (pdt)
US11666411B2 (en) 2018-05-10 2023-06-06 Memorial Sloan Kettering Cancer Center Systems for augmented reality surgical and clinical visualization
CN108715833B (en) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 Preparation method of microsphere loaded with platelet lysate
US11320738B2 (en) 2018-06-27 2022-05-03 Taiwan Semiconductor Manufacturing Co., Ltd. Pattern formation method and material for manufacturing semiconductor devices
CN110760301A (en) * 2018-07-26 2020-02-07 合皓股份有限公司 Siloxane organic fluorescent powder and preparation method thereof
US20220229065A1 (en) * 2019-05-24 2022-07-21 Bambu Vault Llc Sensors and methods for rapid microbial detection
CN110530832B (en) * 2019-08-26 2022-09-27 河南师范大学 Method for selectively determining 2, 4-dinitrophenol in surface water sample based on fluorescence analysis
JP7349578B2 (en) 2020-10-27 2023-09-22 エルシダ オンコロジー, インコーポレイテッド Nanoparticle drug conjugates targeted to folate receptors and their uses

Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279617A (en) * 1979-02-26 1981-07-21 Technicon Instruments Corporation Iummunoassay involving agglutination
US4774339A (en) * 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US4810636A (en) * 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
US4812409A (en) * 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US5187288A (en) * 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5248782A (en) * 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5260957A (en) * 1992-10-29 1993-11-09 The Charles Stark Draper Laboratory, Inc. Quantum dot Laser
US5274113A (en) * 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5405752A (en) * 1988-10-03 1995-04-11 Nilsson; Kurt G. I. Enzyme conjugate prepared with insoluble nonoparticle
US5433896A (en) * 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5753517A (en) * 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US5830912A (en) * 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6132773A (en) * 1996-04-22 2000-10-17 Rhodia Chimie Method for preparing particles comprising a core and a silica shell
US6180415B1 (en) * 1997-02-20 2001-01-30 The Regents Of The University Of California Plasmon resonant particles, methods and apparatus
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6251303B1 (en) * 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6268222B1 (en) * 1998-01-22 2001-07-31 Luminex Corporation Microparticles attached to nanoparticles labeled with flourescent dye
US6274323B1 (en) * 1999-05-07 2001-08-14 Quantum Dot Corporation Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label
US6306610B1 (en) * 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
US6322901B1 (en) * 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US6326144B1 (en) * 1998-09-18 2001-12-04 Massachusetts Institute Of Technology Biological applications of quantum dots
US6344272B1 (en) * 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US6426513B1 (en) * 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
US6428811B1 (en) * 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US6479146B1 (en) * 1998-03-19 2002-11-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
US6500622B2 (en) * 2000-03-22 2002-12-31 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US20030017264A1 (en) * 2001-07-20 2003-01-23 Treadway Joseph A. Luminescent nanoparticles and methods for their preparation
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6576219B2 (en) * 1994-12-09 2003-06-10 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US20030124564A1 (en) * 2001-06-29 2003-07-03 Mathias Trau Synthesis and use of organosilica particles
US6649138B2 (en) * 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870791A (en) 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US3867519A (en) 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (en) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantable dosing device
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4255415A (en) 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4918200A (en) * 1984-07-16 1990-04-17 Huls America Inc. Chromogenic and fluorogenic silanes and using the same
US4665024A (en) 1984-10-01 1987-05-12 Becton, Dickinson And Company Fluorescent gram stain
US4931279A (en) 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4668506A (en) 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4788603A (en) 1985-10-19 1988-11-29 Fuji Photo Film Co., Ltd. Camera for sequentially photographing a subject using a reference optical system and a telescopic optical system
US4810639A (en) * 1985-12-20 1989-03-07 E. I. Du Pont De Nemours And Company Immunoassay for CK-MB using bound and soluble antibodies
US4713224A (en) 1986-03-31 1987-12-15 The Boc Group, Inc. One-step process for purifying an inert gas
EP0594763B1 (en) 1991-07-16 1998-09-23 Transmed Biotech Incorporated Methods and compositions for simultaneous analysis of multiple analytes
KR970706628A (en) 1994-09-29 1997-11-03 로버츠 사이먼 크리스토퍼 Optical fiber with quantum dots (OPTICAL FIBER WITH QUANTUM DOTS)
US6361944B1 (en) 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6451044B1 (en) 1996-09-20 2002-09-17 Board Of Regents, The University Of Texas System Method and apparatus for heating inflammed tissue
US6480746B1 (en) 1997-08-13 2002-11-12 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US5795158A (en) 1996-12-02 1998-08-18 Warinner; Peter Apparatus to review clinical microbiology
US5968820A (en) 1997-02-26 1999-10-19 The Cleveland Clinic Foundation Method for magnetically separating cells into fractionated flow streams
US6221586B1 (en) 1997-04-09 2001-04-24 California Institute Of Technology Electrochemical sensor using intercalative, redox-active moieties
US6082205A (en) 1998-02-06 2000-07-04 Ohio State University System and device for determining particle characteristics
US6501091B1 (en) 1998-04-01 2002-12-31 Massachusetts Institute Of Technology Quantum dot white and colored light emitting diodes
AUPP737298A0 (en) * 1998-11-30 1998-12-24 University Of Queensland, The Combinatorial libraries
GB9910155D0 (en) * 1999-04-30 1999-06-30 Microbiological Research Agenc Augmented agglutination assay
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
JPWO2003060037A1 (en) * 2001-12-27 2005-05-19 株式会社テクノネットワーク四国 Silica spheres containing fluorescent dye molecules
JP2003270154A (en) * 2001-12-27 2003-09-25 Techno Network Shikoku Co Ltd Fluorescent dye molecule-containing silica ball
US20040101822A1 (en) * 2002-11-26 2004-05-27 Ulrich Wiesner Fluorescent silica-based nanoparticles

Patent Citations (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279617A (en) * 1979-02-26 1981-07-21 Technicon Instruments Corporation Iummunoassay involving agglutination
US4812409A (en) * 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US4810636A (en) * 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
US4774339A (en) * 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US5405752A (en) * 1988-10-03 1995-04-11 Nilsson; Kurt G. I. Enzyme conjugate prepared with insoluble nonoparticle
US5248782A (en) * 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5187288A (en) * 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5274113A (en) * 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5260957A (en) * 1992-10-29 1993-11-09 The Charles Stark Draper Laboratory, Inc. Quantum dot Laser
US5433896A (en) * 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US6576219B2 (en) * 1994-12-09 2003-06-10 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5753517A (en) * 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6132773A (en) * 1996-04-22 2000-10-17 Rhodia Chimie Method for preparing particles comprising a core and a silica shell
US5830912A (en) * 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US6180415B1 (en) * 1997-02-20 2001-01-30 The Regents Of The University Of California Plasmon resonant particles, methods and apparatus
US6344272B1 (en) * 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US6322901B1 (en) * 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6423551B1 (en) * 1997-11-25 2002-07-23 The Regents Of The University Of California Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6268222B1 (en) * 1998-01-22 2001-07-31 Luminex Corporation Microparticles attached to nanoparticles labeled with flourescent dye
US6428811B1 (en) * 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
US6479146B1 (en) * 1998-03-19 2002-11-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
US6251303B1 (en) * 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6326144B1 (en) * 1998-09-18 2001-12-04 Massachusetts Institute Of Technology Biological applications of quantum dots
US6426513B1 (en) * 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
US6319426B1 (en) * 1998-09-18 2001-11-20 Massachusetts Institute Of Technology Water-soluble fluorescent semiconductor nanocrystals
US6444143B2 (en) * 1998-09-18 2002-09-03 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6306610B1 (en) * 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US6274323B1 (en) * 1999-05-07 2001-08-14 Quantum Dot Corporation Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label
US6500622B2 (en) * 2000-03-22 2002-12-31 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6649138B2 (en) * 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20030124564A1 (en) * 2001-06-29 2003-07-03 Mathias Trau Synthesis and use of organosilica particles
US20030017264A1 (en) * 2001-07-20 2003-01-23 Treadway Joseph A. Luminescent nanoparticles and methods for their preparation

Cited By (1577)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070051674A1 (en) * 2000-02-04 2007-03-08 Bratten Jack R Lift station and method
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US9326953B2 (en) 2003-04-25 2016-05-03 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20050025820A1 (en) * 2003-04-25 2005-02-03 Mark Kester Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US9028863B2 (en) * 2003-04-25 2015-05-12 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US9060770B2 (en) 2003-05-20 2015-06-23 Ethicon Endo-Surgery, Inc. Robotically-driven surgical instrument with E-beam driver
US8783541B2 (en) 2003-05-20 2014-07-22 Frederick E. Shelton, IV Robotically-controlled surgical end effector system
US10203326B2 (en) 2003-10-02 2019-02-12 Furukawa Electric Co., Ltd. Method of detecting target substance
FR2873021A1 (en) * 2004-07-16 2006-01-20 Oreal Cosmetic composition, used as a make-up and/or skin care (particularly face, lips and/or keratinous fibers) product, comprises a photo luminescent mineral nanoparticles in a medium
WO2006011014A1 (en) * 2004-07-16 2006-02-02 L'oreal Cosmetic composition containing photoluminescent particles
US10687817B2 (en) 2004-07-28 2020-06-23 Ethicon Llc Stapling device comprising a firing member lockout
US10383634B2 (en) 2004-07-28 2019-08-20 Ethicon Llc Stapling system incorporating a firing lockout
US9510830B2 (en) 2004-07-28 2016-12-06 Ethicon Endo-Surgery, Llc Staple cartridge
US10293100B2 (en) 2004-07-28 2019-05-21 Ethicon Llc Surgical stapling instrument having a medical substance dispenser
US10292707B2 (en) 2004-07-28 2019-05-21 Ethicon Llc Articulating surgical stapling instrument incorporating a firing mechanism
US11882987B2 (en) 2004-07-28 2024-01-30 Cilag Gmbh International Articulating surgical stapling instrument incorporating a two-piece E-beam firing mechanism
US10314590B2 (en) 2004-07-28 2019-06-11 Ethicon Llc Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism
US10799240B2 (en) 2004-07-28 2020-10-13 Ethicon Llc Surgical instrument comprising a staple firing lockout
US11083456B2 (en) 2004-07-28 2021-08-10 Cilag Gmbh International Articulating surgical instrument incorporating a two-piece firing mechanism
US11812960B2 (en) 2004-07-28 2023-11-14 Cilag Gmbh International Method of segmenting the operation of a surgical stapling instrument
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US10716563B2 (en) 2004-07-28 2020-07-21 Ethicon Llc Stapling system comprising an instrument assembly including a lockout
US10278702B2 (en) 2004-07-28 2019-05-07 Ethicon Llc Stapling system comprising a firing bar and a lockout
US9844379B2 (en) 2004-07-28 2017-12-19 Ethicon Llc Surgical stapling instrument having a clearanced opening
US10568629B2 (en) 2004-07-28 2020-02-25 Ethicon Llc Articulating surgical stapling instrument
US9585663B2 (en) 2004-07-28 2017-03-07 Ethicon Endo-Surgery, Llc Surgical stapling instrument configured to apply a compressive pressure to tissue
US11684365B2 (en) 2004-07-28 2023-06-27 Cilag Gmbh International Replaceable staple cartridges for surgical instruments
US11116502B2 (en) 2004-07-28 2021-09-14 Cilag Gmbh International Surgical stapling instrument incorporating a two-piece firing mechanism
US9737303B2 (en) 2004-07-28 2017-08-22 Ethicon Llc Articulating surgical stapling instrument incorporating a two-piece E-beam firing mechanism
US9737302B2 (en) 2004-07-28 2017-08-22 Ethicon Llc Surgical stapling instrument having a restraining member
US10485547B2 (en) 2004-07-28 2019-11-26 Ethicon Llc Surgical staple cartridges
US9282966B2 (en) 2004-07-28 2016-03-15 Ethicon Endo-Surgery, Inc. Surgical stapling instrument
US11135352B2 (en) 2004-07-28 2021-10-05 Cilag Gmbh International End effector including a gradually releasable medical adjunct
US11896225B2 (en) 2004-07-28 2024-02-13 Cilag Gmbh International Staple cartridge comprising a pan
US7306963B2 (en) 2004-11-30 2007-12-11 Spire Corporation Precision synthesis of quantum dot nanostructures for fluorescent and optoelectronic devices
US20060115917A1 (en) * 2004-11-30 2006-06-01 Linden Kurt J Precision synthesis of quantum dot nanostructures for fluorescent and optoelectronic devices
US7514725B2 (en) 2004-11-30 2009-04-07 Spire Corporation Nanophotovoltaic devices
US20090165852A1 (en) * 2004-11-30 2009-07-02 Spire Corporation Nanophotovoltaic devices
US8242009B2 (en) 2004-11-30 2012-08-14 Spire Corporation Nanophotovoltaic devices
US20060113557A1 (en) * 2004-11-30 2006-06-01 Spire Corporation Nanophotovoltaic devices
US20110237015A1 (en) * 2004-11-30 2011-09-29 Spire Corporation Nanophotovoltaic devices
US7759257B2 (en) 2004-11-30 2010-07-20 Spire Corporation Precision synthesis of quantum dot nanostructures for fluorescent and optoelectronic devices
US7955965B2 (en) 2004-11-30 2011-06-07 Spire Corporation Nanophotovoltaic devices
US7772612B2 (en) 2004-11-30 2010-08-10 Spire Corporation Nanophotovoltaic devices
US20100297803A1 (en) * 2004-11-30 2010-11-25 Spire Corporation Nanophotovoltaic devices
US20080241266A1 (en) * 2005-01-14 2008-10-02 Bringley Joseph F Amine polymer-modified nanoparticulate carriers
US20060293396A1 (en) * 2005-01-14 2006-12-28 Eastman Kodak Company Amine polymer-modified nanoparticulate carriers
US20090060846A1 (en) * 2005-03-18 2009-03-05 Washington, University Of Nanoparticles having reactive ester groups covalently coupled thereto and related methods
US7462446B2 (en) * 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods
US20060216239A1 (en) * 2005-03-18 2006-09-28 Washington, University Of Magnetic nanoparticle compositions and methods
US7666394B2 (en) 2005-03-18 2010-02-23 University Of Washington Nanoparticles having reactive ester groups covalently coupled thereto and related methods
US7272275B2 (en) 2005-03-31 2007-09-18 Eastman Kodak Company Polarized light emitting source with an electro-optical addressing architecture
US20060222286A1 (en) * 2005-03-31 2006-10-05 Eastman Kodak Company Polarized light emitting source with an electro-optical addressing architecture
US20060222292A1 (en) * 2005-03-31 2006-10-05 Eastman Kodak Company Placement of lumiphores within a light emitting resonator in a visual display with electro-optical addressing architecture
US7352926B2 (en) 2005-03-31 2008-04-01 Eastman Kodak Company Visual display with electro-optical addressing architecture
US7120332B1 (en) 2005-03-31 2006-10-10 Eastman Kodak Company Placement of lumiphores within a light emitting resonator in a visual display with electro-optical addressing architecture
US20060227840A1 (en) * 2005-03-31 2006-10-12 Eastman Kodak Company Visual display with electro-optical addressing architecture
US20070154965A1 (en) * 2005-04-22 2007-07-05 Miqin Zhang Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumors
US20080279780A1 (en) * 2005-04-22 2008-11-13 Washington, University Of Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
US8778310B2 (en) 2005-04-22 2014-07-15 University Of Washington Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
US20060245971A1 (en) * 2005-05-02 2006-11-02 Burns Andrew A Photoluminescent silica-based sensors and methods of use
CN101198672B (en) * 2005-05-02 2012-09-05 科内尔研究基金会 Photoluminescent silica-based sensors and methods of use
US8084001B2 (en) 2005-05-02 2011-12-27 Cornell Research Foundation, Inc. Photoluminescent silica-based sensors and methods of use
US20060291769A1 (en) * 2005-05-27 2006-12-28 Eastman Kodak Company Light emitting source incorporating vertical cavity lasers and other MEMS devices within an electro-optical addressing architecture
EP1883676A1 (en) * 2005-05-27 2008-02-06 Ciba Specialty Chemicals Holding Inc. Functionalized nanoparticles
US20090099282A1 (en) * 2005-05-27 2009-04-16 Martin Muller Functionalized nanoparticles
US20090137060A1 (en) * 2005-07-11 2009-05-28 Rikshospitalet Hf Multicolored particles
US7897407B2 (en) 2005-07-11 2011-03-01 Rikshospitalet Hf Multicolored particles
US20110135929A1 (en) * 2005-07-11 2011-06-09 Rikshospitalet Hf Multicolored particles
US9307988B2 (en) 2005-08-31 2016-04-12 Ethicon Endo-Surgery, Llc Staple cartridges for forming staples having differing formed staple heights
US11399828B2 (en) 2005-08-31 2022-08-02 Cilag Gmbh International Fastener cartridge assembly comprising a fixed anvil and different staple heights
US11730474B2 (en) 2005-08-31 2023-08-22 Cilag Gmbh International Fastener cartridge assembly comprising a movable cartridge and a staple driver arrangement
US10070863B2 (en) 2005-08-31 2018-09-11 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil
US10463369B2 (en) 2005-08-31 2019-11-05 Ethicon Llc Disposable end effector for use with a surgical instrument
US11172927B2 (en) 2005-08-31 2021-11-16 Cilag Gmbh International Staple cartridges for forming staples having differing formed staple heights
US10271846B2 (en) 2005-08-31 2019-04-30 Ethicon Llc Staple cartridge for use with a surgical stapler
US9561032B2 (en) 2005-08-31 2017-02-07 Ethicon Endo-Surgery, Llc Staple cartridge comprising a staple driver arrangement
US11179153B2 (en) 2005-08-31 2021-11-23 Cilag Gmbh International Staple cartridges for forming staples having differing formed staple heights
US8317070B2 (en) 2005-08-31 2012-11-27 Ethicon Endo-Surgery, Inc. Surgical stapling devices that produce formed staples having different lengths
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US9848873B2 (en) 2005-08-31 2017-12-26 Ethicon Llc Fastener cartridge assembly comprising a driver and staple cavity arrangement
US10271845B2 (en) 2005-08-31 2019-04-30 Ethicon Llc Fastener cartridge assembly comprising a cam and driver arrangement
US10420553B2 (en) 2005-08-31 2019-09-24 Ethicon Llc Staple cartridge comprising a staple driver arrangement
US11576673B2 (en) 2005-08-31 2023-02-14 Cilag Gmbh International Stapling assembly for forming staples to different heights
US11090045B2 (en) 2005-08-31 2021-08-17 Cilag Gmbh International Staple cartridges for forming staples having differing formed staple heights
US9844373B2 (en) 2005-08-31 2017-12-19 Ethicon Llc Fastener cartridge assembly comprising a driver row arrangement
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US7673781B2 (en) 2005-08-31 2010-03-09 Ethicon Endo-Surgery, Inc. Surgical stapling device with staple driver that supports multiple wire diameter staples
US11771425B2 (en) 2005-08-31 2023-10-03 Cilag Gmbh International Stapling assembly for forming staples to different formed heights
US10729436B2 (en) 2005-08-31 2020-08-04 Ethicon Llc Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US9839427B2 (en) 2005-08-31 2017-12-12 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and a staple driver arrangement
US20070262116A1 (en) * 2005-08-31 2007-11-15 Hueil Joseph C Surgical stapling device with multiple stacked actuator wedge cams for driving staple drivers
US11484311B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US10159482B2 (en) 2005-08-31 2018-12-25 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US9795382B2 (en) 2005-08-31 2017-10-24 Ethicon Llc Fastener cartridge assembly comprising a cam and driver arrangement
US9326768B2 (en) 2005-08-31 2016-05-03 Ethicon Endo-Surgery, Llc Staple cartridges for forming staples having differing formed staple heights
US20110174863A1 (en) * 2005-08-31 2011-07-21 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US8464923B2 (en) 2005-08-31 2013-06-18 Ethicon Endo-Surgery, Inc. Surgical stapling devices for forming staples with different formed heights
US11793512B2 (en) 2005-08-31 2023-10-24 Cilag Gmbh International Staple cartridges for forming staples having differing formed staple heights
US10278697B2 (en) 2005-08-31 2019-05-07 Ethicon Llc Staple cartridge comprising a staple driver arrangement
US10842488B2 (en) 2005-08-31 2020-11-24 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US9592052B2 (en) 2005-08-31 2017-03-14 Ethicon Endo-Surgery, Llc Stapling assembly for forming different formed staple heights
US10842489B2 (en) 2005-08-31 2020-11-24 Ethicon Llc Fastener cartridge assembly comprising a cam and driver arrangement
US8567656B2 (en) 2005-08-31 2013-10-29 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US10869664B2 (en) 2005-08-31 2020-12-22 Ethicon Llc End effector for use with a surgical stapling instrument
US8800838B2 (en) 2005-08-31 2014-08-12 Ethicon Endo-Surgery, Inc. Robotically-controlled cable-based surgical end effectors
US11134947B2 (en) 2005-08-31 2021-10-05 Cilag Gmbh International Fastener cartridge assembly comprising a camming sled with variable cam arrangements
US10245035B2 (en) 2005-08-31 2019-04-02 Ethicon Llc Stapling assembly configured to produce different formed staple heights
US10245032B2 (en) 2005-08-31 2019-04-02 Ethicon Llc Staple cartridges for forming staples having differing formed staple heights
US11272928B2 (en) 2005-08-31 2022-03-15 Cilag GmbH Intemational Staple cartridges for forming staples having differing formed staple heights
US11839375B2 (en) 2005-08-31 2023-12-12 Cilag Gmbh International Fastener cartridge assembly comprising an anvil and different staple heights
US10321909B2 (en) 2005-08-31 2019-06-18 Ethicon Llc Staple cartridge comprising a staple including deformable members
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US8636187B2 (en) 2005-08-31 2014-01-28 Ethicon Endo-Surgery, Inc. Surgical stapling systems that produce formed staples having different lengths
US10932774B2 (en) 2005-08-31 2021-03-02 Ethicon Llc Surgical end effector for forming staples to different heights
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
WO2007029980A1 (en) * 2005-09-08 2007-03-15 Biterials Co., Ltd. Magnetic nanoparticle having fluorescent and preparation method thereof and use thereof
KR100821192B1 (en) * 2005-09-08 2008-04-11 주식회사바이테리얼즈 Magnetic nanoparticle having fluorescent and preparation method thereof
US20080286371A1 (en) * 2005-09-12 2008-11-20 Cristalia Produtos Quimicos Farmaceuticos Ltda Immunogenical Complex Formed by Vaccinal Antigens Encapsulated by Nanostructured Mesoporous Silica
US8642258B2 (en) * 2005-09-12 2014-02-04 Cristalia Produtos Quimicos Farmaceuticos Ltda. Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
US10149679B2 (en) 2005-11-09 2018-12-11 Ethicon Llc Surgical instrument comprising drive systems
US10806449B2 (en) 2005-11-09 2020-10-20 Ethicon Llc End effectors for surgical staplers
US10993713B2 (en) 2005-11-09 2021-05-04 Ethicon Llc Surgical instruments
US9895147B2 (en) 2005-11-09 2018-02-20 Ethicon Llc End effectors for surgical staplers
US11793511B2 (en) 2005-11-09 2023-10-24 Cilag Gmbh International Surgical instruments
US9968356B2 (en) 2005-11-09 2018-05-15 Ethicon Llc Surgical instrument drive systems
US10028742B2 (en) 2005-11-09 2018-07-24 Ethicon Llc Staple cartridge comprising staples with different unformed heights
US8974767B2 (en) 2005-11-16 2015-03-10 Signalomics Gmbh Fluorescent nanoparticles
US20090226371A1 (en) * 2005-11-16 2009-09-10 Signalomics Gmbh Fluorescent nanoparticles
US7875212B2 (en) * 2005-12-20 2011-01-25 University Of Hawaii Polymer matrix composites with nano-scale reinforcements
US20100327482A1 (en) * 2005-12-20 2010-12-30 University Of Hawaii Polymer matrix composites with nano-scale reinforcements
USRE45911E1 (en) 2005-12-20 2016-03-01 University Of Hawaii Polymer matrix composites with nano-scale reinforcements
US9260656B2 (en) * 2005-12-27 2016-02-16 The Furukawa Electric Co., Ltd. Fluorescent silica nano-particle, fluorescent nano-material, and biochip and assay using the same
US20080293584A1 (en) * 2005-12-27 2008-11-27 The Furukawa Electric Co., Ltd. Fluorescent silica nano-particle, fluorescent nano-material, and biochip and assay using the same
US10463384B2 (en) 2006-01-31 2019-11-05 Ethicon Llc Stapling assembly
US8746529B2 (en) 2006-01-31 2014-06-10 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US10653417B2 (en) 2006-01-31 2020-05-19 Ethicon Llc Surgical instrument
US8161977B2 (en) 2006-01-31 2012-04-24 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US8167185B2 (en) 2006-01-31 2012-05-01 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US8172124B2 (en) 2006-01-31 2012-05-08 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US10653435B2 (en) 2006-01-31 2020-05-19 Ethicon Llc Motor-driven surgical cutting and fastening instrument with tactile position feedback
US8752747B2 (en) 2006-01-31 2014-06-17 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US9861359B2 (en) 2006-01-31 2018-01-09 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US11648008B2 (en) 2006-01-31 2023-05-16 Cilag Gmbh International Surgical instrument having force feedback capabilities
US9743928B2 (en) 2006-01-31 2017-08-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US9113874B2 (en) 2006-01-31 2015-08-25 Ethicon Endo-Surgery, Inc. Surgical instrument system
US10675028B2 (en) 2006-01-31 2020-06-09 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US11660110B2 (en) 2006-01-31 2023-05-30 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with tactile position feedback
US11051811B2 (en) 2006-01-31 2021-07-06 Ethicon Llc End effector for use with a surgical instrument
US11051813B2 (en) 2006-01-31 2021-07-06 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US11648024B2 (en) 2006-01-31 2023-05-16 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with position feedback
US10004498B2 (en) 2006-01-31 2018-06-26 Ethicon Llc Surgical instrument comprising a plurality of articulation joints
US8292155B2 (en) 2006-01-31 2012-10-23 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with tactile position feedback
US10010322B2 (en) 2006-01-31 2018-07-03 Ethicon Llc Surgical instrument
US20110174860A1 (en) * 2006-01-31 2011-07-21 Ethicon Endo-Surgery, Inc. Surgical instrument with force-feedback capabilities
US10709468B2 (en) 2006-01-31 2020-07-14 Ethicon Llc Motor-driven surgical cutting and fastening instrument
US10499890B2 (en) 2006-01-31 2019-12-10 Ethicon Llc Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US11166717B2 (en) 2006-01-31 2021-11-09 Cilag Gmbh International Surgical instrument with firing lockout
US11020113B2 (en) 2006-01-31 2021-06-01 Cilag Gmbh International Surgical instrument having force feedback capabilities
US10743849B2 (en) 2006-01-31 2020-08-18 Ethicon Llc Stapling system including an articulation system
US11103269B2 (en) 2006-01-31 2021-08-31 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with tactile position feedback
US10052099B2 (en) 2006-01-31 2018-08-21 Ethicon Llc Surgical instrument system comprising a firing system including a rotatable shaft and first and second actuation ramps
US11000275B2 (en) 2006-01-31 2021-05-11 Ethicon Llc Surgical instrument
US10993717B2 (en) 2006-01-31 2021-05-04 Ethicon Llc Surgical stapling system comprising a control system
US10052100B2 (en) 2006-01-31 2018-08-21 Ethicon Llc Surgical instrument system configured to detect resistive forces experienced by a tissue cutting implement
US10058963B2 (en) 2006-01-31 2018-08-28 Ethicon Llc Automated end effector component reloading system for use with a robotic system
US10485539B2 (en) 2006-01-31 2019-11-26 Ethicon Llc Surgical instrument with firing lockout
US11224454B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with tactile position feedback
US10463383B2 (en) 2006-01-31 2019-11-05 Ethicon Llc Stapling instrument including a sensing system
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US8157153B2 (en) 2006-01-31 2012-04-17 Ethicon Endo-Surgery, Inc. Surgical instrument with force-feedback capabilities
US10299817B2 (en) 2006-01-31 2019-05-28 Ethicon Llc Motor-driven fastening assembly
US10426463B2 (en) 2006-01-31 2019-10-01 Ehticon LLC Surgical instrument having a feedback system
US10842491B2 (en) 2006-01-31 2020-11-24 Ethicon Llc Surgical system with an actuation console
US11364046B2 (en) 2006-01-31 2022-06-21 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with tactile position feedback
US10201363B2 (en) 2006-01-31 2019-02-12 Ethicon Llc Motor-driven surgical instrument
US9320520B2 (en) 2006-01-31 2016-04-26 Ethicon Endo-Surgery, Inc. Surgical instrument system
US9326770B2 (en) 2006-01-31 2016-05-03 Ethicon Endo-Surgery, Llc Surgical instrument
US11350916B2 (en) 2006-01-31 2022-06-07 Cilag Gmbh International Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US8844789B2 (en) 2006-01-31 2014-09-30 Ethicon Endo-Surgery, Inc. Automated end effector component reloading system for use with a robotic system
US9326769B2 (en) 2006-01-31 2016-05-03 Ethicon Endo-Surgery, Llc Surgical instrument
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US11058420B2 (en) 2006-01-31 2021-07-13 Cilag Gmbh International Surgical stapling apparatus comprising a lockout system
US11246616B2 (en) 2006-01-31 2022-02-15 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument with tactile position feedback
US11890029B2 (en) 2006-01-31 2024-02-06 Cilag Gmbh International Motor-driven surgical cutting and fastening instrument
US10959722B2 (en) 2006-01-31 2021-03-30 Ethicon Llc Surgical instrument for deploying fasteners by way of rotational motion
US11890008B2 (en) 2006-01-31 2024-02-06 Cilag Gmbh International Surgical instrument with firing lockout
US10952728B2 (en) 2006-01-31 2021-03-23 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US11883020B2 (en) 2006-01-31 2024-01-30 Cilag Gmbh International Surgical instrument having a feedback system
US9370358B2 (en) 2006-01-31 2016-06-21 Ethicon Endo-Surgery, Llc Motor-driven surgical cutting and fastening instrument with tactile position feedback
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US10278722B2 (en) 2006-01-31 2019-05-07 Ethicon Llc Motor-driven surgical cutting and fastening instrument
US8820605B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical instruments
US9517068B2 (en) 2006-01-31 2016-12-13 Ethicon Endo-Surgery, Llc Surgical instrument with automatically-returned firing member
US10335144B2 (en) 2006-01-31 2019-07-02 Ethicon Llc Surgical instrument
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US10918380B2 (en) 2006-01-31 2021-02-16 Ethicon Llc Surgical instrument system including a control system
US10806479B2 (en) 2006-01-31 2020-10-20 Ethicon Llc Motor-driven surgical cutting and fastening instrument with tactile position feedback
US9451958B2 (en) 2006-01-31 2016-09-27 Ethicon Endo-Surgery, Llc Surgical instrument with firing actuator lockout
US9439649B2 (en) 2006-01-31 2016-09-13 Ethicon Endo-Surgery, Llc Surgical instrument having force feedback capabilities
US11801051B2 (en) 2006-01-31 2023-10-31 Cilag Gmbh International Accessing data stored in a memory of a surgical instrument
US11612393B2 (en) 2006-01-31 2023-03-28 Cilag Gmbh International Robotically-controlled end effector
US10342533B2 (en) 2006-01-31 2019-07-09 Ethicon Llc Surgical instrument
US8763879B2 (en) 2006-01-31 2014-07-01 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of surgical instrument
US10893853B2 (en) 2006-01-31 2021-01-19 Ethicon Llc Stapling assembly including motor drive systems
US10098636B2 (en) 2006-01-31 2018-10-16 Ethicon Llc Surgical instrument having force feedback capabilities
US20070203584A1 (en) * 2006-02-14 2007-08-30 Amit Bandyopadhyay Bone replacement materials
US9327056B2 (en) 2006-02-14 2016-05-03 Washington State University Bone replacement materials
US10661390B2 (en) 2006-02-14 2020-05-26 Washington State University Bone replacement materials
US10064688B2 (en) 2006-03-23 2018-09-04 Ethicon Llc Surgical system with selectively articulatable end effector
US10070861B2 (en) 2006-03-23 2018-09-11 Ethicon Llc Articulatable surgical device
US10213262B2 (en) 2006-03-23 2019-02-26 Ethicon Llc Manipulatable surgical systems with selectively articulatable fastening device
US8911471B2 (en) 2006-03-23 2014-12-16 Ethicon Endo-Surgery, Inc. Articulatable surgical device
US9402626B2 (en) 2006-03-23 2016-08-02 Ethicon Endo-Surgery, Llc Rotary actuatable surgical fastener and cutter
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US9149274B2 (en) 2006-03-23 2015-10-06 Ethicon Endo-Surgery, Inc. Articulating endoscopic accessory channel
US9301759B2 (en) 2006-03-23 2016-04-05 Ethicon Endo-Surgery, Llc Robotically-controlled surgical instrument with selectively articulatable end effector
US9492167B2 (en) 2006-03-23 2016-11-15 Ethicon Endo-Surgery, Llc Articulatable surgical device with rotary driven cutting member
US20090068272A1 (en) * 2006-04-25 2009-03-12 Washington State University Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents
US9539359B2 (en) 2006-04-25 2017-01-10 Washington State University Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents
US9028871B2 (en) 2006-04-25 2015-05-12 Washington State University Resorbable ceramics with controlled strength loss rates
US20090276056A1 (en) * 2006-04-25 2009-11-05 Washington State University Resorbable ceramics with controlled strength loss rates
US8916198B2 (en) * 2006-04-25 2014-12-23 Washington State University Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents
US9795716B2 (en) 2006-04-25 2017-10-24 Washington State University Resorbable ceramics with controlled strength loss rates
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US20080043230A1 (en) * 2006-05-31 2008-02-21 Gerhard Krampert Method for spatially high-resolution imaging
EP1862794A1 (en) * 2006-05-31 2007-12-05 Carl Zeiss MicroImaging GmbH Method for high resolution spatial images
US10087082B2 (en) 2006-06-06 2018-10-02 Florida State University Research Foundation, Inc. Stabilized silica colloid
US20090202816A1 (en) * 2006-06-06 2009-08-13 Florida State University Research Foundation, Inc. Stabilized silica colloid
US10420560B2 (en) 2006-06-27 2019-09-24 Ethicon Llc Manually driven surgical cutting and fastening instrument
US10314589B2 (en) 2006-06-27 2019-06-11 Ethicon Llc Surgical instrument including a shifting assembly
US9320521B2 (en) 2006-06-27 2016-04-26 Ethicon Endo-Surgery, Llc Surgical instrument
US11272938B2 (en) 2006-06-27 2022-03-15 Cilag Gmbh International Surgical instrument including dedicated firing and retraction assemblies
US20100040693A1 (en) * 2006-08-09 2010-02-18 Korea Research Institute Of Bioscience And Biotech Silica capsules having nano-holes or nano-pores on their surfaces and method for preparing the same
US20080086051A1 (en) * 2006-09-20 2008-04-10 Ethicon Endo-Surgery, Inc. System, storage medium for a computer program, and method for displaying medical images
US9079762B2 (en) 2006-09-22 2015-07-14 Ethicon Endo-Surgery, Inc. Micro-electromechanical device
US20080073163A1 (en) * 2006-09-22 2008-03-27 Weir Michael P Micro-electromechanical device
US10130359B2 (en) 2006-09-29 2018-11-20 Ethicon Llc Method for forming a staple
US7966799B2 (en) 2006-09-29 2011-06-28 Ethicon Endo-Surgery, Inc. Method of manufacturing staples
US10172616B2 (en) 2006-09-29 2019-01-08 Ethicon Llc Surgical staple cartridge
US8499993B2 (en) 2006-09-29 2013-08-06 Ethicon Endo-Surgery, Inc. Surgical staple cartridge
US8485412B2 (en) 2006-09-29 2013-07-16 Ethicon Endo-Surgery, Inc. Surgical staples having attached drivers and stapling instruments for deploying the same
US10448952B2 (en) 2006-09-29 2019-10-22 Ethicon Llc End effector for use with a surgical fastening instrument
US10595862B2 (en) 2006-09-29 2020-03-24 Ethicon Llc Staple cartridge including a compressible member
US8973804B2 (en) 2006-09-29 2015-03-10 Ethicon Endo-Surgery, Inc. Cartridge assembly having a buttressing member
US7794475B2 (en) 2006-09-29 2010-09-14 Ethicon Endo-Surgery, Inc. Surgical staples having compressible or crushable members for securing tissue therein and stapling instruments for deploying the same
US11633182B2 (en) 2006-09-29 2023-04-25 Cilag Gmbh International Surgical stapling assemblies
US8720766B2 (en) 2006-09-29 2014-05-13 Ethicon Endo-Surgery, Inc. Surgical stapling instruments and staples
US8763875B2 (en) 2006-09-29 2014-07-01 Ethicon Endo-Surgery, Inc. End effector for use with a surgical fastening instrument
US8899465B2 (en) 2006-09-29 2014-12-02 Ethicon Endo-Surgery, Inc. Staple cartridge comprising drivers for deploying a plurality of staples
US11406379B2 (en) 2006-09-29 2022-08-09 Cilag Gmbh International Surgical end effectors with staple cartridges
US9603595B2 (en) 2006-09-29 2017-03-28 Ethicon Endo-Surgery, Llc Surgical instrument comprising an adjustable system configured to accommodate different jaw heights
US11622785B2 (en) 2006-09-29 2023-04-11 Cilag Gmbh International Surgical staples having attached drivers and stapling instruments for deploying the same
US7665647B2 (en) 2006-09-29 2010-02-23 Ethicon Endo-Surgery, Inc. Surgical cutting and stapling device with closure apparatus for limiting maximum tissue compression force
US9179911B2 (en) 2006-09-29 2015-11-10 Ethicon Endo-Surgery, Inc. End effector for use with a surgical fastening instrument
US9706991B2 (en) 2006-09-29 2017-07-18 Ethicon Endo-Surgery, Inc. Staple cartridge comprising staples including a lateral base
US9408604B2 (en) 2006-09-29 2016-08-09 Ethicon Endo-Surgery, Llc Surgical instrument comprising a firing system including a compliant portion
US8365976B2 (en) 2006-09-29 2013-02-05 Ethicon Endo-Surgery, Inc. Surgical staples having dissolvable, bioabsorbable or biofragmentable portions and stapling instruments for deploying the same
US8360297B2 (en) 2006-09-29 2013-01-29 Ethicon Endo-Surgery, Inc. Surgical cutting and stapling instrument with self adjusting anvil
US8348131B2 (en) 2006-09-29 2013-01-08 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with mechanical indicator to show levels of tissue compression
US11571231B2 (en) 2006-09-29 2023-02-07 Cilag Gmbh International Staple cartridge having a driver for driving multiple staples
US8808325B2 (en) 2006-09-29 2014-08-19 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with staples having crown features for increasing formed staple footprint
US10695053B2 (en) 2006-09-29 2020-06-30 Ethicon Llc Surgical end effectors with staple cartridges
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US11678876B2 (en) 2006-09-29 2023-06-20 Cilag Gmbh International Powered surgical instrument
US8220690B2 (en) 2006-09-29 2012-07-17 Ethicon Endo-Surgery, Inc. Connected surgical staples and stapling instruments for deploying the same
US10342541B2 (en) 2006-10-03 2019-07-09 Ethicon Llc Surgical instruments with E-beam driver and rotary drive arrangements
US11382626B2 (en) 2006-10-03 2022-07-12 Cilag Gmbh International Surgical system including a knife bar supported for rotational and axial travel
US10206678B2 (en) 2006-10-03 2019-02-19 Ethicon Llc Surgical stapling instrument with lockout features to prevent advancement of a firing assembly unless an unfired surgical staple cartridge is operably mounted in an end effector portion of the instrument
US11877748B2 (en) 2006-10-03 2024-01-23 Cilag Gmbh International Robotically-driven surgical instrument with E-beam driver
US20100297725A1 (en) * 2006-11-01 2010-11-25 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US8618265B2 (en) 2006-11-01 2013-12-31 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US9719986B2 (en) 2006-11-01 2017-08-01 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof preparation and method for their preparation and use
US8846320B2 (en) 2006-11-01 2014-09-30 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US20100184087A1 (en) * 2006-11-01 2010-07-22 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
FR2909869A1 (en) * 2006-12-13 2008-06-20 Oreal Use of hybrid particles for dyeing keratinous fibers, obtained from an organosilane compound carrying a colored species
WO2008071772A2 (en) * 2006-12-13 2008-06-19 L'oreal Use of coloured or fluorescent hybrid particles for treating keratin fibres
WO2008071772A3 (en) * 2006-12-13 2008-10-02 Oreal Use of coloured or fluorescent hybrid particles for treating keratin fibres
US7713265B2 (en) 2006-12-22 2010-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for medically treating a tattoo
US8801606B2 (en) 2007-01-09 2014-08-12 Ethicon Endo-Surgery, Inc. Method of in vivo monitoring using an imaging system including scanned beam imaging unit
US8273015B2 (en) 2007-01-09 2012-09-25 Ethicon Endo-Surgery, Inc. Methods for imaging the anatomy with an anatomically secured scanner assembly
US20080167521A1 (en) * 2007-01-09 2008-07-10 Sheetz Jane A Method of in vivo monitoring using an imaging system including scanned beam imaging unit
US8746530B2 (en) 2007-01-10 2014-06-10 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and remote sensor
US11918211B2 (en) 2007-01-10 2024-03-05 Cilag Gmbh International Surgical stapling instrument for use with a robotic system
US10952727B2 (en) 2007-01-10 2021-03-23 Ethicon Llc Surgical instrument for assessing the state of a staple cartridge
US11000277B2 (en) 2007-01-10 2021-05-11 Ethicon Llc Surgical instrument with wireless communication between control unit and remote sensor
US10945729B2 (en) 2007-01-10 2021-03-16 Ethicon Llc Interlock and surgical instrument including same
US8840603B2 (en) 2007-01-10 2014-09-23 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US11350929B2 (en) 2007-01-10 2022-06-07 Cilag Gmbh International Surgical instrument with wireless communication between control unit and sensor transponders
US9757123B2 (en) 2007-01-10 2017-09-12 Ethicon Llc Powered surgical instrument having a transmission system
US11064998B2 (en) 2007-01-10 2021-07-20 Cilag Gmbh International Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US11666332B2 (en) 2007-01-10 2023-06-06 Cilag Gmbh International Surgical instrument comprising a control circuit configured to adjust the operation of a motor
US11006951B2 (en) 2007-01-10 2021-05-18 Ethicon Llc Surgical instrument with wireless communication between control unit and sensor transponders
US10278780B2 (en) 2007-01-10 2019-05-07 Ethicon Llc Surgical instrument for use with robotic system
US8479969B2 (en) 2007-01-10 2013-07-09 Ethicon Endo-Surgery, Inc. Drive interface for operably coupling a manipulatable surgical tool to a robot
US10517682B2 (en) 2007-01-10 2019-12-31 Ethicon Llc Surgical instrument with wireless communication between control unit and remote sensor
US11812961B2 (en) 2007-01-10 2023-11-14 Cilag Gmbh International Surgical instrument including a motor control system
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US8517243B2 (en) 2007-01-10 2013-08-27 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and remote sensor
US10517590B2 (en) 2007-01-10 2019-12-31 Ethicon Llc Powered surgical instrument having a transmission system
US10918386B2 (en) 2007-01-10 2021-02-16 Ethicon Llc Interlock and surgical instrument including same
US11849947B2 (en) 2007-01-10 2023-12-26 Cilag Gmbh International Surgical system including a control circuit and a passively-powered transponder
US10751138B2 (en) 2007-01-10 2020-08-25 Ethicon Llc Surgical instrument for use with a robotic system
US11134943B2 (en) 2007-01-10 2021-10-05 Cilag Gmbh International Powered surgical instrument including a control unit and sensor
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US11771426B2 (en) 2007-01-10 2023-10-03 Cilag Gmbh International Surgical instrument with wireless communication
US8684253B2 (en) 2007-01-10 2014-04-01 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US8459520B2 (en) 2007-01-10 2013-06-11 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and remote sensor
US10433918B2 (en) 2007-01-10 2019-10-08 Ethicon Llc Surgical instrument system configured to evaluate the load applied to a firing member at the initiation of a firing stroke
US11844521B2 (en) 2007-01-10 2023-12-19 Cilag Gmbh International Surgical instrument for use with a robotic system
US10441369B2 (en) 2007-01-10 2019-10-15 Ethicon Llc Articulatable surgical instrument configured for detachable use with a robotic system
US11166720B2 (en) 2007-01-10 2021-11-09 Cilag Gmbh International Surgical instrument including a control module for assessing an end effector
US9603598B2 (en) 2007-01-11 2017-03-28 Ethicon Endo-Surgery, Llc Surgical stapling device with a curved end effector
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US9724091B2 (en) 2007-01-11 2017-08-08 Ethicon Llc Surgical stapling device
US10912575B2 (en) 2007-01-11 2021-02-09 Ethicon Llc Surgical stapling device having supports for a flexible drive mechanism
US9999431B2 (en) 2007-01-11 2018-06-19 Ethicon Endo-Surgery, Llc Surgical stapling device having supports for a flexible drive mechanism
US9730692B2 (en) 2007-01-11 2017-08-15 Ethicon Llc Surgical stapling device with a curved staple cartridge
US9700321B2 (en) 2007-01-11 2017-07-11 Ethicon Llc Surgical stapling device having supports for a flexible drive mechanism
US9775613B2 (en) 2007-01-11 2017-10-03 Ethicon Llc Surgical stapling device with a curved end effector
US11839352B2 (en) 2007-01-11 2023-12-12 Cilag Gmbh International Surgical stapling device with an end effector
US9675355B2 (en) 2007-01-11 2017-06-13 Ethicon Llc Surgical stapling device with a curved end effector
US9655624B2 (en) 2007-01-11 2017-05-23 Ethicon Llc Surgical stapling device with a curved end effector
US8540128B2 (en) 2007-01-11 2013-09-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with a curved end effector
US9750501B2 (en) 2007-01-11 2017-09-05 Ethicon Endo-Surgery, Llc Surgical stapling devices having laterally movable anvils
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US9757130B2 (en) 2007-02-28 2017-09-12 Ethicon Llc Stapling assembly for forming different formed staple heights
US20100119500A1 (en) * 2007-02-28 2010-05-13 Mika Jokinen Method for preparing silica compositions, silica compositions and uses thereof
US20080221434A1 (en) * 2007-03-09 2008-09-11 Voegele James W Displaying an internal image of a body lumen of a patient
US20080226034A1 (en) * 2007-03-12 2008-09-18 Weir Michael P Power modulation of a scanning beam for imaging, therapy, and/or diagnosis
US8216214B2 (en) 2007-03-12 2012-07-10 Ethicon Endo-Surgery, Inc. Power modulation of a scanning beam for imaging, therapy, and/or diagnosis
US9289206B2 (en) 2007-03-15 2016-03-22 Ethicon Endo-Surgery, Llc Lateral securement members for surgical staple cartridges
US8991676B2 (en) 2007-03-15 2015-03-31 Ethicon Endo-Surgery, Inc. Surgical staple having a slidable crown
US8668130B2 (en) 2007-03-15 2014-03-11 Ethicon Endo-Surgery, Inc. Surgical stapling systems and staple cartridges for deploying surgical staples with tissue compression features
US20090001128A1 (en) * 2007-03-15 2009-01-01 Weisenburgh Ii William B Washer for use with a surgical stapling instrument
US7673782B2 (en) 2007-03-15 2010-03-09 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a releasable buttress material
US11337693B2 (en) 2007-03-15 2022-05-24 Cilag Gmbh International Surgical stapling instrument having a releasable buttress material
US8925788B2 (en) 2007-03-15 2015-01-06 Ethicon Endo-Surgery, Inc. End effectors for surgical stapling instruments
US8590762B2 (en) 2007-03-15 2013-11-26 Ethicon Endo-Surgery, Inc. Staple cartridge cavity configurations
US8186560B2 (en) 2007-03-15 2012-05-29 Ethicon Endo-Surgery, Inc. Surgical stapling systems and staple cartridges for deploying surgical staples with tissue compression features
US20090001130A1 (en) * 2007-03-15 2009-01-01 Hess Christopher J Surgical procedure using a cutting and stapling instrument having releasable staple-forming pockets
US9872682B2 (en) 2007-03-15 2018-01-23 Ethicon Llc Surgical stapling instrument having a releasable buttress material
US8672208B2 (en) 2007-03-15 2014-03-18 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a releasable buttress material
US7669747B2 (en) 2007-03-15 2010-03-02 Ethicon Endo-Surgery, Inc. Washer for use with a surgical stapling instrument
US10702267B2 (en) 2007-03-15 2020-07-07 Ethicon Llc Surgical stapling instrument having a releasable buttress material
US7735703B2 (en) 2007-03-15 2010-06-15 Ethicon Endo-Surgery, Inc. Re-loadable surgical stapling instrument
US20090001125A1 (en) * 2007-03-15 2009-01-01 Hess Christopher J Surgical stapling instrument having a releasable buttress material
US8727197B2 (en) 2007-03-15 2014-05-20 Ethicon Endo-Surgery, Inc. Staple cartridge cavity configuration with cooperative surgical staple
US20080234544A1 (en) * 2007-03-20 2008-09-25 Ethicon Endo-Sugery, Inc. Displaying images interior and exterior to a body lumen of a patient
US20080234566A1 (en) * 2007-03-21 2008-09-25 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in a patient image data
US8457718B2 (en) 2007-03-21 2013-06-04 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in a patient image data
US8081810B2 (en) 2007-03-22 2011-12-20 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in image data of a patient
US20080232656A1 (en) * 2007-03-22 2008-09-25 Ethicon Endo-Surgery, Inc. Recognizing a real world fiducial in image data of a patient
US20080242967A1 (en) * 2007-03-27 2008-10-02 Ethicon Endo-Surgery, Inc. Medical imaging and therapy utilizing a scanned beam system operating at multiple wavelengths
US10398433B2 (en) 2007-03-28 2019-09-03 Ethicon Llc Laparoscopic clamp load measuring devices
US8239008B2 (en) 2007-04-13 2012-08-07 Ethicon Endo-Surgery, Inc. Sentinel node identification using fluorescent nanoparticles
US20080255460A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Nanoparticle tissue based identification and illumination
US8239007B2 (en) 2007-04-13 2012-08-07 Ethicon Endo-Surgert, Inc. Biocompatible nanoparticle compositions and methods
US20080255537A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Biocompatible nanoparticle compositions and methods
US8062215B2 (en) 2007-04-13 2011-11-22 Ethicon Endo-Surgery, Inc. Fluorescent nanoparticle scope
US20080255458A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. System and method using fluorescence to examine within a patient's anatomy
US20080255403A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Magnetic nanoparticle therapies
WO2008128051A3 (en) * 2007-04-13 2010-10-28 Ethicon Endo-Surgery, Inc Fluorescent nanoparticle compositions, methods and devices
US20080255459A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Sentinel node identification using fluorescent nanoparticles
US20080252778A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Combined SBI and conventional image processor
US8626271B2 (en) * 2007-04-13 2014-01-07 Ethicon Endo-Surgery, Inc. System and method using fluorescence to examine within a patient's anatomy
US20080255414A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Fluorescent nanoparticle scope
WO2008127880A1 (en) * 2007-04-13 2008-10-23 Ethicon Endo-Surgery, Inc A system and method using fluorescence to examine within a patient's anatomy
US20080255425A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Nanoparticle treated medical devices
WO2008128051A2 (en) * 2007-04-13 2008-10-23 Ethicon Endo-Surgery, Inc Fluorescent nanoparticle compositions, methods, and devices
US7995045B2 (en) 2007-04-13 2011-08-09 Ethicon Endo-Surgery, Inc. Combined SBI and conventional image processor
US9937129B2 (en) 2007-04-16 2018-04-10 The Regents Of The University Of California Materials and methods for delivering compositions to selected tissues
US20090289225A1 (en) * 2007-04-19 2009-11-26 Naiyong Jing Reducing fluorescent self-quenching with nanoparticles
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20080275305A1 (en) * 2007-05-01 2008-11-06 Ethicon Endo-Surgery, Inc. Medical scanned beam imager and components associated therewith
US7682789B2 (en) * 2007-05-04 2010-03-23 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
US20080274463A1 (en) * 2007-05-04 2008-11-06 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
US8486620B2 (en) 2007-05-23 2013-07-16 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US9103822B2 (en) 2007-05-23 2015-08-11 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US9575067B2 (en) 2007-05-23 2017-02-21 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US9017954B2 (en) 2007-05-23 2015-04-28 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US8445191B2 (en) 2007-05-23 2013-05-21 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US8931682B2 (en) 2007-06-04 2015-01-13 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US10368863B2 (en) 2007-06-04 2019-08-06 Ethicon Llc Robotically-controlled shaft based rotary drive systems for surgical instruments
US8616431B2 (en) 2007-06-04 2013-12-31 Ethicon Endo-Surgery, Inc. Shiftable drive interface for robotically-controlled surgical tool
US9186143B2 (en) 2007-06-04 2015-11-17 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US11154298B2 (en) 2007-06-04 2021-10-26 Cilag Gmbh International Stapling system for use with a robotic surgical system
US11857181B2 (en) 2007-06-04 2024-01-02 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US9750498B2 (en) 2007-06-04 2017-09-05 Ethicon Endo Surgery, Llc Drive systems for surgical instruments
US8534528B2 (en) 2007-06-04 2013-09-17 Ethicon Endo-Surgery, Inc. Surgical instrument having a multiple rate directional switching mechanism
US11672531B2 (en) 2007-06-04 2023-06-13 Cilag Gmbh International Rotary drive systems for surgical instruments
US11559302B2 (en) 2007-06-04 2023-01-24 Cilag Gmbh International Surgical instrument including a firing member movable at different speeds
US10299787B2 (en) 2007-06-04 2019-05-28 Ethicon Llc Stapling system comprising rotary inputs
US11911028B2 (en) 2007-06-04 2024-02-27 Cilag Gmbh International Surgical instruments for use with a robotic surgical system
US10441280B2 (en) 2007-06-04 2019-10-15 Ethicon Llc Robotically-controlled shaft based rotary drive systems for surgical instruments
US9987003B2 (en) 2007-06-04 2018-06-05 Ethicon Llc Robotic actuator assembly
US10327765B2 (en) 2007-06-04 2019-06-25 Ethicon Llc Drive systems for surgical instruments
US8196796B2 (en) 2007-06-04 2012-06-12 Ethicon Endo-Surgery, Inc. Shaft based rotary drive system for surgical instruments
US9795381B2 (en) 2007-06-04 2017-10-24 Ethicon Endo-Surgery, Llc Robotically-controlled shaft based rotary drive systems for surgical instruments
US11147549B2 (en) 2007-06-04 2021-10-19 Cilag Gmbh International Stapling instrument including a firing system and a closure system
US10363033B2 (en) 2007-06-04 2019-07-30 Ethicon Llc Robotically-controlled surgical instruments
US11564682B2 (en) 2007-06-04 2023-01-31 Cilag Gmbh International Surgical stapler device
US9585658B2 (en) 2007-06-04 2017-03-07 Ethicon Endo-Surgery, Llc Stapling systems
US11134938B2 (en) 2007-06-04 2021-10-05 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US11648006B2 (en) 2007-06-04 2023-05-16 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US8424740B2 (en) 2007-06-04 2013-04-23 Ethicon Endo-Surgery, Inc. Surgical instrument having a directional switching mechanism
US20080312490A1 (en) * 2007-06-18 2008-12-18 Ethicon Endo-Surgery, Inc. Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly
US8160678B2 (en) 2007-06-18 2012-04-17 Ethicon Endo-Surgery, Inc. Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly
US11013511B2 (en) 2007-06-22 2021-05-25 Ethicon Llc Surgical stapling instrument with an articulatable end effector
US9138225B2 (en) 2007-06-22 2015-09-22 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with an articulatable end effector
US9662110B2 (en) 2007-06-22 2017-05-30 Ethicon Endo-Surgery, Llc Surgical stapling instrument with an articulatable end effector
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
US11925346B2 (en) 2007-06-29 2024-03-12 Cilag Gmbh International Surgical staple cartridge including tissue supporting surfaces
US7558455B2 (en) 2007-06-29 2009-07-07 Ethicon Endo-Surgery, Inc Receiver aperture broadening for scanned beam imaging
US7982776B2 (en) 2007-07-13 2011-07-19 Ethicon Endo-Surgery, Inc. SBI motion artifact removal apparatus and method
WO2009017695A1 (en) * 2007-07-26 2009-02-05 The Regents Of The University Of California A single cell surgery tool and a cell transfection device utilizing the photothermal properties of thin films and/or metal nanoparticles
US9125552B2 (en) 2007-07-31 2015-09-08 Ethicon Endo-Surgery, Inc. Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy
US20090035802A1 (en) * 2007-07-31 2009-02-05 Digital Bio Technology, Co., Ltd. Method for detection and enumeration of cell surface markers
US20090043109A1 (en) * 2007-08-07 2009-02-12 Spangler Brenda D Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source
US8155728B2 (en) 2007-08-22 2012-04-10 Ethicon Endo-Surgery, Inc. Medical system, method, and storage medium concerning a natural orifice transluminal medical procedure
US20090054761A1 (en) * 2007-08-22 2009-02-26 Ethicon Endo-Surgery, Inc. Medical system, method, and storage medium concerning a natural orifice transluminal medical procedure
US20090062658A1 (en) * 2007-08-27 2009-03-05 Dunki-Jacobs Robert J Position tracking and control for a scanning assembly
US7983739B2 (en) 2007-08-27 2011-07-19 Ethicon Endo-Surgery, Inc. Position tracking and control for a scanning assembly
US20090062659A1 (en) * 2007-08-28 2009-03-05 Weir Michael P Medical device including scanned beam unit with operational control features
US7925333B2 (en) 2007-08-28 2011-04-12 Ethicon Endo-Surgery, Inc. Medical device including scanned beam unit with operational control features
US20110028662A1 (en) * 2007-08-31 2011-02-03 Hybrid Silica Technologies, Inc. Peg-coated core-shell silica nanoparticles and methods of manufacture and use
US20090060381A1 (en) * 2007-08-31 2009-03-05 Ethicon Endo-Surgery, Inc. Dynamic range and amplitude control for imaging
WO2009059677A1 (en) * 2007-11-08 2009-05-14 Merck Patent Gmbh Method for the production of coated luminescent substances
US8519609B2 (en) 2007-11-08 2013-08-27 Merck Patent Gmbh Process for the preparation of coated phosphors
US20100264809A1 (en) * 2007-11-08 2010-10-21 Merck Patent Gmbh Process for the preparation of coated phosphors
WO2009073193A3 (en) * 2007-12-03 2009-12-23 The Johns Hopkins University Methods of synthesis and use of chemospheres
WO2009073193A2 (en) * 2007-12-03 2009-06-11 The Johns Hopkins University Methods of synthesis and use of chemospheres
US20110104052A1 (en) * 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres
US20100310872A1 (en) * 2007-12-06 2010-12-09 The University Of Tokushima Nanofunctional silica particles and manufacturing method thereof
US9265729B2 (en) * 2007-12-06 2016-02-23 The University Of Tokushima Nanofunctional silica particles and manufacturing method thereof
US20100311871A1 (en) * 2008-02-12 2010-12-09 Nissan Chemical Industries, Ltd. Colloidal silica particles, process for producing the same, and organic solvent-dispersed silica sol, polymerizable compound-dispersed silica sol, and dicarboxylic anhydride-dispersed silica sol each obtained from the same
US20160145110A1 (en) * 2008-02-12 2016-05-26 Nissan Chemical Industries, Ltd. Colloidal silica particles, process for producing the same, and organic solvent-dispersed silica sol, polymerizable compound-dispersed silica sol, and dicarboxylic anhydride-dispersed silica sol each obtained from the same
US9284197B2 (en) * 2008-02-12 2016-03-15 Nissan Chemical Industries, Ltd. Colloidal silica particles, process for producing the same, and organic solvent-dispersed silica sol, polymerizable compound-dispersed silica sol, and dicarboxylic anhydride-dispersed silica sol each obtained from the same
US9527749B2 (en) * 2008-02-12 2016-12-27 Nissan Chemical Industries, Ltd. Colloidal silica particles, process for producing the same, and organic solvent-dispersed silica sol, polymerizable compound-dispersed silica sol, and dicarboxylic anhydride-dispersed silica sol each obtained from the same
US10765424B2 (en) 2008-02-13 2020-09-08 Ethicon Llc Surgical stapling instrument
US11612395B2 (en) 2008-02-14 2023-03-28 Cilag Gmbh International Surgical system including a control system having an RFID tag reader
US10888330B2 (en) 2008-02-14 2021-01-12 Ethicon Llc Surgical system
US10682142B2 (en) 2008-02-14 2020-06-16 Ethicon Llc Surgical stapling apparatus including an articulation system
US10542974B2 (en) 2008-02-14 2020-01-28 Ethicon Llc Surgical instrument including a control system
US11801047B2 (en) 2008-02-14 2023-10-31 Cilag Gmbh International Surgical stapling system comprising a control circuit configured to selectively monitor tissue impedance and adjust control of a motor
US10238385B2 (en) 2008-02-14 2019-03-26 Ethicon Llc Surgical instrument system for evaluating tissue impedance
US8622274B2 (en) 2008-02-14 2014-01-07 Ethicon Endo-Surgery, Inc. Motorized cutting and fastening instrument having control circuit for optimizing battery usage
US11464514B2 (en) 2008-02-14 2022-10-11 Cilag Gmbh International Motorized surgical stapling system including a sensing array
US10206676B2 (en) 2008-02-14 2019-02-19 Ethicon Llc Surgical cutting and fastening instrument
US10238387B2 (en) 2008-02-14 2019-03-26 Ethicon Llc Surgical instrument comprising a control system
US10765432B2 (en) 2008-02-14 2020-09-08 Ethicon Llc Surgical device including a control system
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US10779822B2 (en) 2008-02-14 2020-09-22 Ethicon Llc System including a surgical cutting and fastening instrument
US11484307B2 (en) 2008-02-14 2022-11-01 Cilag Gmbh International Loading unit coupleable to a surgical stapling system
US10806450B2 (en) 2008-02-14 2020-10-20 Ethicon Llc Surgical cutting and fastening instrument having a control system
US10265067B2 (en) 2008-02-14 2019-04-23 Ethicon Llc Surgical instrument including a regulator and a control system
US10743851B2 (en) 2008-02-14 2020-08-18 Ethicon Llc Interchangeable tools for surgical instruments
US10925605B2 (en) 2008-02-14 2021-02-23 Ethicon Llc Surgical stapling system
US10004505B2 (en) 2008-02-14 2018-06-26 Ethicon Llc Detachable motor powered surgical instrument
US9211121B2 (en) 2008-02-14 2015-12-15 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus
US10743870B2 (en) 2008-02-14 2020-08-18 Ethicon Llc Surgical stapling apparatus with interlockable firing system
US9522029B2 (en) 2008-02-14 2016-12-20 Ethicon Endo-Surgery, Llc Motorized surgical cutting and fastening instrument having handle based power source
US10682141B2 (en) 2008-02-14 2020-06-16 Ethicon Llc Surgical device including a control system
US9498219B2 (en) 2008-02-14 2016-11-22 Ethicon Endo-Surgery, Llc Detachable motor powered surgical instrument
US8998058B2 (en) 2008-02-14 2015-04-07 Ethicon Endo-Surgery, Inc. Detachable motor powered surgical instrument
US11638583B2 (en) 2008-02-14 2023-05-02 Cilag Gmbh International Motorized surgical system having a plurality of power sources
US10470763B2 (en) 2008-02-14 2019-11-12 Ethicon Llc Surgical cutting and fastening instrument including a sensing system
US9980729B2 (en) 2008-02-14 2018-05-29 Ethicon Endo-Surgery, Llc Detachable motor powered surgical instrument
US8991677B2 (en) 2008-02-14 2015-03-31 Ethicon Endo-Surgery, Inc. Detachable motor powered surgical instrument
US9204878B2 (en) 2008-02-14 2015-12-08 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US11446034B2 (en) 2008-02-14 2022-09-20 Cilag Gmbh International Surgical stapling assembly comprising first and second actuation systems configured to perform different functions
US10463370B2 (en) 2008-02-14 2019-11-05 Ethicon Llc Motorized surgical instrument
US8657174B2 (en) 2008-02-14 2014-02-25 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument having handle based power source
US11571212B2 (en) 2008-02-14 2023-02-07 Cilag Gmbh International Surgical stapling system including an impedance sensor
US8584919B2 (en) 2008-02-14 2013-11-19 Ethicon Endo-Sugery, Inc. Surgical stapling apparatus with load-sensitive firing mechanism
US9962158B2 (en) 2008-02-14 2018-05-08 Ethicon Llc Surgical stapling apparatuses with lockable end effector positioning systems
US10307163B2 (en) 2008-02-14 2019-06-04 Ethicon Llc Detachable motor powered surgical instrument
US10874396B2 (en) 2008-02-14 2020-12-29 Ethicon Llc Stapling instrument for use with a surgical robot
US10722232B2 (en) 2008-02-14 2020-07-28 Ethicon Llc Surgical instrument for use with different cartridges
US11717285B2 (en) 2008-02-14 2023-08-08 Cilag Gmbh International Surgical cutting and fastening instrument having RF electrodes
US9095339B2 (en) 2008-02-14 2015-08-04 Ethicon Endo-Surgery, Inc. Detachable motor powered surgical instrument
US8113410B2 (en) 2008-02-14 2012-02-14 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features
US8196795B2 (en) 2008-02-14 2012-06-12 Ethicon Endo-Surgery, Inc. Disposable motor-driven loading unit for use with a surgical cutting and stapling apparatus
US9999426B2 (en) 2008-02-14 2018-06-19 Ethicon Llc Detachable motor powered surgical instrument
US9867618B2 (en) 2008-02-14 2018-01-16 Ethicon Llc Surgical stapling apparatus including firing force regulation
US8573461B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with cam-driven staple deployment arrangements
US9872684B2 (en) 2008-02-14 2018-01-23 Ethicon Llc Surgical stapling apparatus including firing force regulation
US10716568B2 (en) 2008-02-14 2020-07-21 Ethicon Llc Surgical stapling apparatus with control features operable with one hand
US9877723B2 (en) 2008-02-14 2018-01-30 Ethicon Llc Surgical stapling assembly comprising a selector arrangement
US9072515B2 (en) 2008-02-14 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus
US10660640B2 (en) 2008-02-14 2020-05-26 Ethicon Llc Motorized surgical cutting and fastening instrument
US10888329B2 (en) 2008-02-14 2021-01-12 Ethicon Llc Detachable motor powered surgical instrument
US8657178B2 (en) 2008-02-14 2014-02-25 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus
US9084601B2 (en) 2008-02-14 2015-07-21 Ethicon Endo-Surgery, Inc. Detachable motor powered surgical instrument
US8752749B2 (en) 2008-02-14 2014-06-17 Ethicon Endo-Surgery, Inc. Robotically-controlled disposable motor-driven loading unit
US10898195B2 (en) 2008-02-14 2021-01-26 Ethicon Llc Detachable motor powered surgical instrument
US9901344B2 (en) 2008-02-14 2018-02-27 Ethicon Llc Stapling assembly
US9901345B2 (en) 2008-02-14 2018-02-27 Ethicon Llc Stapling assembly
US10898194B2 (en) 2008-02-14 2021-01-26 Ethicon Llc Detachable motor powered surgical instrument
US9901346B2 (en) 2008-02-14 2018-02-27 Ethicon Llc Stapling assembly
US10905426B2 (en) 2008-02-14 2021-02-02 Ethicon Llc Detachable motor powered surgical instrument
US10905427B2 (en) 2008-02-14 2021-02-02 Ethicon Llc Surgical System
US8459525B2 (en) 2008-02-14 2013-06-11 Ethicon Endo-Sugery, Inc. Motorized surgical cutting and fastening instrument having a magnetic drive train torque limiting device
US10639036B2 (en) 2008-02-14 2020-05-05 Ethicon Llc Robotically-controlled motorized surgical cutting and fastening instrument
US8573465B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical end effector system with rotary actuated closure systems
US9179912B2 (en) 2008-02-14 2015-11-10 Ethicon Endo-Surgery, Inc. Robotically-controlled motorized surgical cutting and fastening instrument
US8540130B2 (en) 2008-02-14 2013-09-24 Ethicon Endo-Surgery, Inc. Disposable motor-driven loading unit for use with a surgical cutting and stapling apparatus
US10390823B2 (en) 2008-02-15 2019-08-27 Ethicon Llc End effector comprising an adjunct
US20100317537A1 (en) * 2008-02-15 2010-12-16 University Of Florida Research Foundation, Inc. Biophysical parameters for systems biology
US11058418B2 (en) 2008-02-15 2021-07-13 Cilag Gmbh International Surgical end effector having buttress retention features
US11154297B2 (en) 2008-02-15 2021-10-26 Cilag Gmbh International Layer arrangements for surgical staple cartridges
US11272927B2 (en) 2008-02-15 2022-03-15 Cilag Gmbh International Layer arrangements for surgical staple cartridges
US9770245B2 (en) 2008-02-15 2017-09-26 Ethicon Llc Layer arrangements for surgical staple cartridges
US9585657B2 (en) 2008-02-15 2017-03-07 Ethicon Endo-Surgery, Llc Actuator for releasing a layer of material from a surgical end effector
US10856866B2 (en) 2008-02-15 2020-12-08 Ethicon Llc Surgical end effector having buttress retention features
US20110288234A1 (en) * 2008-02-19 2011-11-24 The Research Foundation on State University of NY Silica nanoparticles postloaded with photosensitizers for drug delivery in photodynamic therapy
US20090217932A1 (en) * 2008-03-03 2009-09-03 Ethicon Endo-Surgery, Inc. Intraluminal tissue markers
EP2098187A1 (en) 2008-03-03 2009-09-09 Ethicon Endo-Surgery, Inc. Intraluminal tissue markers
US8050520B2 (en) 2008-03-27 2011-11-01 Ethicon Endo-Surgery, Inc. Method for creating a pixel image from sampled data of a scanned beam imager
US8332014B2 (en) 2008-04-25 2012-12-11 Ethicon Endo-Surgery, Inc. Scanned beam device and method using same which measures the reflectance of patient tissue
US9603952B2 (en) 2008-05-15 2017-03-28 Morphotek, Inc. Treatment of metastatic tumors
US9023595B2 (en) 2008-05-15 2015-05-05 Morphotek, Inc. Treatment of metastatic tumors
US10718693B2 (en) 2008-06-05 2020-07-21 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US20140178929A1 (en) * 2008-06-05 2014-06-26 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US8703490B2 (en) 2008-06-05 2014-04-22 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US20110111233A1 (en) * 2008-07-07 2011-05-12 Kazuya Tsukada Inorganic nanoparticle labeling agent
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
WO2010021512A3 (en) * 2008-08-22 2010-04-15 Snu R&Db Foundation Silica-based fluorescent nanoparticles
CN101457139B (en) * 2008-08-22 2012-06-13 吉林大学 High quantum production rate luminescent silicon ball with controllable structure and preparation method thereof
WO2010021512A2 (en) * 2008-08-22 2010-02-25 Snu R&Db Foundation Silica-based fluorescent nanoparticles
US11123071B2 (en) 2008-09-19 2021-09-21 Cilag Gmbh International Staple cartridge for us with a surgical instrument
US10258336B2 (en) 2008-09-19 2019-04-16 Ethicon Llc Stapling system configured to produce different formed staple heights
US11517304B2 (en) 2008-09-23 2022-12-06 Cilag Gmbh International Motor-driven surgical cutting instrument
US11684361B2 (en) 2008-09-23 2023-06-27 Cilag Gmbh International Motor-driven surgical cutting instrument
US11103241B2 (en) 2008-09-23 2021-08-31 Cilag Gmbh International Motor-driven surgical cutting instrument
US10765425B2 (en) 2008-09-23 2020-09-08 Ethicon Llc Robotically-controlled motorized surgical instrument with an end effector
US11812954B2 (en) 2008-09-23 2023-11-14 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US11406380B2 (en) 2008-09-23 2022-08-09 Cilag Gmbh International Motorized surgical instrument
US10485537B2 (en) 2008-09-23 2019-11-26 Ethicon Llc Motorized surgical instrument
US10420549B2 (en) 2008-09-23 2019-09-24 Ethicon Llc Motorized surgical instrument
US10130361B2 (en) 2008-09-23 2018-11-20 Ethicon Llc Robotically-controller motorized surgical tool with an end effector
US10045778B2 (en) 2008-09-23 2018-08-14 Ethicon Llc Robotically-controlled motorized surgical instrument with an end effector
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US9549732B2 (en) 2008-09-23 2017-01-24 Ethicon Endo-Surgery, Llc Motor-driven surgical cutting instrument
US10898184B2 (en) 2008-09-23 2021-01-26 Ethicon Llc Motor-driven surgical cutting instrument
US11871923B2 (en) 2008-09-23 2024-01-16 Cilag Gmbh International Motorized surgical instrument
US11617576B2 (en) 2008-09-23 2023-04-04 Cilag Gmbh International Motor-driven surgical cutting instrument
US8602288B2 (en) 2008-09-23 2013-12-10 Ethicon Endo-Surgery. Inc. Robotically-controlled motorized surgical end effector system with rotary actuated closure systems having variable actuation speeds
US9050083B2 (en) 2008-09-23 2015-06-09 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US10105136B2 (en) 2008-09-23 2018-10-23 Ethicon Llc Robotically-controlled motorized surgical instrument with an end effector
US10238389B2 (en) 2008-09-23 2019-03-26 Ethicon Llc Robotically-controlled motorized surgical instrument with an end effector
US9028519B2 (en) 2008-09-23 2015-05-12 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US9386983B2 (en) 2008-09-23 2016-07-12 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument
US8602287B2 (en) 2008-09-23 2013-12-10 Ethicon Endo-Surgery, Inc. Motor driven surgical cutting instrument
US10736628B2 (en) 2008-09-23 2020-08-11 Ethicon Llc Motor-driven surgical cutting instrument
US10980535B2 (en) 2008-09-23 2021-04-20 Ethicon Llc Motorized surgical instrument with an end effector
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US10456133B2 (en) 2008-09-23 2019-10-29 Ethicon Llc Motorized surgical instrument
US9655614B2 (en) 2008-09-23 2017-05-23 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument with an end effector
US11045189B2 (en) 2008-09-23 2021-06-29 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US11617575B2 (en) 2008-09-23 2023-04-04 Cilag Gmbh International Motor-driven surgical cutting instrument
US11730477B2 (en) 2008-10-10 2023-08-22 Cilag Gmbh International Powered surgical system with manually retractable firing system
US10932778B2 (en) 2008-10-10 2021-03-02 Ethicon Llc Powered surgical cutting and stapling apparatus with manually retractable firing system
US8608045B2 (en) 2008-10-10 2013-12-17 Ethicon Endo-Sugery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
US20100089970A1 (en) * 2008-10-10 2010-04-15 Ethicon Endo-Surgery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
US10149683B2 (en) 2008-10-10 2018-12-11 Ethicon Llc Powered surgical cutting and stapling apparatus with manually retractable firing system
US11793521B2 (en) 2008-10-10 2023-10-24 Cilag Gmbh International Powered surgical cutting and stapling apparatus with manually retractable firing system
US11583279B2 (en) 2008-10-10 2023-02-21 Cilag Gmbh International Powered surgical cutting and stapling apparatus with manually retractable firing system
US9370364B2 (en) 2008-10-10 2016-06-21 Ethicon Endo-Surgery, Llc Powered surgical cutting and stapling apparatus with manually retractable firing system
US10758233B2 (en) 2009-02-05 2020-09-01 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US8397971B2 (en) 2009-02-05 2013-03-19 Ethicon Endo-Surgery, Inc. Sterilizable surgical instrument
US11129615B2 (en) 2009-02-05 2021-09-28 Cilag Gmbh International Surgical stapling system
US8414577B2 (en) 2009-02-05 2013-04-09 Ethicon Endo-Surgery, Inc. Surgical instruments and components for use in sterile environments
US9486214B2 (en) 2009-02-06 2016-11-08 Ethicon Endo-Surgery, Llc Motor driven surgical fastener device with switching system configured to prevent firing initiation until activated
US10420550B2 (en) 2009-02-06 2019-09-24 Ethicon Llc Motor driven surgical fastener device with switching system configured to prevent firing initiation until activated
US9393015B2 (en) 2009-02-06 2016-07-19 Ethicon Endo-Surgery, Llc Motor driven surgical fastener device with cutting member reversing mechanism
US20110300222A1 (en) * 2009-02-20 2011-12-08 The Regents Of The University Of California Luminescent porous silicon nanoparticles, methods of making and using same
US20100260686A1 (en) * 2009-04-09 2010-10-14 Washington, University Of Nanoparticles for brain tumor imaging
US8961825B2 (en) 2009-04-15 2015-02-24 Cornell University Fluorescent silica nanoparticles through silica densification
US20100330366A1 (en) * 2009-06-30 2010-12-30 Keiser Bruce A Silica-based particle composition
EP2448864A4 (en) * 2009-06-30 2015-10-14 Nalco Co Silica-based particle composition
US9999694B2 (en) 2009-07-02 2018-06-19 Sloan-Kettering Institute For Cancer Research Multimodal silica-based nanoparticles
US9625456B2 (en) 2009-07-02 2017-04-18 Sloan-Kettering Institute For Cancer Research Fluorescent silica-based nanoparticles
US10548998B2 (en) 2009-07-02 2020-02-04 Sloan-Kettering Institute For Cancer Research Multimodal silica-based nanoparticles
US10548997B2 (en) 2009-07-02 2020-02-04 Sloan-Kettering Institute For Cancer Research Fluorescent silica-based nanoparticles
US11419955B2 (en) 2009-07-02 2022-08-23 Sloan-Kettering Institute For Cancer Research Multimodal silica-based nanoparticles
US10520500B2 (en) * 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
US20130064776A1 (en) * 2009-10-09 2013-03-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10191060B2 (en) 2009-11-09 2019-01-29 University Of Washington Functionalized chromophoric polymer dots and bioconjugates thereof
US11835526B2 (en) 2009-11-09 2023-12-05 University Of Washington Functionalized chromophoric polymer dots and bioconjugates thereof
US20110110858A1 (en) * 2009-11-11 2011-05-12 Omer Aras Gold nanoparticle imaging agents and uses thereof
US20130084643A1 (en) * 2009-12-24 2013-04-04 Total Sa Use of nanoparticles for labelling oil field injection waters
US9260957B2 (en) * 2009-12-24 2016-02-16 Total Sa Use of nanoparticles for labelling oil field injection waters
US10751076B2 (en) 2009-12-24 2020-08-25 Ethicon Llc Motor-driven surgical cutting instrument with electric actuator directional control assembly
US11291449B2 (en) 2009-12-24 2022-04-05 Cilag Gmbh International Surgical cutting instrument that analyzes tissue thickness
US20120252140A1 (en) * 2009-12-25 2012-10-04 Konica Minolta Medical & Graphic, Inc. Fluorescent substance-containing silica nanoparticles and biosubstance labeling agent
US8513031B2 (en) * 2009-12-25 2013-08-20 Konica Minolta Medical & Graphic, Inc. Fluorescent substance-containing silica nanoparticles with coating having high bulk refractive index
US9068084B2 (en) 2010-01-19 2015-06-30 Wuxi Zodolabs Biotech Co., Ltd. Silica nanoparticles doped with dye having negative charge and preparing method thereof
US9234015B2 (en) 2010-02-04 2016-01-12 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
US10183975B2 (en) 2010-02-04 2019-01-22 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
US9637526B2 (en) 2010-02-04 2017-05-02 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
US9018347B2 (en) 2010-02-04 2015-04-28 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US20110203023P1 (en) * 2010-02-16 2011-08-18 Menachem Bronstein Gypsophila Plant Named 'Pearl Blossom''
US10125601B2 (en) * 2010-03-04 2018-11-13 University Of Utah Research Foundation Colloidal-crystal quantum dots as tracers in underground formations
US20110214488A1 (en) * 2010-03-04 2011-09-08 Rose Peter E Colloidal-crystal quantum dots as tracers in underground formations
US10822381B2 (en) 2010-05-11 2020-11-03 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
US9944683B2 (en) 2010-05-11 2018-04-17 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
US11478247B2 (en) 2010-07-30 2022-10-25 Cilag Gmbh International Tissue acquisition arrangements and methods for surgical stapling devices
US8789741B2 (en) 2010-09-24 2014-07-29 Ethicon Endo-Surgery, Inc. Surgical instrument with trigger assembly for generating multiple actuation motions
US10213198B2 (en) 2010-09-30 2019-02-26 Ethicon Llc Actuator for releasing a tissue thickness compensator from a fastener cartridge
US10588623B2 (en) 2010-09-30 2020-03-17 Ethicon Llc Adhesive film laminate
US9592050B2 (en) 2010-09-30 2017-03-14 Ethicon Endo-Surgery, Llc End effector comprising a distal tissue abutment member
US9232941B2 (en) 2010-09-30 2016-01-12 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a reservoir
US9788834B2 (en) 2010-09-30 2017-10-17 Ethicon Llc Layer comprising deployable attachment members
US11672536B2 (en) 2010-09-30 2023-06-13 Cilag Gmbh International Layer of material for a surgical end effector
US9795383B2 (en) 2010-09-30 2017-10-24 Ethicon Llc Tissue thickness compensator comprising resilient members
US9615826B2 (en) 2010-09-30 2017-04-11 Ethicon Endo-Surgery, Llc Multiple thickness implantable layers for surgical stapling devices
US9801634B2 (en) 2010-09-30 2017-10-31 Ethicon Llc Tissue thickness compensator for a surgical stapler
US9808247B2 (en) 2010-09-30 2017-11-07 Ethicon Llc Stapling system comprising implantable layers
US9814462B2 (en) 2010-09-30 2017-11-14 Ethicon Llc Assembly for fastening tissue comprising a compressible layer
US9592053B2 (en) 2010-09-30 2017-03-14 Ethicon Endo-Surgery, Llc Staple cartridge comprising multiple regions
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US10194910B2 (en) 2010-09-30 2019-02-05 Ethicon Llc Stapling assemblies comprising a layer
US11883025B2 (en) 2010-09-30 2024-01-30 Cilag Gmbh International Tissue thickness compensator comprising a plurality of layers
US11406377B2 (en) 2010-09-30 2022-08-09 Cilag Gmbh International Adhesive film laminate
US11083452B2 (en) 2010-09-30 2021-08-10 Cilag Gmbh International Staple cartridge including a tissue thickness compensator
US9572574B2 (en) 2010-09-30 2017-02-21 Ethicon Endo-Surgery, Llc Tissue thickness compensators comprising therapeutic agents
US11684360B2 (en) 2010-09-30 2023-06-27 Cilag Gmbh International Staple cartridge comprising a variable thickness compressible portion
US9272406B2 (en) 2010-09-30 2016-03-01 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a cutting member for releasing a tissue thickness compensator
US10182819B2 (en) 2010-09-30 2019-01-22 Ethicon Llc Implantable layer assemblies
US10258330B2 (en) 2010-09-30 2019-04-16 Ethicon Llc End effector including an implantable arrangement
US10258332B2 (en) 2010-09-30 2019-04-16 Ethicon Llc Stapling system comprising an adjunct and a flowable adhesive
US10548600B2 (en) 2010-09-30 2020-02-04 Ethicon Llc Multiple thickness implantable layers for surgical stapling devices
US11911027B2 (en) 2010-09-30 2024-02-27 Cilag Gmbh International Adhesive film laminate
US9566061B2 (en) 2010-09-30 2017-02-14 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a releasably attached tissue thickness compensator
US10265072B2 (en) 2010-09-30 2019-04-23 Ethicon Llc Surgical stapling system comprising an end effector including an implantable layer
US9220501B2 (en) 2010-09-30 2015-12-29 Ethicon Endo-Surgery, Inc. Tissue thickness compensators
US10265074B2 (en) 2010-09-30 2019-04-23 Ethicon Llc Implantable layers for surgical stapling devices
US9277919B2 (en) 2010-09-30 2016-03-08 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising fibers to produce a resilient load
US9220500B2 (en) 2010-09-30 2015-12-29 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising structure to produce a resilient load
US10149682B2 (en) 2010-09-30 2018-12-11 Ethicon Llc Stapling system including an actuation system
US11395651B2 (en) 2010-09-30 2022-07-26 Cilag Gmbh International Adhesive film laminate
US10136890B2 (en) 2010-09-30 2018-11-27 Ethicon Llc Staple cartridge comprising a variable thickness compressible portion
US10485536B2 (en) 2010-09-30 2019-11-26 Ethicon Llc Tissue stapler having an anti-microbial agent
US10835251B2 (en) 2010-09-30 2020-11-17 Ethicon Llc Surgical instrument assembly including an end effector configurable in different positions
US9826978B2 (en) 2010-09-30 2017-11-28 Ethicon Llc End effectors with same side closure and firing motions
US9833238B2 (en) 2010-09-30 2017-12-05 Ethicon Endo-Surgery, Llc Retainer assembly including a tissue thickness compensator
US10743877B2 (en) 2010-09-30 2020-08-18 Ethicon Llc Surgical stapler with floating anvil
US9833236B2 (en) 2010-09-30 2017-12-05 Ethicon Llc Tissue thickness compensator for surgical staplers
US10123798B2 (en) 2010-09-30 2018-11-13 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US9833242B2 (en) 2010-09-30 2017-12-05 Ethicon Endo-Surgery, Llc Tissue thickness compensators
US8978954B2 (en) 2010-09-30 2015-03-17 Ethicon Endo-Surgery, Inc. Staple cartridge comprising an adjustable distal portion
US10869669B2 (en) 2010-09-30 2020-12-22 Ethicon Llc Surgical instrument assembly
US9480476B2 (en) 2010-09-30 2016-11-01 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising resilient members
US11857187B2 (en) 2010-09-30 2024-01-02 Cilag Gmbh International Tissue thickness compensator comprising controlled release and expansion
US9839420B2 (en) 2010-09-30 2017-12-12 Ethicon Llc Tissue thickness compensator comprising at least one medicament
US11571215B2 (en) 2010-09-30 2023-02-07 Cilag Gmbh International Layer of material for a surgical end effector
US11850310B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge including an adjunct
US8893949B2 (en) 2010-09-30 2014-11-25 Ethicon Endo-Surgery, Inc. Surgical stapler with floating anvil
US11849952B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US9433419B2 (en) 2010-09-30 2016-09-06 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a plurality of layers
US11154296B2 (en) 2010-09-30 2021-10-26 Cilag Gmbh International Anvil layer attached to a proximal end of an end effector
US11925354B2 (en) 2010-09-30 2024-03-12 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US9282962B2 (en) 2010-09-30 2016-03-15 Ethicon Endo-Surgery, Llc Adhesive film laminate
US9844372B2 (en) 2010-09-30 2017-12-19 Ethicon Llc Retainer assembly including a tissue thickness compensator
US9332974B2 (en) 2010-09-30 2016-05-10 Ethicon Endo-Surgery, Llc Layered tissue thickness compensator
US10463372B2 (en) 2010-09-30 2019-11-05 Ethicon Llc Staple cartridge comprising multiple regions
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US9848875B2 (en) 2010-09-30 2017-12-26 Ethicon Llc Anvil layer attached to a proximal end of an end effector
US9861361B2 (en) 2010-09-30 2018-01-09 Ethicon Llc Releasable tissue thickness compensator and fastener cartridge having the same
US9386988B2 (en) 2010-09-30 2016-07-12 Ethicon End-Surgery, LLC Retainer assembly including a tissue thickness compensator
US10888328B2 (en) 2010-09-30 2021-01-12 Ethicon Llc Surgical end effector
US10064624B2 (en) 2010-09-30 2018-09-04 Ethicon Llc End effector with implantable layer
US10898193B2 (en) 2010-09-30 2021-01-26 Ethicon Llc End effector for use with a surgical instrument
US9700317B2 (en) 2010-09-30 2017-07-11 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a releasable tissue thickness compensator
US10335148B2 (en) 2010-09-30 2019-07-02 Ethicon Llc Staple cartridge including a tissue thickness compensator for a surgical stapler
US9301753B2 (en) 2010-09-30 2016-04-05 Ethicon Endo-Surgery, Llc Expandable tissue thickness compensator
US10335150B2 (en) 2010-09-30 2019-07-02 Ethicon Llc Staple cartridge comprising an implantable layer
US10398436B2 (en) 2010-09-30 2019-09-03 Ethicon Llc Staple cartridge comprising staples positioned within a compressible portion thereof
US9364233B2 (en) 2010-09-30 2016-06-14 Ethicon Endo-Surgery, Llc Tissue thickness compensators for circular surgical staplers
US9358005B2 (en) 2010-09-30 2016-06-07 Ethicon Endo-Surgery, Llc End effector layer including holding features
US10028743B2 (en) 2010-09-30 2018-07-24 Ethicon Llc Staple cartridge assembly comprising an implantable layer
US9301752B2 (en) 2010-09-30 2016-04-05 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising a plurality of capsules
US11540824B2 (en) 2010-09-30 2023-01-03 Cilag Gmbh International Tissue thickness compensator
US9307965B2 (en) 2010-09-30 2016-04-12 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating an anti-microbial agent
US11812965B2 (en) 2010-09-30 2023-11-14 Cilag Gmbh International Layer of material for a surgical end effector
US10363031B2 (en) 2010-09-30 2019-07-30 Ethicon Llc Tissue thickness compensators for surgical staplers
US11737754B2 (en) 2010-09-30 2023-08-29 Cilag Gmbh International Surgical stapler with floating anvil
US11602340B2 (en) 2010-09-30 2023-03-14 Cilag Gmbh International Adhesive film laminate
US9314246B2 (en) 2010-09-30 2016-04-19 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US9345477B2 (en) 2010-09-30 2016-05-24 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator comprising incorporating a hemostatic agent
US10624861B2 (en) 2010-09-30 2020-04-21 Ethicon Llc Tissue thickness compensator configured to redistribute compressive forces
US11559496B2 (en) 2010-09-30 2023-01-24 Cilag Gmbh International Tissue thickness compensator configured to redistribute compressive forces
US9883861B2 (en) 2010-09-30 2018-02-06 Ethicon Llc Retainer assembly including a tissue thickness compensator
US11583277B2 (en) 2010-09-30 2023-02-21 Cilag Gmbh International Layer of material for a surgical end effector
US9320518B2 (en) 2010-09-30 2016-04-26 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating an oxygen generating agent
US10987102B2 (en) 2010-09-30 2021-04-27 Ethicon Llc Tissue thickness compensator comprising a plurality of layers
US9924947B2 (en) 2010-09-30 2018-03-27 Ethicon Llc Staple cartridge comprising a compressible portion
US10405854B2 (en) 2010-09-30 2019-09-10 Ethicon Llc Surgical stapling cartridge with layer retention features
US10695062B2 (en) 2010-10-01 2020-06-30 Ethicon Llc Surgical instrument including a retractable firing member
US11529142B2 (en) 2010-10-01 2022-12-20 Cilag Gmbh International Surgical instrument having a power control circuit
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US9579283B2 (en) 2011-04-28 2017-02-28 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
US9351730B2 (en) 2011-04-29 2016-05-31 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising channels
US11504116B2 (en) 2011-04-29 2022-11-22 Cilag Gmbh International Layer of material for a surgical end effector
US10117652B2 (en) 2011-04-29 2018-11-06 Ethicon Llc End effector comprising a tissue thickness compensator and progressively released attachment members
US9211120B2 (en) 2011-04-29 2015-12-15 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising a plurality of medicaments
US9241714B2 (en) 2011-04-29 2016-01-26 Ethicon Endo-Surgery, Inc. Tissue thickness compensator and method for making the same
US10435661B2 (en) 2011-05-13 2019-10-08 The Regents Of The University Of California Photothermal substrates for selective transfection of cells
US9271799B2 (en) 2011-05-27 2016-03-01 Ethicon Endo-Surgery, Llc Robotic surgical system with removable motor housing
US11612394B2 (en) 2011-05-27 2023-03-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US10426478B2 (en) 2011-05-27 2019-10-01 Ethicon Llc Surgical stapling systems
US10524790B2 (en) 2011-05-27 2020-01-07 Ethicon Llc Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US10383633B2 (en) 2011-05-27 2019-08-20 Ethicon Llc Robotically-driven surgical assembly
US10813641B2 (en) 2011-05-27 2020-10-27 Ethicon Llc Robotically-driven surgical instrument
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
US10980534B2 (en) 2011-05-27 2021-04-20 Ethicon Llc Robotically-controlled motorized surgical instrument with an end effector
US10780539B2 (en) 2011-05-27 2020-09-22 Ethicon Llc Stapling instrument for use with a robotic system
US11583278B2 (en) 2011-05-27 2023-02-21 Cilag Gmbh International Surgical stapling system having multi-direction articulation
US9913648B2 (en) 2011-05-27 2018-03-13 Ethicon Endo-Surgery, Llc Surgical system
US10485546B2 (en) 2011-05-27 2019-11-26 Ethicon Llc Robotically-driven surgical assembly
US10420561B2 (en) 2011-05-27 2019-09-24 Ethicon Llc Robotically-driven surgical instrument
US10617420B2 (en) 2011-05-27 2020-04-14 Ethicon Llc Surgical system comprising drive systems
US10130366B2 (en) 2011-05-27 2018-11-20 Ethicon Llc Automated reloading devices for replacing used end effectors on robotic surgical systems
US10231794B2 (en) 2011-05-27 2019-03-19 Ethicon Llc Surgical stapling instruments with rotatable staple deployment arrangements
US11266410B2 (en) 2011-05-27 2022-03-08 Cilag Gmbh International Surgical device for use with a robotic system
US9775614B2 (en) 2011-05-27 2017-10-03 Ethicon Endo-Surgery, Llc Surgical stapling instruments with rotatable staple deployment arrangements
US10004506B2 (en) 2011-05-27 2018-06-26 Ethicon Llc Surgical system
US11129616B2 (en) 2011-05-27 2021-09-28 Cilag Gmbh International Surgical stapling system
US10736634B2 (en) 2011-05-27 2020-08-11 Ethicon Llc Robotically-driven surgical instrument including a drive system
US11918208B2 (en) 2011-05-27 2024-03-05 Cilag Gmbh International Robotically-controlled shaft based rotary drive systems for surgical instruments
US10335151B2 (en) 2011-05-27 2019-07-02 Ethicon Llc Robotically-driven surgical instrument
US11439470B2 (en) 2011-05-27 2022-09-13 Cilag Gmbh International Robotically-controlled surgical instrument with selectively articulatable end effector
US10071452B2 (en) 2011-05-27 2018-09-11 Ethicon Llc Automated end effector component reloading system for use with a robotic system
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US9532949B2 (en) 2011-07-19 2017-01-03 Stc.Unm Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
JP2016027340A (en) * 2011-09-09 2016-02-18 コニカミノルタ株式会社 Fluorescent labelling compound for detecting biological substance
US10551386B2 (en) * 2011-09-09 2020-02-04 Konica Minolta, Inc. Biological substance detection method
US20170115300A1 (en) * 2011-09-09 2017-04-27 Konica Minolta, Inc. Biological substance detection method
US20140220598A1 (en) * 2011-09-09 2014-08-07 Tohoku University Biological substance detection method
US9687237B2 (en) 2011-09-23 2017-06-27 Ethicon Endo-Surgery, Llc Staple cartridge including collapsible deck arrangement
US9592054B2 (en) 2011-09-23 2017-03-14 Ethicon Endo-Surgery, Llc Surgical stapler with stationary staple drivers
US9050084B2 (en) 2011-09-23 2015-06-09 Ethicon Endo-Surgery, Inc. Staple cartridge including collapsible deck arrangement
US9055941B2 (en) 2011-09-23 2015-06-16 Ethicon Endo-Surgery, Inc. Staple cartridge including collapsible deck
US9216019B2 (en) 2011-09-23 2015-12-22 Ethicon Endo-Surgery, Inc. Surgical stapler with stationary staple drivers
CN103013016A (en) * 2011-09-28 2013-04-03 国家纳米科学中心 Medical carrier and medical composition and preparation method thereof
US11697713B2 (en) 2011-12-30 2023-07-11 University Of Washington Through Its Center For Commercialization Chromophoric polymer dots with narrow-band emission
US9042765B2 (en) 2012-01-16 2015-05-26 Samsung Electronics Co., Ltd. Image forming apparatus with improved heat transmission
US10695063B2 (en) 2012-02-13 2020-06-30 Ethicon Llc Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
US9044230B2 (en) 2012-02-13 2015-06-02 Ethicon Endo-Surgery, Inc. Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
US9730697B2 (en) 2012-02-13 2017-08-15 Ethicon Endo-Surgery, Llc Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
EP2833144A4 (en) * 2012-03-28 2015-08-26 Konica Minolta Inc Method for detection biological substance
US9918716B2 (en) 2012-03-28 2018-03-20 Ethicon Llc Staple cartridge comprising implantable layers
US11793509B2 (en) 2012-03-28 2023-10-24 Cilag Gmbh International Staple cartridge including an implantable layer
US9632081B2 (en) 2012-03-28 2017-04-25 Konica Minolta, Inc. Detection method for biological substance
US9517063B2 (en) 2012-03-28 2016-12-13 Ethicon Endo-Surgery, Llc Movable member for use with a tissue thickness compensator
US9974538B2 (en) 2012-03-28 2018-05-22 Ethicon Llc Staple cartridge comprising a compressible layer
US9204880B2 (en) 2012-03-28 2015-12-08 Ethicon Endo-Surgery, Inc. Tissue thickness compensator comprising capsules defining a low pressure environment
US9198662B2 (en) 2012-03-28 2015-12-01 Ethicon Endo-Surgery, Inc. Tissue thickness compensator having improved visibility
US9724098B2 (en) 2012-03-28 2017-08-08 Ethicon Endo-Surgery, Llc Staple cartridge comprising an implantable layer
US9307989B2 (en) 2012-03-28 2016-04-12 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorportating a hydrophobic agent
US9314247B2 (en) 2012-03-28 2016-04-19 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating a hydrophilic agent
JPWO2013146694A1 (en) * 2012-03-28 2015-12-14 コニカミノルタ株式会社 Detection method of biological material
US10441285B2 (en) 2012-03-28 2019-10-15 Ethicon Llc Tissue thickness compensator comprising tissue ingrowth features
US9414838B2 (en) 2012-03-28 2016-08-16 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprised of a plurality of materials
US9320523B2 (en) 2012-03-28 2016-04-26 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising tissue ingrowth features
US11406378B2 (en) 2012-03-28 2022-08-09 Cilag Gmbh International Staple cartridge comprising a compressible tissue thickness compensator
US10667808B2 (en) 2012-03-28 2020-06-02 Ethicon Llc Staple cartridge comprising an absorbable adjunct
US11918220B2 (en) 2012-03-28 2024-03-05 Cilag Gmbh International Tissue thickness compensator comprising tissue ingrowth features
US11707273B2 (en) 2012-06-15 2023-07-25 Cilag Gmbh International Articulatable surgical instrument comprising a firing drive
US10959725B2 (en) 2012-06-15 2021-03-30 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
US10064621B2 (en) 2012-06-15 2018-09-04 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US9028494B2 (en) 2012-06-28 2015-05-12 Ethicon Endo-Surgery, Inc. Interchangeable end effector coupling arrangement
US11197671B2 (en) 2012-06-28 2021-12-14 Cilag Gmbh International Stapling assembly comprising a lockout
US10413294B2 (en) 2012-06-28 2019-09-17 Ethicon Llc Shaft assembly arrangements for surgical instruments
US11779420B2 (en) 2012-06-28 2023-10-10 Cilag Gmbh International Robotic surgical attachments having manually-actuated retraction assemblies
US9649111B2 (en) 2012-06-28 2017-05-16 Ethicon Endo-Surgery, Llc Replaceable clip cartridge for a clip applier
US9119657B2 (en) 2012-06-28 2015-09-01 Ethicon Endo-Surgery, Inc. Rotary actuatable closure arrangement for surgical end effector
US9226751B2 (en) 2012-06-28 2016-01-05 Ethicon Endo-Surgery, Inc. Surgical instrument system including replaceable end effectors
US11109860B2 (en) 2012-06-28 2021-09-07 Cilag Gmbh International Surgical end effectors for use with hand-held and robotically-controlled rotary powered surgical systems
US10874391B2 (en) 2012-06-28 2020-12-29 Ethicon Llc Surgical instrument system including replaceable end effectors
US10420555B2 (en) 2012-06-28 2019-09-24 Ethicon Llc Hand held rotary powered surgical instruments with end effectors that are articulatable about multiple axes
US10639115B2 (en) 2012-06-28 2020-05-05 Ethicon Llc Surgical end effectors having angled tissue-contacting surfaces
US11918213B2 (en) 2012-06-28 2024-03-05 Cilag Gmbh International Surgical stapler including couplers for attaching a shaft to an end effector
US11278284B2 (en) 2012-06-28 2022-03-22 Cilag Gmbh International Rotary drive arrangements for surgical instruments
US8747238B2 (en) 2012-06-28 2014-06-10 Ethicon Endo-Surgery, Inc. Rotary drive shaft assemblies for surgical instruments with articulatable end effectors
US11039837B2 (en) 2012-06-28 2021-06-22 Cilag Gmbh International Firing system lockout arrangements for surgical instruments
US10485541B2 (en) 2012-06-28 2019-11-26 Ethicon Llc Robotically powered surgical device with manually-actuatable reversing system
US11083457B2 (en) 2012-06-28 2021-08-10 Cilag Gmbh International Surgical instrument system including replaceable end effectors
US9282974B2 (en) 2012-06-28 2016-03-15 Ethicon Endo-Surgery, Llc Empty clip cartridge lockout
US10383630B2 (en) 2012-06-28 2019-08-20 Ethicon Llc Surgical stapling device with rotary driven firing member
US10932775B2 (en) 2012-06-28 2021-03-02 Ethicon Llc Firing system lockout arrangements for surgical instruments
US11154299B2 (en) 2012-06-28 2021-10-26 Cilag Gmbh International Stapling assembly comprising a firing lockout
US11464513B2 (en) 2012-06-28 2022-10-11 Cilag Gmbh International Surgical instrument system including replaceable end effectors
US10258333B2 (en) 2012-06-28 2019-04-16 Ethicon Llc Surgical fastening apparatus with a rotary end effector drive shaft for selective engagement with a motorized drive system
US9561038B2 (en) 2012-06-28 2017-02-07 Ethicon Endo-Surgery, Llc Interchangeable clip applier
US11241230B2 (en) 2012-06-28 2022-02-08 Cilag Gmbh International Clip applier tool for use with a robotic surgical system
US11510671B2 (en) 2012-06-28 2022-11-29 Cilag Gmbh International Firing system lockout arrangements for surgical instruments
US11857189B2 (en) 2012-06-28 2024-01-02 Cilag Gmbh International Surgical instrument including first and second articulation joints
US9907620B2 (en) 2012-06-28 2018-03-06 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
US11202631B2 (en) 2012-06-28 2021-12-21 Cilag Gmbh International Stapling assembly comprising a firing lockout
US9125662B2 (en) 2012-06-28 2015-09-08 Ethicon Endo-Surgery, Inc. Multi-axis articulating and rotating surgical tools
US9204879B2 (en) 2012-06-28 2015-12-08 Ethicon Endo-Surgery, Inc. Flexible drive member
US9072536B2 (en) 2012-06-28 2015-07-07 Ethicon Endo-Surgery, Inc. Differential locking arrangements for rotary powered surgical instruments
US9101385B2 (en) 2012-06-28 2015-08-11 Ethicon Endo-Surgery, Inc. Electrode connections for rotary driven surgical tools
US11622766B2 (en) 2012-06-28 2023-04-11 Cilag Gmbh International Empty clip cartridge lockout
US9408606B2 (en) 2012-06-28 2016-08-09 Ethicon Endo-Surgery, Llc Robotically powered surgical device with manually-actuatable reversing system
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
US11007004B2 (en) 2012-06-28 2021-05-18 Ethicon Llc Powered multi-axial articulable electrosurgical device with external dissection features
US11806013B2 (en) 2012-06-28 2023-11-07 Cilag Gmbh International Firing system arrangements for surgical instruments
US11058423B2 (en) 2012-06-28 2021-07-13 Cilag Gmbh International Stapling system including first and second closure systems for use with a surgical robot
US11141155B2 (en) 2012-06-28 2021-10-12 Cilag Gmbh International Drive system for surgical tool
US11602346B2 (en) 2012-06-28 2023-03-14 Cilag Gmbh International Robotically powered surgical device with manually-actuatable reversing system
US11141156B2 (en) 2012-06-28 2021-10-12 Cilag Gmbh International Surgical stapling assembly comprising flexible output shaft
US10687812B2 (en) 2012-06-28 2020-06-23 Ethicon Llc Surgical instrument system including replaceable end effectors
US11534162B2 (en) 2012-06-28 2022-12-27 Cilag GmbH Inlernational Robotically powered surgical device with manually-actuatable reversing system
US9364230B2 (en) 2012-06-28 2016-06-14 Ethicon Endo-Surgery, Llc Surgical stapling instruments with rotary joint assemblies
US11540829B2 (en) 2012-06-28 2023-01-03 Cilag Gmbh International Surgical instrument system including replaceable end effectors
US11373755B2 (en) 2012-08-23 2022-06-28 Cilag Gmbh International Surgical device drive system including a ratchet mechanism
EP2903603A4 (en) * 2012-09-27 2016-08-10 Cynvenio Biosystems Inc Stimulus-sensitive microparticles and methods of use
US9988686B2 (en) 2012-09-27 2018-06-05 Cynvenio Biosystems, Inc. Stimulus-sensitive microparticles and methods of use
WO2014052875A1 (en) 2012-09-27 2014-04-03 Cynvenio Biosystems, Inc. Stimulus-sensitive microparticles and methods of use
CN104981236A (en) * 2012-09-27 2015-10-14 辛温尼奥生物系统公司 Stimulus-sensitive microparticles and methods of use
CN102921014A (en) * 2012-11-15 2013-02-13 中国科学院化学研究所 Biocompatible nano composite drug carrier with synergistic anti-tumor effect, drug with synergistic anti-tumor effect and preparation methods of biocompatible nano composite drug carrier and drug
US10557846B2 (en) 2012-11-16 2020-02-11 Quantamatrix Inc. Encoded polymeric microparticles
JP2016501286A (en) * 2012-11-16 2016-01-18 エスエヌユー アールアンドディービー ファウンデーショ Coded polymer particles
US10156559B2 (en) 2012-12-10 2018-12-18 Fred Hutchinson Cancer Research Center Lipocalin fusion partners
US8873041B1 (en) 2013-01-29 2014-10-28 Bayspec, Inc. Raman spectroscopy using multiple excitation wavelengths
US9386984B2 (en) 2013-02-08 2016-07-12 Ethicon Endo-Surgery, Llc Staple cartridge comprising a releasable cover
US10092292B2 (en) 2013-02-28 2018-10-09 Ethicon Llc Staple forming features for surgical stapling instrument
US9358003B2 (en) 2013-03-01 2016-06-07 Ethicon Endo-Surgery, Llc Electromechanical surgical device with signal relay arrangement
US9468438B2 (en) 2013-03-01 2016-10-18 Eticon Endo-Surgery, LLC Sensor straightened end effector during removal through trocar
US9326767B2 (en) 2013-03-01 2016-05-03 Ethicon Endo-Surgery, Llc Joystick switch assemblies for surgical instruments
US9554794B2 (en) 2013-03-01 2017-01-31 Ethicon Endo-Surgery, Llc Multiple processor motor control for modular surgical instruments
US10285695B2 (en) 2013-03-01 2019-05-14 Ethicon Llc Articulatable surgical instruments with conductive pathways
US10575868B2 (en) 2013-03-01 2020-03-03 Ethicon Llc Surgical instrument with coupler assembly
US11246618B2 (en) 2013-03-01 2022-02-15 Cilag Gmbh International Surgical instrument soft stop
US9700309B2 (en) 2013-03-01 2017-07-11 Ethicon Llc Articulatable surgical instruments with conductive pathways for signal communication
US10226249B2 (en) 2013-03-01 2019-03-12 Ethicon Llc Articulatable surgical instruments with conductive pathways for signal communication
US9782169B2 (en) 2013-03-01 2017-10-10 Ethicon Llc Rotary powered articulation joints for surgical instruments
US11529138B2 (en) 2013-03-01 2022-12-20 Cilag Gmbh International Powered surgical instrument including a rotary drive screw
US9398911B2 (en) 2013-03-01 2016-07-26 Ethicon Endo-Surgery, Llc Rotary powered surgical instruments with multiple degrees of freedom
US9307986B2 (en) 2013-03-01 2016-04-12 Ethicon Endo-Surgery, Llc Surgical instrument soft stop
US9345481B2 (en) 2013-03-13 2016-05-24 Ethicon Endo-Surgery, Llc Staple cartridge tissue thickness sensor system
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
EP2972349B1 (en) * 2013-03-14 2019-10-23 University Of Washington Through Its Center For Commercialization Polymer dot compositions and related methods
US9332987B2 (en) 2013-03-14 2016-05-10 Ethicon Endo-Surgery, Llc Control arrangements for a drive member of a surgical instrument
US9808244B2 (en) 2013-03-14 2017-11-07 Ethicon Llc Sensor arrangements for absolute positioning system for surgical instruments
US10514381B2 (en) 2013-03-14 2019-12-24 University Of Washington Through Its Center For Commercialization Polymer dot compositions and related methods
US10238391B2 (en) 2013-03-14 2019-03-26 Ethicon Llc Drive train control arrangements for modular surgical instruments
WO2014153051A1 (en) 2013-03-14 2014-09-25 University Of Washington Through Its Center For Commercialization Polymer dot compositions and related methods
US11266406B2 (en) 2013-03-14 2022-03-08 Cilag Gmbh International Control systems for surgical instruments
US9629623B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgery, Llc Drive system lockout arrangements for modular surgical instruments
US9687230B2 (en) 2013-03-14 2017-06-27 Ethicon Llc Articulatable surgical instrument comprising a firing drive
US9351727B2 (en) 2013-03-14 2016-05-31 Ethicon Endo-Surgery, Llc Drive train control arrangements for modular surgical instruments
US10893867B2 (en) 2013-03-14 2021-01-19 Ethicon Llc Drive train control arrangements for modular surgical instruments
US10617416B2 (en) 2013-03-14 2020-04-14 Ethicon Llc Control systems for surgical instruments
US10470762B2 (en) 2013-03-14 2019-11-12 Ethicon Llc Multi-function motor for a surgical instrument
US9888919B2 (en) 2013-03-14 2018-02-13 Ethicon Llc Method and system for operating a surgical instrument
US9351726B2 (en) 2013-03-14 2016-05-31 Ethicon Endo-Surgery, Llc Articulation control system for articulatable surgical instruments
US9883860B2 (en) 2013-03-14 2018-02-06 Ethicon Llc Interchangeable shaft assemblies for use with a surgical instrument
US10039847B2 (en) 2013-03-15 2018-08-07 Sloan-Kettering Institute For Cancer Research Multimodal silica-based nanoparticles
US10982217B2 (en) 2013-03-15 2021-04-20 The Regents Of The University Of California High-throughput cargo delivery into live cells using photothermal platforms
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
US9795384B2 (en) 2013-03-27 2017-10-24 Ethicon Llc Fastener cartridge comprising a tissue thickness compensator and a gap setting element
US9572577B2 (en) 2013-03-27 2017-02-21 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a tissue thickness compensator including openings therein
US9332984B2 (en) 2013-03-27 2016-05-10 Ethicon Endo-Surgery, Llc Fastener cartridge assemblies
US11633183B2 (en) 2013-04-16 2023-04-25 Cilag International GmbH Stapling assembly comprising a retraction drive
US11395652B2 (en) 2013-04-16 2022-07-26 Cilag Gmbh International Powered surgical stapler
US9814460B2 (en) 2013-04-16 2017-11-14 Ethicon Llc Modular motor driven surgical instruments with status indication arrangements
US11622763B2 (en) 2013-04-16 2023-04-11 Cilag Gmbh International Stapling assembly comprising a shiftable drive
US9844368B2 (en) 2013-04-16 2017-12-19 Ethicon Llc Surgical system comprising first and second drive systems
US10888318B2 (en) 2013-04-16 2021-01-12 Ethicon Llc Powered surgical stapler
US11406381B2 (en) 2013-04-16 2022-08-09 Cilag Gmbh International Powered surgical stapler
US11690615B2 (en) 2013-04-16 2023-07-04 Cilag Gmbh International Surgical system including an electric motor and a surgical instrument
US9826976B2 (en) 2013-04-16 2017-11-28 Ethicon Llc Motor driven surgical instruments with lockable dual drive shafts
US10405857B2 (en) 2013-04-16 2019-09-10 Ethicon Llc Powered linear surgical stapler
US11564679B2 (en) 2013-04-16 2023-01-31 Cilag Gmbh International Powered surgical stapler
US9867612B2 (en) 2013-04-16 2018-01-16 Ethicon Llc Powered surgical stapler
US11638581B2 (en) 2013-04-16 2023-05-02 Cilag Gmbh International Powered surgical stapler
US9649110B2 (en) 2013-04-16 2017-05-16 Ethicon Llc Surgical instrument comprising a closing drive and a firing drive operated from the same rotatable output
US10702266B2 (en) 2013-04-16 2020-07-07 Ethicon Llc Surgical instrument system
US10136887B2 (en) 2013-04-16 2018-11-27 Ethicon Llc Drive system decoupling arrangement for a surgical instrument
US10149680B2 (en) 2013-04-16 2018-12-11 Ethicon Llc Surgical instrument comprising a gap setting system
US9801626B2 (en) 2013-04-16 2017-10-31 Ethicon Llc Modular motor driven surgical instruments with alignment features for aligning rotary drive shafts with surgical end effector shafts
US9574644B2 (en) 2013-05-30 2017-02-21 Ethicon Endo-Surgery, Llc Power module for use with a surgical instrument
US9775609B2 (en) 2013-08-23 2017-10-03 Ethicon Llc Tamper proof circuit for surgical instrument battery pack
US11918209B2 (en) 2013-08-23 2024-03-05 Cilag Gmbh International Torque optimization for surgical instruments
US11134940B2 (en) 2013-08-23 2021-10-05 Cilag Gmbh International Surgical instrument including a variable speed firing member
US11109858B2 (en) 2013-08-23 2021-09-07 Cilag Gmbh International Surgical instrument including a display which displays the position of a firing element
US10869665B2 (en) 2013-08-23 2020-12-22 Ethicon Llc Surgical instrument system including a control system
US11504119B2 (en) 2013-08-23 2022-11-22 Cilag Gmbh International Surgical instrument including an electronic firing lockout
US11389160B2 (en) 2013-08-23 2022-07-19 Cilag Gmbh International Surgical system comprising a display
US10828032B2 (en) 2013-08-23 2020-11-10 Ethicon Llc End effector detection systems for surgical instruments
US9510828B2 (en) 2013-08-23 2016-12-06 Ethicon Endo-Surgery, Llc Conductor arrangements for electrically powered surgical instruments with rotatable end effectors
US9924942B2 (en) 2013-08-23 2018-03-27 Ethicon Llc Motor-powered articulatable surgical instruments
US9987006B2 (en) 2013-08-23 2018-06-05 Ethicon Llc Shroud retention arrangement for sterilizable surgical instruments
US11026680B2 (en) 2013-08-23 2021-06-08 Cilag Gmbh International Surgical instrument configured to operate in different states
US10624634B2 (en) 2013-08-23 2020-04-21 Ethicon Llc Firing trigger lockout arrangements for surgical instruments
US9808249B2 (en) 2013-08-23 2017-11-07 Ethicon Llc Attachment portions for surgical instrument assemblies
US11000274B2 (en) 2013-08-23 2021-05-11 Ethicon Llc Powered surgical instrument
US11376001B2 (en) 2013-08-23 2022-07-05 Cilag Gmbh International Surgical stapling device with rotary multi-turn retraction mechanism
US10201349B2 (en) 2013-08-23 2019-02-12 Ethicon Llc End effector detection and firing rate modulation systems for surgical instruments
US9445813B2 (en) 2013-08-23 2016-09-20 Ethicon Endo-Surgery, Llc Closure indicator systems for surgical instruments
US9700310B2 (en) 2013-08-23 2017-07-11 Ethicon Llc Firing member retraction devices for powered surgical instruments
US11133106B2 (en) 2013-08-23 2021-09-28 Cilag Gmbh International Surgical instrument assembly comprising a retraction assembly
US9283054B2 (en) 2013-08-23 2016-03-15 Ethicon Endo-Surgery, Llc Interactive displays
US10898190B2 (en) 2013-08-23 2021-01-26 Ethicon Llc Secondary battery arrangements for powered surgical instruments
US11701110B2 (en) 2013-08-23 2023-07-18 Cilag Gmbh International Surgical instrument including a drive assembly movable in a non-motorized mode of operation
US10441281B2 (en) 2013-08-23 2019-10-15 Ethicon Llc surgical instrument including securing and aligning features
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11719644B2 (en) * 2013-12-20 2023-08-08 Sicpa Holding Sa Thermoluminescent composite particle and marking comprising same
US20150177153A1 (en) * 2013-12-20 2015-06-25 Sicpa Holding Sa Thermoluminescent composite particle and marking comprising same
US11759201B2 (en) 2013-12-23 2023-09-19 Cilag Gmbh International Surgical stapling system comprising an end effector including an anvil with an anvil cap
US11779327B2 (en) 2013-12-23 2023-10-10 Cilag Gmbh International Surgical stapling system including a push bar
US11896223B2 (en) 2013-12-23 2024-02-13 Cilag Gmbh International Surgical cutting and stapling instruments with independent jaw control features
US11246587B2 (en) 2013-12-23 2022-02-15 Cilag Gmbh International Surgical cutting and stapling instruments
US11583273B2 (en) 2013-12-23 2023-02-21 Cilag Gmbh International Surgical stapling system including a firing beam extending through an articulation region
US11364028B2 (en) 2013-12-23 2022-06-21 Cilag Gmbh International Modular surgical system
US10265065B2 (en) 2013-12-23 2019-04-23 Ethicon Llc Surgical staples and staple cartridges
US11026677B2 (en) 2013-12-23 2021-06-08 Cilag Gmbh International Surgical stapling assembly
US11020109B2 (en) 2013-12-23 2021-06-01 Ethicon Llc Surgical stapling assembly for use with a powered surgical interface
US10588624B2 (en) 2013-12-23 2020-03-17 Ethicon Llc Surgical staples, staple cartridges and surgical end effectors
US10925599B2 (en) 2013-12-23 2021-02-23 Ethicon Llc Modular surgical instruments
US11123065B2 (en) 2013-12-23 2021-09-21 Cilag Gmbh International Surgical cutting and stapling instruments with independent jaw control features
US10986997B2 (en) 2013-12-31 2021-04-27 Memorial Sloan Kettering Cancer Center Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time
US20150202848A1 (en) * 2014-01-22 2015-07-23 Samsung Display Co., Ltd. Display device
US9962161B2 (en) 2014-02-12 2018-05-08 Ethicon Llc Deliverable surgical instrument
US11020115B2 (en) 2014-02-12 2021-06-01 Cilag Gmbh International Deliverable surgical instrument
US9839423B2 (en) 2014-02-24 2017-12-12 Ethicon Llc Implantable layers and methods for modifying the shape of the implantable layers for use with a surgical fastening instrument
US9775608B2 (en) 2014-02-24 2017-10-03 Ethicon Llc Fastening system comprising a firing member lockout
US10426481B2 (en) 2014-02-24 2019-10-01 Ethicon Llc Implantable layer assemblies
US9884456B2 (en) 2014-02-24 2018-02-06 Ethicon Llc Implantable layers and methods for altering one or more properties of implantable layers for use with fastening instruments
US9757124B2 (en) 2014-02-24 2017-09-12 Ethicon Llc Implantable layer assemblies
US9839422B2 (en) 2014-02-24 2017-12-12 Ethicon Llc Implantable layers and methods for altering implantable layers for use with surgical fastening instruments
US9693777B2 (en) 2014-02-24 2017-07-04 Ethicon Llc Implantable layers comprising a pressed region
US10136889B2 (en) 2014-03-26 2018-11-27 Ethicon Llc Systems and methods for controlling a segmented circuit
US9743929B2 (en) 2014-03-26 2017-08-29 Ethicon Llc Modular powered surgical instrument with detachable shaft assemblies
US11259799B2 (en) 2014-03-26 2022-03-01 Cilag Gmbh International Interface systems for use with surgical instruments
US11497488B2 (en) 2014-03-26 2022-11-15 Cilag Gmbh International Systems and methods for controlling a segmented circuit
US9730695B2 (en) 2014-03-26 2017-08-15 Ethicon Endo-Surgery, Llc Power management through segmented circuit
US10004497B2 (en) 2014-03-26 2018-06-26 Ethicon Llc Interface systems for use with surgical instruments
US9913642B2 (en) 2014-03-26 2018-03-13 Ethicon Llc Surgical instrument comprising a sensor system
US9804618B2 (en) 2014-03-26 2017-10-31 Ethicon Llc Systems and methods for controlling a segmented circuit
US10863981B2 (en) 2014-03-26 2020-12-15 Ethicon Llc Interface systems for use with surgical instruments
US10013049B2 (en) 2014-03-26 2018-07-03 Ethicon Llc Power management through sleep options of segmented circuit and wake up control
US10028761B2 (en) 2014-03-26 2018-07-24 Ethicon Llc Feedback algorithms for manual bailout systems for surgical instruments
US10588626B2 (en) 2014-03-26 2020-03-17 Ethicon Llc Surgical instrument displaying subsequent step of use
US9750499B2 (en) 2014-03-26 2017-09-05 Ethicon Llc Surgical stapling instrument system
US10898185B2 (en) 2014-03-26 2021-01-26 Ethicon Llc Surgical instrument power management through sleep and wake up control
US10117653B2 (en) 2014-03-26 2018-11-06 Ethicon Llc Systems and methods for controlling a segmented circuit
US10201364B2 (en) 2014-03-26 2019-02-12 Ethicon Llc Surgical instrument comprising a rotatable shaft
US9733663B2 (en) 2014-03-26 2017-08-15 Ethicon Llc Power management through segmented circuit and variable voltage protection
US9820738B2 (en) 2014-03-26 2017-11-21 Ethicon Llc Surgical instrument comprising interactive systems
US9826977B2 (en) 2014-03-26 2017-11-28 Ethicon Llc Sterilization verification circuit
US9690362B2 (en) 2014-03-26 2017-06-27 Ethicon Llc Surgical instrument control circuit having a safety processor
US10472651B2 (en) 2014-03-28 2019-11-12 The Regents Of The University Of California Efficient delivery of large cargos into cells on a porous substrate
US10470768B2 (en) 2014-04-16 2019-11-12 Ethicon Llc Fastener cartridge including a layer attached thereto
US11717294B2 (en) 2014-04-16 2023-08-08 Cilag Gmbh International End effector arrangements comprising indicators
US11298134B2 (en) 2014-04-16 2022-04-12 Cilag Gmbh International Fastener cartridge comprising non-uniform fasteners
US10542988B2 (en) 2014-04-16 2020-01-28 Ethicon Llc End effector comprising an anvil including projections extending therefrom
US11883026B2 (en) 2014-04-16 2024-01-30 Cilag Gmbh International Fastener cartridge assemblies and staple retainer cover arrangements
US11266409B2 (en) 2014-04-16 2022-03-08 Cilag Gmbh International Fastener cartridge comprising a sled including longitudinally-staggered ramps
US9833241B2 (en) 2014-04-16 2017-12-05 Ethicon Llc Surgical fastener cartridges with driver stabilizing arrangements
US11382627B2 (en) 2014-04-16 2022-07-12 Cilag Gmbh International Surgical stapling assembly comprising a firing member including a lateral extension
US11596406B2 (en) 2014-04-16 2023-03-07 Cilag Gmbh International Fastener cartridges including extensions having different configurations
US9844369B2 (en) 2014-04-16 2017-12-19 Ethicon Llc Surgical end effectors with firing element monitoring arrangements
US11382625B2 (en) 2014-04-16 2022-07-12 Cilag Gmbh International Fastener cartridge comprising non-uniform fasteners
US11918222B2 (en) 2014-04-16 2024-03-05 Cilag Gmbh International Stapling assembly having firing member viewing windows
US11925353B2 (en) 2014-04-16 2024-03-12 Cilag Gmbh International Surgical stapling instrument comprising internal passage between stapling cartridge and elongate channel
US11185330B2 (en) 2014-04-16 2021-11-30 Cilag Gmbh International Fastener cartridge assemblies and staple retainer cover arrangements
US10327776B2 (en) 2014-04-16 2019-06-25 Ethicon Llc Surgical stapling buttresses and adjunct materials
US10299792B2 (en) 2014-04-16 2019-05-28 Ethicon Llc Fastener cartridge comprising non-uniform fasteners
US10010324B2 (en) 2014-04-16 2018-07-03 Ethicon Llc Fastener cartridge compromising fastener cavities including fastener control features
US10561422B2 (en) 2014-04-16 2020-02-18 Ethicon Llc Fastener cartridge comprising deployable tissue engaging members
US9877721B2 (en) 2014-04-16 2018-01-30 Ethicon Llc Fastener cartridge comprising tissue control features
US11517315B2 (en) 2014-04-16 2022-12-06 Cilag Gmbh International Fastener cartridges including extensions having different configurations
US10485881B2 (en) 2014-05-29 2019-11-26 Memorial Sloan Kettering Cancer Center Nanoparticle drug conjugates
US10111963B2 (en) 2014-05-29 2018-10-30 Memorial Sloan Kettering Cancer Center Nanoparticle drug conjugates
US10045781B2 (en) 2014-06-13 2018-08-14 Ethicon Llc Closure lockout systems for surgical instruments
US10905423B2 (en) 2014-09-05 2021-02-02 Ethicon Llc Smart cartridge wake up operation and data retention
US11406386B2 (en) 2014-09-05 2022-08-09 Cilag Gmbh International End effector including magnetic and impedance sensors
US10135242B2 (en) 2014-09-05 2018-11-20 Ethicon Llc Smart cartridge wake up operation and data retention
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US9757128B2 (en) 2014-09-05 2017-09-12 Ethicon Llc Multiple sensors with one sensor affecting a second sensor's output or interpretation
US10111679B2 (en) 2014-09-05 2018-10-30 Ethicon Llc Circuitry and sensors for powered medical device
US11389162B2 (en) 2014-09-05 2022-07-19 Cilag Gmbh International Smart cartridge wake up operation and data retention
US11071545B2 (en) 2014-09-05 2021-07-27 Cilag Gmbh International Smart cartridge wake up operation and data retention
US9724094B2 (en) 2014-09-05 2017-08-08 Ethicon Llc Adjunct with integrated sensors to quantify tissue compression
US11653918B2 (en) 2014-09-05 2023-05-23 Cilag Gmbh International Local display of tissue parameter stabilization
US10016199B2 (en) 2014-09-05 2018-07-10 Ethicon Llc Polarity of hall magnet to identify cartridge type
US9737301B2 (en) 2014-09-05 2017-08-22 Ethicon Llc Monitoring device degradation based on component evaluation
US11717297B2 (en) 2014-09-05 2023-08-08 Cilag Gmbh International Smart cartridge wake up operation and data retention
US11076854B2 (en) 2014-09-05 2021-08-03 Cilag Gmbh International Smart cartridge wake up operation and data retention
US9788836B2 (en) 2014-09-05 2017-10-17 Ethicon Llc Multiple motor control for powered medical device
US11284898B2 (en) 2014-09-18 2022-03-29 Cilag Gmbh International Surgical instrument including a deployable knife
US10426477B2 (en) 2014-09-26 2019-10-01 Ethicon Llc Staple cartridge assembly including a ramp
US10426476B2 (en) 2014-09-26 2019-10-01 Ethicon Llc Circular fastener cartridges for applying radially expandable fastener lines
US11202633B2 (en) 2014-09-26 2021-12-21 Cilag Gmbh International Surgical stapling buttresses and adjunct materials
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
US9801627B2 (en) 2014-09-26 2017-10-31 Ethicon Llc Fastener cartridge for creating a flexible staple line
US10327764B2 (en) 2014-09-26 2019-06-25 Ethicon Llc Method for creating a flexible staple line
US9801628B2 (en) 2014-09-26 2017-10-31 Ethicon Llc Surgical staple and driver arrangements for staple cartridges
US10206677B2 (en) 2014-09-26 2019-02-19 Ethicon Llc Surgical staple and driver arrangements for staple cartridges
US10751053B2 (en) 2014-09-26 2020-08-25 Ethicon Llc Fastener cartridges for applying expandable fastener lines
US10736630B2 (en) 2014-10-13 2020-08-11 Ethicon Llc Staple cartridge
US10076325B2 (en) 2014-10-13 2018-09-18 Ethicon Llc Surgical stapling apparatus comprising a tissue stop
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US10905418B2 (en) 2014-10-16 2021-02-02 Ethicon Llc Staple cartridge comprising a tissue thickness compensator
US10052104B2 (en) 2014-10-16 2018-08-21 Ethicon Llc Staple cartridge comprising a tissue thickness compensator
US11185325B2 (en) 2014-10-16 2021-11-30 Cilag Gmbh International End effector including different tissue gaps
US11701114B2 (en) 2014-10-16 2023-07-18 Cilag Gmbh International Staple cartridge
US11918210B2 (en) 2014-10-16 2024-03-05 Cilag Gmbh International Staple cartridge comprising a cartridge body including a plurality of wells
US11864760B2 (en) 2014-10-29 2024-01-09 Cilag Gmbh International Staple cartridges comprising driver arrangements
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US11457918B2 (en) 2014-10-29 2022-10-04 Cilag Gmbh International Cartridge assemblies for surgical staplers
US11241229B2 (en) 2014-10-29 2022-02-08 Cilag Gmbh International Staple cartridges comprising driver arrangements
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US11337698B2 (en) 2014-11-06 2022-05-24 Cilag Gmbh International Staple cartridge comprising a releasable adjunct material
US10617417B2 (en) 2014-11-06 2020-04-14 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
US11382628B2 (en) 2014-12-10 2022-07-12 Cilag Gmbh International Articulatable surgical instrument system
US11547404B2 (en) 2014-12-18 2023-01-10 Cilag Gmbh International Surgical instrument assembly comprising a flexible articulation system
US11547403B2 (en) 2014-12-18 2023-01-10 Cilag Gmbh International Surgical instrument having a laminate firing actuator and lateral buckling supports
US10245027B2 (en) 2014-12-18 2019-04-02 Ethicon Llc Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge
US11517311B2 (en) 2014-12-18 2022-12-06 Cilag Gmbh International Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US10117649B2 (en) 2014-12-18 2018-11-06 Ethicon Llc Surgical instrument assembly comprising a lockable articulation system
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US11678877B2 (en) 2014-12-18 2023-06-20 Cilag Gmbh International Surgical instrument including a flexible support configured to support a flexible firing member
US11399831B2 (en) 2014-12-18 2022-08-02 Cilag Gmbh International Drive arrangements for articulatable surgical instruments
US9943309B2 (en) 2014-12-18 2018-04-17 Ethicon Llc Surgical instruments with articulatable end effectors and movable firing beam support arrangements
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US11083453B2 (en) 2014-12-18 2021-08-10 Cilag Gmbh International Surgical stapling system including a flexible firing actuator and lateral buckling supports
US9968355B2 (en) 2014-12-18 2018-05-15 Ethicon Llc Surgical instruments with articulatable end effectors and improved firing beam support arrangements
US10695058B2 (en) 2014-12-18 2020-06-30 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US11812958B2 (en) 2014-12-18 2023-11-14 Cilag Gmbh International Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US10188385B2 (en) 2014-12-18 2019-01-29 Ethicon Llc Surgical instrument system comprising lockable systems
US10806448B2 (en) 2014-12-18 2020-10-20 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US10743873B2 (en) 2014-12-18 2020-08-18 Ethicon Llc Drive arrangements for articulatable surgical instruments
US10945728B2 (en) 2014-12-18 2021-03-16 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US11553911B2 (en) 2014-12-18 2023-01-17 Cilag Gmbh International Surgical instrument assembly comprising a flexible articulation system
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
US10004501B2 (en) 2014-12-18 2018-06-26 Ethicon Llc Surgical instruments with improved closure arrangements
US11571207B2 (en) 2014-12-18 2023-02-07 Cilag Gmbh International Surgical system including lateral supports for a flexible drive member
US11324506B2 (en) 2015-02-27 2022-05-10 Cilag Gmbh International Modular stapling assembly
US10045779B2 (en) 2015-02-27 2018-08-14 Ethicon Llc Surgical instrument system comprising an inspection station
US10159483B2 (en) 2015-02-27 2018-12-25 Ethicon Llc Surgical apparatus configured to track an end-of-life parameter
US9931118B2 (en) 2015-02-27 2018-04-03 Ethicon Endo-Surgery, Llc Reinforced battery for a surgical instrument
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
US10226250B2 (en) 2015-02-27 2019-03-12 Ethicon Llc Modular stapling assembly
US10321907B2 (en) 2015-02-27 2019-06-18 Ethicon Llc System for monitoring whether a surgical instrument needs to be serviced
US10245028B2 (en) 2015-02-27 2019-04-02 Ethicon Llc Power adapter for a surgical instrument
US9993258B2 (en) 2015-02-27 2018-06-12 Ethicon Llc Adaptable surgical instrument handle
US10180463B2 (en) 2015-02-27 2019-01-15 Ethicon Llc Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band
US11744588B2 (en) 2015-02-27 2023-09-05 Cilag Gmbh International Surgical stapling instrument including a removably attachable battery pack
US10182816B2 (en) 2015-02-27 2019-01-22 Ethicon Llc Charging system that enables emergency resolutions for charging a battery
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
US9808246B2 (en) 2015-03-06 2017-11-07 Ethicon Endo-Surgery, Llc Method of operating a powered surgical instrument
US10052044B2 (en) 2015-03-06 2018-08-21 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US10524787B2 (en) 2015-03-06 2020-01-07 Ethicon Llc Powered surgical instrument with parameter-based firing rate
US10617412B2 (en) 2015-03-06 2020-04-14 Ethicon Llc System for detecting the mis-insertion of a staple cartridge into a surgical stapler
US9895148B2 (en) 2015-03-06 2018-02-20 Ethicon Endo-Surgery, Llc Monitoring speed control and precision incrementing of motor for powered surgical instruments
US11224423B2 (en) 2015-03-06 2022-01-18 Cilag Gmbh International Smart sensors with local signal processing
US11109859B2 (en) 2015-03-06 2021-09-07 Cilag Gmbh International Surgical instrument comprising a lockable battery housing
US10687806B2 (en) 2015-03-06 2020-06-23 Ethicon Llc Adaptive tissue compression techniques to adjust closure rates for multiple tissue types
US10966627B2 (en) 2015-03-06 2021-04-06 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US10045776B2 (en) 2015-03-06 2018-08-14 Ethicon Llc Control techniques and sub-processor contained within modular shaft with select control processing from handle
US9901342B2 (en) 2015-03-06 2018-02-27 Ethicon Endo-Surgery, Llc Signal and power communication system positioned on a rotatable shaft
US11426160B2 (en) 2015-03-06 2022-08-30 Cilag Gmbh International Smart sensors with local signal processing
US10206605B2 (en) 2015-03-06 2019-02-19 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US11826132B2 (en) 2015-03-06 2023-11-28 Cilag Gmbh International Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US9924961B2 (en) 2015-03-06 2018-03-27 Ethicon Endo-Surgery, Llc Interactive feedback system for powered surgical instruments
US10531887B2 (en) 2015-03-06 2020-01-14 Ethicon Llc Powered surgical instrument including speed display
US11350843B2 (en) 2015-03-06 2022-06-07 Cilag Gmbh International Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US10729432B2 (en) 2015-03-06 2020-08-04 Ethicon Llc Methods for operating a powered surgical instrument
US10772625B2 (en) 2015-03-06 2020-09-15 Ethicon Llc Signal and power communication system positioned on a rotatable shaft
US10548504B2 (en) 2015-03-06 2020-02-04 Ethicon Llc Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression
US10390825B2 (en) 2015-03-31 2019-08-27 Ethicon Llc Surgical instrument with progressive rotary drive systems
US10213201B2 (en) 2015-03-31 2019-02-26 Ethicon Llc Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw
US11918212B2 (en) 2015-03-31 2024-03-05 Cilag Gmbh International Surgical instrument with selectively disengageable drive systems
US10433844B2 (en) 2015-03-31 2019-10-08 Ethicon Llc Surgical instrument with selectively disengageable threaded drive systems
US10548989B2 (en) * 2015-04-07 2020-02-04 Memorial Sloan Kettering Cancer Center Nanoparticle immunoconjugates
US20200024592A1 (en) * 2015-05-28 2020-01-23 Bioneer Corporation Highly active silica magnetic nanoparticles for purifying biomaterial and preparation method thereof
US10724031B2 (en) * 2015-05-28 2020-07-28 Bioneer Corporation Highly active silica magnetic nanoparticles for purifying biomaterial and preparation method thereof
US10736972B2 (en) 2015-05-29 2020-08-11 Memorial Sloan Kettering Cancer Center Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis
US11246946B2 (en) 2015-05-29 2022-02-15 Memorial Sloan Kettering Cancer Center Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis
US10052102B2 (en) 2015-06-18 2018-08-21 Ethicon Llc Surgical end effectors with dual cam actuated jaw closing features
US20180155564A1 (en) * 2015-06-18 2018-06-07 Sicpa Holding Sa Thermoluminescent and superparamagnetic composite particle and marking comprising same
US11629264B2 (en) * 2015-06-18 2023-04-18 Sicpa Holding Sa Thermoluminescent and superparamagnetic composite particle and marking comprising same
US11058425B2 (en) 2015-08-17 2021-07-13 Ethicon Llc Implantable layers for a surgical instrument
US10617418B2 (en) 2015-08-17 2020-04-14 Ethicon Llc Implantable layers for a surgical instrument
US10835249B2 (en) 2015-08-17 2020-11-17 Ethicon Llc Implantable layers for a surgical instrument
US10357251B2 (en) 2015-08-26 2019-07-23 Ethicon Llc Surgical staples comprising hardness variations for improved fastening of tissue
US10188394B2 (en) 2015-08-26 2019-01-29 Ethicon Llc Staples configured to support an implantable adjunct
US10966724B2 (en) 2015-08-26 2021-04-06 Ethicon Llc Surgical staples comprising a guide
US10166026B2 (en) 2015-08-26 2019-01-01 Ethicon Llc Staple cartridge assembly including features for controlling the rotation of staples when being ejected therefrom
US11103248B2 (en) 2015-08-26 2021-08-31 Cilag Gmbh International Surgical staples for minimizing staple roll
US11219456B2 (en) 2015-08-26 2022-01-11 Cilag Gmbh International Surgical staple strips for permitting varying staple properties and enabling easy cartridge loading
US10433845B2 (en) 2015-08-26 2019-10-08 Ethicon Llc Surgical staple strips for permitting varying staple properties and enabling easy cartridge loading
US10098642B2 (en) 2015-08-26 2018-10-16 Ethicon Llc Surgical staples comprising features for improved fastening of tissue
US10980538B2 (en) 2015-08-26 2021-04-20 Ethicon Llc Surgical stapling configurations for curved and circular stapling instruments
US11510675B2 (en) 2015-08-26 2022-11-29 Cilag Gmbh International Surgical end effector assembly including a connector strip interconnecting a plurality of staples
US10470769B2 (en) 2015-08-26 2019-11-12 Ethicon Llc Staple cartridge assembly comprising staple alignment features on a firing member
US10390829B2 (en) 2015-08-26 2019-08-27 Ethicon Llc Staples comprising a cover
US10213203B2 (en) 2015-08-26 2019-02-26 Ethicon Llc Staple cartridge assembly without a bottom cover
US10517599B2 (en) 2015-08-26 2019-12-31 Ethicon Llc Staple cartridge assembly comprising staple cavities for providing better staple guidance
US11051817B2 (en) 2015-08-26 2021-07-06 Cilag Gmbh International Method for forming a staple against an anvil of a surgical stapling instrument
US11058426B2 (en) 2015-08-26 2021-07-13 Cilag Gmbh International Staple cartridge assembly comprising various tissue compression gaps and staple forming gaps
US10238390B2 (en) 2015-09-02 2019-03-26 Ethicon Llc Surgical staple cartridges with driver arrangements for establishing herringbone staple patterns
US10172619B2 (en) 2015-09-02 2019-01-08 Ethicon Llc Surgical staple driver arrays
US11382624B2 (en) 2015-09-02 2022-07-12 Cilag Gmbh International Surgical staple cartridge with improved staple driver configurations
US10314587B2 (en) 2015-09-02 2019-06-11 Ethicon Llc Surgical staple cartridge with improved staple driver configurations
US11589868B2 (en) 2015-09-02 2023-02-28 Cilag Gmbh International Surgical staple configurations with camming surfaces located between portions supporting surgical staples
US10357252B2 (en) 2015-09-02 2019-07-23 Ethicon Llc Surgical staple configurations with camming surfaces located between portions supporting surgical staples
US10251648B2 (en) 2015-09-02 2019-04-09 Ethicon Llc Surgical staple cartridge staple drivers with central support features
US11213295B2 (en) 2015-09-02 2022-01-04 Cilag Gmbh International Surgical staple configurations with camming surfaces located between portions supporting surgical staples
US10085751B2 (en) 2015-09-23 2018-10-02 Ethicon Llc Surgical stapler having temperature-based motor control
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US11026678B2 (en) 2015-09-23 2021-06-08 Cilag Gmbh International Surgical stapler having motor control based on an electrical parameter related to a motor current
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10076326B2 (en) 2015-09-23 2018-09-18 Ethicon Llc Surgical stapler having current mirror-based motor control
US10863986B2 (en) 2015-09-23 2020-12-15 Ethicon Llc Surgical stapler having downstream current-based motor control
US10363036B2 (en) 2015-09-23 2019-07-30 Ethicon Llc Surgical stapler having force-based motor control
US11490889B2 (en) 2015-09-23 2022-11-08 Cilag Gmbh International Surgical stapler having motor control based on an electrical parameter related to a motor current
US11849946B2 (en) 2015-09-23 2023-12-26 Cilag Gmbh International Surgical stapler having downstream current-based motor control
US11344299B2 (en) 2015-09-23 2022-05-31 Cilag Gmbh International Surgical stapler having downstream current-based motor control
US10327769B2 (en) 2015-09-23 2019-06-25 Ethicon Llc Surgical stapler having motor control based on a drive system component
US11076929B2 (en) 2015-09-25 2021-08-03 Cilag Gmbh International Implantable adjunct systems for determining adjunct skew
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
US10561420B2 (en) 2015-09-30 2020-02-18 Ethicon Llc Tubular absorbable constructs
US11712244B2 (en) 2015-09-30 2023-08-01 Cilag Gmbh International Implantable layer with spacer fibers
US10433846B2 (en) 2015-09-30 2019-10-08 Ethicon Llc Compressible adjunct with crossing spacer fibers
US10327777B2 (en) 2015-09-30 2019-06-25 Ethicon Llc Implantable layer comprising plastically deformed fibers
US10932779B2 (en) 2015-09-30 2021-03-02 Ethicon Llc Compressible adjunct with crossing spacer fibers
US10271849B2 (en) 2015-09-30 2019-04-30 Ethicon Llc Woven constructs with interlocked standing fibers
US10736633B2 (en) 2015-09-30 2020-08-11 Ethicon Llc Compressible adjunct with looping members
US10478188B2 (en) 2015-09-30 2019-11-19 Ethicon Llc Implantable layer comprising a constricted configuration
US10172620B2 (en) 2015-09-30 2019-01-08 Ethicon Llc Compressible adjuncts with bonding nodes
US11890015B2 (en) 2015-09-30 2024-02-06 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10307160B2 (en) 2015-09-30 2019-06-04 Ethicon Llc Compressible adjunct assemblies with attachment layers
US10285699B2 (en) 2015-09-30 2019-05-14 Ethicon Llc Compressible adjunct
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
US11553916B2 (en) 2015-09-30 2023-01-17 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US11690623B2 (en) 2015-09-30 2023-07-04 Cilag Gmbh International Method for applying an implantable layer to a fastener cartridge
US11903586B2 (en) 2015-09-30 2024-02-20 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10603039B2 (en) 2015-09-30 2020-03-31 Ethicon Llc Progressively releasable implantable adjunct for use with a surgical stapling instrument
US10524788B2 (en) 2015-09-30 2020-01-07 Ethicon Llc Compressible adjunct with attachment regions
US11793522B2 (en) 2015-09-30 2023-10-24 Cilag Gmbh International Staple cartridge assembly including a compressible adjunct
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
US11083454B2 (en) 2015-12-30 2021-08-10 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11484309B2 (en) 2015-12-30 2022-11-01 Cilag Gmbh International Surgical stapling system comprising a controller configured to cause a motor to reset a firing sequence
US11759208B2 (en) 2015-12-30 2023-09-19 Cilag Gmbh International Mechanisms for compensating for battery pack failure in powered surgical instruments
US11129613B2 (en) 2015-12-30 2021-09-28 Cilag Gmbh International Surgical instruments with separable motors and motor control circuits
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US11058422B2 (en) 2015-12-30 2021-07-13 Cilag Gmbh International Mechanisms for compensating for battery pack failure in powered surgical instruments
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US10413291B2 (en) 2016-02-09 2019-09-17 Ethicon Llc Surgical instrument articulation mechanism with slotted secondary constraint
US10245030B2 (en) 2016-02-09 2019-04-02 Ethicon Llc Surgical instruments with tensioning arrangements for cable driven articulation systems
US11523823B2 (en) 2016-02-09 2022-12-13 Cilag Gmbh International Surgical instruments with non-symmetrical articulation arrangements
US10470764B2 (en) 2016-02-09 2019-11-12 Ethicon Llc Surgical instruments with closure stroke reduction arrangements
US10433837B2 (en) 2016-02-09 2019-10-08 Ethicon Llc Surgical instruments with multiple link articulation arrangements
US11730471B2 (en) 2016-02-09 2023-08-22 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US10588625B2 (en) 2016-02-09 2020-03-17 Ethicon Llc Articulatable surgical instruments with off-axis firing beam arrangements
US10653413B2 (en) 2016-02-09 2020-05-19 Ethicon Llc Surgical instruments with an end effector that is highly articulatable relative to an elongate shaft assembly
US10245029B2 (en) 2016-02-09 2019-04-02 Ethicon Llc Surgical instrument with articulating and axially translatable end effector
US11779336B2 (en) 2016-02-12 2023-10-10 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11826045B2 (en) 2016-02-12 2023-11-28 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10258331B2 (en) 2016-02-12 2019-04-16 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11344303B2 (en) 2016-02-12 2022-05-31 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10617413B2 (en) 2016-04-01 2020-04-14 Ethicon Llc Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts
US10376263B2 (en) 2016-04-01 2019-08-13 Ethicon Llc Anvil modification members for surgical staplers
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
US11771454B2 (en) 2016-04-15 2023-10-03 Cilag Gmbh International Stapling assembly including a controller for monitoring a clamping laod
US11026684B2 (en) 2016-04-15 2021-06-08 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US11311292B2 (en) 2016-04-15 2022-04-26 Cilag Gmbh International Surgical instrument with detection sensors
US11284891B2 (en) 2016-04-15 2022-03-29 Cilag Gmbh International Surgical instrument with multiple program responses during a firing motion
US11517306B2 (en) 2016-04-15 2022-12-06 Cilag Gmbh International Surgical instrument with detection sensors
US11350932B2 (en) 2016-04-15 2022-06-07 Cilag Gmbh International Surgical instrument with improved stop/start control during a firing motion
US10405859B2 (en) 2016-04-15 2019-09-10 Ethicon Llc Surgical instrument with adjustable stop/start control during a firing motion
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US11317910B2 (en) 2016-04-15 2022-05-03 Cilag Gmbh International Surgical instrument with detection sensors
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US11642125B2 (en) 2016-04-15 2023-05-09 Cilag Gmbh International Robotic surgical system including a user interface and a control circuit
US11051810B2 (en) 2016-04-15 2021-07-06 Cilag Gmbh International Modular surgical instrument with configurable operating mode
US11191545B2 (en) 2016-04-15 2021-12-07 Cilag Gmbh International Staple formation detection mechanisms
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US11147554B2 (en) 2016-04-18 2021-10-19 Cilag Gmbh International Surgical instrument system comprising a magnetic lockout
US10426469B2 (en) 2016-04-18 2019-10-01 Ethicon Llc Surgical instrument comprising a primary firing lockout and a secondary firing lockout
US11350928B2 (en) 2016-04-18 2022-06-07 Cilag Gmbh International Surgical instrument comprising a tissue thickness lockout and speed control system
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
US10368867B2 (en) 2016-04-18 2019-08-06 Ethicon Llc Surgical instrument comprising a lockout
US10478181B2 (en) 2016-04-18 2019-11-19 Ethicon Llc Cartridge lockout arrangements for rotary powered surgical cutting and stapling instruments
US10433840B2 (en) 2016-04-18 2019-10-08 Ethicon Llc Surgical instrument comprising a replaceable cartridge jaw
US11811253B2 (en) 2016-04-18 2023-11-07 Cilag Gmbh International Surgical robotic system with fault state detection configurations based on motor current draw
US11559303B2 (en) 2016-04-18 2023-01-24 Cilag Gmbh International Cartridge lockout arrangements for rotary powered surgical cutting and stapling instruments
US10363037B2 (en) 2016-04-18 2019-07-30 Ethicon Llc Surgical instrument system comprising a magnetic lockout
JP2019525379A (en) * 2016-06-06 2019-09-05 ダウ グローバル テクノロジーズ エルエルシー LIGHT EMITTING DEVICE AND ELECTRONIC DEVICE EQUIPPED WITH THE SAME
WO2017210754A1 (en) * 2016-06-10 2017-12-14 The University Of Queensland Detecting an analyte
US11867699B2 (en) 2016-06-10 2024-01-09 The University Of Queensland Detecting an analyte
CN109564218A (en) * 2016-06-10 2019-04-02 昆士兰大学 Test and analyze object
US10893863B2 (en) 2016-06-24 2021-01-19 Ethicon Llc Staple cartridge comprising offset longitudinal staple rows
US10675024B2 (en) 2016-06-24 2020-06-09 Ethicon Llc Staple cartridge comprising overdriven staples
US11786246B2 (en) 2016-06-24 2023-10-17 Cilag Gmbh International Stapling system for use with wire staples and stamped staples
US11000278B2 (en) 2016-06-24 2021-05-11 Ethicon Llc Staple cartridge comprising wire staples and stamped staples
US11690619B2 (en) 2016-06-24 2023-07-04 Cilag Gmbh International Staple cartridge comprising staples having different geometries
USD948043S1 (en) 2016-06-24 2022-04-05 Cilag Gmbh International Surgical fastener
US10702270B2 (en) 2016-06-24 2020-07-07 Ethicon Llc Stapling system for use with wire staples and stamped staples
US10542979B2 (en) 2016-06-24 2020-01-28 Ethicon Llc Stamped staples and staple cartridges using the same
USD847989S1 (en) 2016-06-24 2019-05-07 Ethicon Llc Surgical fastener cartridge
USD894389S1 (en) 2016-06-24 2020-08-25 Ethicon Llc Surgical fastener
USD850617S1 (en) 2016-06-24 2019-06-04 Ethicon Llc Surgical fastener cartridge
USD896380S1 (en) 2016-06-24 2020-09-15 Ethicon Llc Surgical fastener cartridge
USD896379S1 (en) 2016-06-24 2020-09-15 Ethicon Llc Surgical fastener cartridge
WO2018005595A1 (en) * 2016-06-28 2018-01-04 The Trustees Of The University Of Pennsylvania Superoleophobic membranes for oil/water separation
US10843139B2 (en) 2016-06-28 2020-11-24 The Trustees Of The University Of Pennsylvania Superoleophobic membranes for oil/water separation
WO2018060722A1 (en) * 2016-09-30 2018-04-05 Sumitomo Chemical Company Limited Composite particle
US11766260B2 (en) 2016-12-21 2023-09-26 Cilag Gmbh International Methods of stapling tissue
US10499914B2 (en) 2016-12-21 2019-12-10 Ethicon Llc Staple forming pocket arrangements
US11096689B2 (en) 2016-12-21 2021-08-24 Cilag Gmbh International Shaft assembly comprising a lockout
US11090048B2 (en) 2016-12-21 2021-08-17 Cilag Gmbh International Method for resetting a fuse of a surgical instrument shaft
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
US10835245B2 (en) 2016-12-21 2020-11-17 Ethicon Llc Method for attaching a shaft assembly to a surgical instrument and, alternatively, to a surgical robot
US11369376B2 (en) 2016-12-21 2022-06-28 Cilag Gmbh International Surgical stapling systems
US11918215B2 (en) 2016-12-21 2024-03-05 Cilag Gmbh International Staple cartridge with array of staple pockets
US10835247B2 (en) 2016-12-21 2020-11-17 Ethicon Llc Lockout arrangements for surgical end effectors
US11160551B2 (en) 2016-12-21 2021-11-02 Cilag Gmbh International Articulatable surgical stapling instruments
US11160553B2 (en) 2016-12-21 2021-11-02 Cilag Gmbh International Surgical stapling systems
US10856868B2 (en) 2016-12-21 2020-12-08 Ethicon Llc Firing member pin configurations
US10813638B2 (en) 2016-12-21 2020-10-27 Ethicon Llc Surgical end effectors with expandable tissue stop arrangements
US11179155B2 (en) 2016-12-21 2021-11-23 Cilag Gmbh International Anvil arrangements for surgical staplers
US11849948B2 (en) 2016-12-21 2023-12-26 Cilag Gmbh International Method for resetting a fuse of a surgical instrument shaft
US11191543B2 (en) 2016-12-21 2021-12-07 Cilag Gmbh International Assembly comprising a lock
US11191539B2 (en) 2016-12-21 2021-12-07 Cilag Gmbh International Shaft assembly comprising a manually-operable retraction system for use with a motorized surgical instrument system
US11191540B2 (en) 2016-12-21 2021-12-07 Cilag Gmbh International Protective cover arrangements for a joint interface between a movable jaw and actuator shaft of a surgical instrument
US10779823B2 (en) 2016-12-21 2020-09-22 Ethicon Llc Firing member pin angle
US11000276B2 (en) 2016-12-21 2021-05-11 Ethicon Llc Stepped staple cartridge with asymmetrical staples
US10993715B2 (en) 2016-12-21 2021-05-04 Ethicon Llc Staple cartridge comprising staples with different clamping breadths
US10980536B2 (en) 2016-12-21 2021-04-20 Ethicon Llc No-cartridge and spent cartridge lockout arrangements for surgical staplers
US11224428B2 (en) 2016-12-21 2022-01-18 Cilag Gmbh International Surgical stapling systems
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
US10973516B2 (en) 2016-12-21 2021-04-13 Ethicon Llc Surgical end effectors and adaptable firing members therefor
US11766259B2 (en) 2016-12-21 2023-09-26 Cilag Gmbh International Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
US10426471B2 (en) 2016-12-21 2019-10-01 Ethicon Llc Surgical instrument with multiple failure response modes
US10959727B2 (en) 2016-12-21 2021-03-30 Ethicon Llc Articulatable surgical end effector with asymmetric shaft arrangement
US10945727B2 (en) 2016-12-21 2021-03-16 Ethicon Llc Staple cartridge with deformable driver retention features
US10448950B2 (en) 2016-12-21 2019-10-22 Ethicon Llc Surgical staplers with independently actuatable closing and firing systems
US10918385B2 (en) 2016-12-21 2021-02-16 Ethicon Llc Surgical system comprising a firing member rotatable into an articulation state to articulate an end effector of the surgical system
US10905422B2 (en) 2016-12-21 2021-02-02 Ethicon Llc Surgical instrument for use with a robotic surgical system
US10898186B2 (en) 2016-12-21 2021-01-26 Ethicon Llc Staple forming pocket arrangements comprising primary sidewalls and pocket sidewalls
US10485543B2 (en) 2016-12-21 2019-11-26 Ethicon Llc Anvil having a knife slot width
US11701115B2 (en) 2016-12-21 2023-07-18 Cilag Gmbh International Methods of stapling tissue
US10492785B2 (en) 2016-12-21 2019-12-03 Ethicon Llc Shaft assembly comprising a lockout
US10517595B2 (en) 2016-12-21 2019-12-31 Ethicon Llc Jaw actuated lock arrangements for preventing advancement of a firing member in a surgical end effector unless an unfired cartridge is installed in the end effector
US11684367B2 (en) 2016-12-21 2023-06-27 Cilag Gmbh International Stepped assembly having and end-of-life indicator
US10517596B2 (en) 2016-12-21 2019-12-31 Ethicon Llc Articulatable surgical instruments with articulation stroke amplification features
US10524789B2 (en) 2016-12-21 2020-01-07 Ethicon Llc Laterally actuatable articulation lock arrangements for locking an end effector of a surgical instrument in an articulated configuration
US10537325B2 (en) 2016-12-21 2020-01-21 Ethicon Llc Staple forming pocket arrangement to accommodate different types of staples
US10537324B2 (en) 2016-12-21 2020-01-21 Ethicon Llc Stepped staple cartridge with asymmetrical staples
US10542982B2 (en) 2016-12-21 2020-01-28 Ethicon Llc Shaft assembly comprising first and second articulation lockouts
US10893864B2 (en) 2016-12-21 2021-01-19 Ethicon Staple cartridges and arrangements of staples and staple cavities therein
US11653917B2 (en) 2016-12-21 2023-05-23 Cilag Gmbh International Surgical stapling systems
US10568626B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaw opening features for increasing a jaw opening distance
US10568625B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Staple cartridges and arrangements of staples and staple cavities therein
US10568624B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaws that are pivotable about a fixed axis and include separate and distinct closure and firing systems
US10758229B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument comprising improved jaw control
US10758230B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument with primary and safety processors
US10582928B2 (en) 2016-12-21 2020-03-10 Ethicon Llc Articulation lock arrangements for locking an end effector in an articulated position in response to actuation of a jaw closure system
US10588632B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical end effectors and firing members thereof
US11350934B2 (en) 2016-12-21 2022-06-07 Cilag Gmbh International Staple forming pocket arrangement to accommodate different types of staples
US11497499B2 (en) 2016-12-21 2022-11-15 Cilag Gmbh International Articulatable surgical stapling instruments
US10588630B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical tool assemblies with closure stroke reduction features
US10588631B2 (en) 2016-12-21 2020-03-17 Ethicon Llc Surgical instruments with positive jaw opening features
US10888322B2 (en) 2016-12-21 2021-01-12 Ethicon Llc Surgical instrument comprising a cutting member
US10603036B2 (en) 2016-12-21 2020-03-31 Ethicon Llc Articulatable surgical instrument with independent pivotable linkage distal of an articulation lock
US10610224B2 (en) 2016-12-21 2020-04-07 Ethicon Llc Lockout arrangements for surgical end effectors and replaceable tool assemblies
US10617414B2 (en) 2016-12-21 2020-04-14 Ethicon Llc Closure member arrangements for surgical instruments
US10736629B2 (en) 2016-12-21 2020-08-11 Ethicon Llc Surgical tool assemblies with clutching arrangements for shifting between closure systems with closure stroke reduction features and articulation and firing systems
US10624635B2 (en) 2016-12-21 2020-04-21 Ethicon Llc Firing members with non-parallel jaw engagement features for surgical end effectors
US11350935B2 (en) 2016-12-21 2022-06-07 Cilag Gmbh International Surgical tool assemblies with closure stroke reduction features
US11317913B2 (en) 2016-12-21 2022-05-03 Cilag Gmbh International Lockout arrangements for surgical end effectors and replaceable tool assemblies
US10639034B2 (en) 2016-12-21 2020-05-05 Ethicon Llc Surgical instruments with lockout arrangements for preventing firing system actuation unless an unspent staple cartridge is present
US10639035B2 (en) 2016-12-21 2020-05-05 Ethicon Llc Surgical stapling instruments and replaceable tool assemblies thereof
US10667809B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Staple cartridge and staple cartridge channel comprising windows defined therein
US10667810B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Closure members with cam surface arrangements for surgical instruments with separate and distinct closure and firing systems
US10667811B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Surgical stapling instruments and staple-forming anvils
US11571210B2 (en) 2016-12-21 2023-02-07 Cilag Gmbh International Firing assembly comprising a multiple failed-state fuse
US11564688B2 (en) 2016-12-21 2023-01-31 Cilag Gmbh International Robotic surgical tool having a retraction mechanism
US10675026B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Methods of stapling tissue
US10675025B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Shaft assembly comprising separately actuatable and retractable systems
US10682138B2 (en) 2016-12-21 2020-06-16 Ethicon Llc Bilaterally asymmetric staple forming pocket pairs
US10687810B2 (en) 2016-12-21 2020-06-23 Ethicon Llc Stepped staple cartridge with tissue retention and gap setting features
US10881401B2 (en) 2016-12-21 2021-01-05 Ethicon Llc Staple firing member comprising a missing cartridge and/or spent cartridge lockout
US10687809B2 (en) 2016-12-21 2020-06-23 Ethicon Llc Surgical staple cartridge with movable camming member configured to disengage firing member lockout features
US10695055B2 (en) 2016-12-21 2020-06-30 Ethicon Llc Firing assembly comprising a lockout
US11559591B2 (en) 2017-05-25 2023-01-24 Memorial Sloan Kettering Cancer Center Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof
US10624633B2 (en) 2017-06-20 2020-04-21 Ethicon Llc Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US11871939B2 (en) 2017-06-20 2024-01-16 Cilag Gmbh International Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10595882B2 (en) 2017-06-20 2020-03-24 Ethicon Llc Methods for closed loop control of motor velocity of a surgical stapling and cutting instrument
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
USD879809S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with changeable graphical user interface
USD879808S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
US10888321B2 (en) 2017-06-20 2021-01-12 Ethicon Llc Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument
US11793513B2 (en) 2017-06-20 2023-10-24 Cilag Gmbh International Systems and methods for controlling motor speed according to user input for a surgical instrument
US10646220B2 (en) 2017-06-20 2020-05-12 Ethicon Llc Systems and methods for controlling displacement member velocity for a surgical instrument
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US11672532B2 (en) 2017-06-20 2023-06-13 Cilag Gmbh International Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US10980537B2 (en) 2017-06-20 2021-04-20 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10813639B2 (en) 2017-06-20 2020-10-27 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions
US10390841B2 (en) 2017-06-20 2019-08-27 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US10368864B2 (en) 2017-06-20 2019-08-06 Ethicon Llc Systems and methods for controlling displaying motor velocity for a surgical instrument
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
USD890784S1 (en) 2017-06-20 2020-07-21 Ethicon Llc Display panel with changeable graphical user interface
US11213302B2 (en) 2017-06-20 2022-01-04 Cilag Gmbh International Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10327767B2 (en) 2017-06-20 2019-06-25 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US10881396B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Surgical instrument with variable duration trigger arrangement
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US10631859B2 (en) 2017-06-27 2020-04-28 Ethicon Llc Articulation systems for surgical instruments
US10856869B2 (en) 2017-06-27 2020-12-08 Ethicon Llc Surgical anvil arrangements
US11090049B2 (en) 2017-06-27 2021-08-17 Cilag Gmbh International Staple forming pocket arrangements
US10772629B2 (en) 2017-06-27 2020-09-15 Ethicon Llc Surgical anvil arrangements
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US11766258B2 (en) 2017-06-27 2023-09-26 Cilag Gmbh International Surgical anvil arrangements
US11141154B2 (en) 2017-06-27 2021-10-12 Cilag Gmbh International Surgical end effectors and anvils
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
USD851762S1 (en) 2017-06-28 2019-06-18 Ethicon Llc Anvil
US11000279B2 (en) 2017-06-28 2021-05-11 Ethicon Llc Surgical instrument comprising an articulation system ratio
US10779824B2 (en) 2017-06-28 2020-09-22 Ethicon Llc Surgical instrument comprising an articulation system lockable by a closure system
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
US11020114B2 (en) 2017-06-28 2021-06-01 Cilag Gmbh International Surgical instruments with articulatable end effector with axially shortened articulation joint configurations
US11058424B2 (en) 2017-06-28 2021-07-13 Cilag Gmbh International Surgical instrument comprising an offset articulation joint
US10211586B2 (en) 2017-06-28 2019-02-19 Ethicon Llc Surgical shaft assemblies with watertight housings
US10786253B2 (en) 2017-06-28 2020-09-29 Ethicon Llc Surgical end effectors with improved jaw aperture arrangements
US11389161B2 (en) 2017-06-28 2022-07-19 Cilag Gmbh International Surgical instrument comprising selectively actuatable rotatable couplers
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
US10639037B2 (en) 2017-06-28 2020-05-05 Ethicon Llc Surgical instrument with axially movable closure member
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US11642128B2 (en) 2017-06-28 2023-05-09 Cilag Gmbh International Method for articulating a surgical instrument
US10903685B2 (en) 2017-06-28 2021-01-26 Ethicon Llc Surgical shaft assemblies with slip ring assemblies forming capacitive channels
US11529140B2 (en) 2017-06-28 2022-12-20 Cilag Gmbh International Surgical instrument lockout arrangement
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
US11083455B2 (en) 2017-06-28 2021-08-10 Cilag Gmbh International Surgical instrument comprising an articulation system ratio
US11826048B2 (en) 2017-06-28 2023-11-28 Cilag Gmbh International Surgical instrument comprising selectively actuatable rotatable couplers
US10588633B2 (en) 2017-06-28 2020-03-17 Ethicon Llc Surgical instruments with open and closable jaws and axially movable firing member that is initially parked in close proximity to the jaws prior to firing
US11696759B2 (en) 2017-06-28 2023-07-11 Cilag Gmbh International Surgical stapling instruments comprising shortened staple cartridge noses
USD869655S1 (en) 2017-06-28 2019-12-10 Ethicon Llc Surgical fastener cartridge
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
US11678880B2 (en) 2017-06-28 2023-06-20 Cilag Gmbh International Surgical instrument comprising a shaft including a housing arrangement
US10716614B2 (en) 2017-06-28 2020-07-21 Ethicon Llc Surgical shaft assemblies with slip ring assemblies with increased contact pressure
US10758232B2 (en) 2017-06-28 2020-09-01 Ethicon Llc Surgical instrument with positive jaw opening features
US10695057B2 (en) 2017-06-28 2020-06-30 Ethicon Llc Surgical instrument lockout arrangement
US11478242B2 (en) 2017-06-28 2022-10-25 Cilag Gmbh International Jaw retainer arrangement for retaining a pivotable surgical instrument jaw in pivotable retaining engagement with a second surgical instrument jaw
US11484310B2 (en) 2017-06-28 2022-11-01 Cilag Gmbh International Surgical instrument comprising a shaft including a closure tube profile
USD854151S1 (en) 2017-06-28 2019-07-16 Ethicon Llc Surgical instrument shaft
US11007022B2 (en) 2017-06-29 2021-05-18 Ethicon Llc Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US10898183B2 (en) 2017-06-29 2021-01-26 Ethicon Llc Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing
US10398434B2 (en) 2017-06-29 2019-09-03 Ethicon Llc Closed loop velocity control of closure member for robotic surgical instrument
US10258418B2 (en) 2017-06-29 2019-04-16 Ethicon Llc System for controlling articulation forces
US11890005B2 (en) 2017-06-29 2024-02-06 Cilag Gmbh International Methods for closed loop velocity control for robotic surgical instrument
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US10796471B2 (en) 2017-09-29 2020-10-06 Ethicon Llc Systems and methods of displaying a knife position for a surgical instrument
US10765429B2 (en) 2017-09-29 2020-09-08 Ethicon Llc Systems and methods for providing alerts according to the operational state of a surgical instrument
USD907647S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
USD907648S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US10743872B2 (en) 2017-09-29 2020-08-18 Ethicon Llc System and methods for controlling a display of a surgical instrument
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
USD917500S1 (en) 2017-09-29 2021-04-27 Ethicon Llc Display screen or portion thereof with graphical user interface
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US11478244B2 (en) 2017-10-31 2022-10-25 Cilag Gmbh International Cartridge body design with force reduction based on firing completion
US10779903B2 (en) 2017-10-31 2020-09-22 Ethicon Llc Positive shaft rotation lock activated by jaw closure
US10828033B2 (en) 2017-12-15 2020-11-10 Ethicon Llc Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto
US10743875B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member
US10869666B2 (en) 2017-12-15 2020-12-22 Ethicon Llc Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument
US10743874B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Sealed adapters for use with electromechanical surgical instruments
US11033267B2 (en) 2017-12-15 2021-06-15 Ethicon Llc Systems and methods of controlling a clamping member firing rate of a surgical instrument
US10966718B2 (en) 2017-12-15 2021-04-06 Ethicon Llc Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US11006955B2 (en) 2017-12-15 2021-05-18 Ethicon Llc End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US10687813B2 (en) 2017-12-15 2020-06-23 Ethicon Llc Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments
US11896222B2 (en) 2017-12-15 2024-02-13 Cilag Gmbh International Methods of operating surgical end effectors
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US10779825B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments
US11045270B2 (en) 2017-12-19 2021-06-29 Cilag Gmbh International Robotic attachment comprising exterior drive actuator
US11020112B2 (en) 2017-12-19 2021-06-01 Ethicon Llc Surgical tools configured for interchangeable use with different controller interfaces
US11284953B2 (en) 2017-12-19 2022-03-29 Cilag Gmbh International Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US10729509B2 (en) 2017-12-19 2020-08-04 Ethicon Llc Surgical instrument comprising closure and firing locking mechanism
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
USD910847S1 (en) 2017-12-19 2021-02-16 Ethicon Llc Surgical instrument assembly
WO2019123156A1 (en) * 2017-12-19 2019-06-27 3M Innovative Properties Company Compositions and methods to detect microorganisms
US10716565B2 (en) 2017-12-19 2020-07-21 Ethicon Llc Surgical instruments with dual articulation drivers
US11583274B2 (en) 2017-12-21 2023-02-21 Cilag Gmbh International Self-guiding stapling instrument
US10682134B2 (en) 2017-12-21 2020-06-16 Ethicon Llc Continuous use self-propelled stapling instrument
US11364027B2 (en) 2017-12-21 2022-06-21 Cilag Gmbh International Surgical instrument comprising speed control
US11337691B2 (en) 2017-12-21 2022-05-24 Cilag Gmbh International Surgical instrument configured to determine firing path
US11179152B2 (en) 2017-12-21 2021-11-23 Cilag Gmbh International Surgical instrument comprising a tissue grasping system
US11576668B2 (en) 2017-12-21 2023-02-14 Cilag Gmbh International Staple instrument comprising a firing path display
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
US11179151B2 (en) 2017-12-21 2021-11-23 Cilag Gmbh International Surgical instrument comprising a display
US11883019B2 (en) 2017-12-21 2024-01-30 Cilag Gmbh International Stapling instrument comprising a staple feeding system
US11849939B2 (en) 2017-12-21 2023-12-26 Cilag Gmbh International Continuous use self-propelled stapling instrument
US10743868B2 (en) 2017-12-21 2020-08-18 Ethicon Llc Surgical instrument comprising a pivotable distal head
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
US11751867B2 (en) 2017-12-21 2023-09-12 Cilag Gmbh International Surgical instrument comprising sequenced systems
US11369368B2 (en) 2017-12-21 2022-06-28 Cilag Gmbh International Surgical instrument comprising synchronized drive systems
US11129680B2 (en) 2017-12-21 2021-09-28 Cilag Gmbh International Surgical instrument comprising a projector
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
US10842492B2 (en) 2018-08-20 2020-11-24 Ethicon Llc Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US10779821B2 (en) 2018-08-20 2020-09-22 Ethicon Llc Surgical stapler anvils with tissue stop features configured to avoid tissue pinch
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
US10912559B2 (en) 2018-08-20 2021-02-09 Ethicon Llc Reinforced deformable anvil tip for surgical stapler anvil
US10856870B2 (en) 2018-08-20 2020-12-08 Ethicon Llc Switching arrangements for motor powered articulatable surgical instruments
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
USD914878S1 (en) 2018-08-20 2021-03-30 Ethicon Llc Surgical instrument anvil
US11931032B2 (en) 2018-12-28 2024-03-19 Cilag Gmbh International Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11350938B2 (en) 2019-06-28 2022-06-07 Cilag Gmbh International Surgical instrument comprising an aligned rfid sensor
US11241235B2 (en) 2019-06-28 2022-02-08 Cilag Gmbh International Method of using multiple RFID chips with a surgical assembly
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11229437B2 (en) 2019-06-28 2022-01-25 Cilag Gmbh International Method for authenticating the compatibility of a staple cartridge with a surgical instrument
US11553919B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Method for authenticating the compatibility of a staple cartridge with a surgical instrument
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
US11744593B2 (en) 2019-06-28 2023-09-05 Cilag Gmbh International Method for authenticating the compatibility of a staple cartridge with a surgical instrument
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11684369B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Method of using multiple RFID chips with a surgical assembly
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11931033B2 (en) 2019-12-19 2024-03-19 Cilag Gmbh International Staple cartridge comprising a latch lockout
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
WO2021173629A3 (en) * 2020-02-28 2021-11-04 NanoBio Designs, LLC Molecular detection via assembly of particle complexes
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
US11883024B2 (en) 2020-07-28 2024-01-30 Cilag Gmbh International Method of operating a surgical instrument
US11864756B2 (en) 2020-07-28 2024-01-09 Cilag Gmbh International Surgical instruments with flexible ball chain drive arrangements
US11638582B2 (en) 2020-07-28 2023-05-02 Cilag Gmbh International Surgical instruments with torsion spine drive arrangements
US11826013B2 (en) 2020-07-28 2023-11-28 Cilag Gmbh International Surgical instruments with firing member closure features
US11857182B2 (en) 2020-07-28 2024-01-02 Cilag Gmbh International Surgical instruments with combination function articulation joint arrangements
US11660090B2 (en) 2020-07-28 2023-05-30 Cllag GmbH International Surgical instruments with segmented flexible drive arrangements
US11871925B2 (en) 2020-07-28 2024-01-16 Cilag Gmbh International Surgical instruments with dual spherical articulation joint arrangements
US11737748B2 (en) 2020-07-28 2023-08-29 Cilag Gmbh International Surgical instruments with double spherical articulation joints with pivotable links
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
US11931025B2 (en) 2020-10-29 2024-03-19 Cilag Gmbh International Surgical instrument comprising a releasable closure drive lock
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
USD1018577S1 (en) 2020-11-11 2024-03-19 Cilag Gmbh International Display screen or portion thereof with a graphical user interface for a surgical instrument
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11931034B2 (en) 2021-01-12 2024-03-19 Cilag Gmbh International Surgical stapling instruments with smart staple cartridges
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11925349B2 (en) 2021-02-26 2024-03-12 Cilag Gmbh International Adjustment to transfer parameters to improve available power
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11918217B2 (en) 2021-05-28 2024-03-05 Cilag Gmbh International Stapling instrument comprising a staple cartridge insertion stop
US11826047B2 (en) 2021-05-28 2023-11-28 Cilag Gmbh International Stapling instrument comprising jaw mounts
US11723662B2 (en) 2021-05-28 2023-08-15 Cilag Gmbh International Stapling instrument comprising an articulation control display
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters
US11931425B2 (en) 2021-12-30 2024-03-19 Memorial Sloan Kettering Cancer Center Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis
US11931028B2 (en) 2022-02-03 2024-03-19 Cilag Gmbh International Surgical instrument with multiple program responses during a firing motion
US11931031B2 (en) 2022-05-27 2024-03-19 Cilag Gmbh International Staple cartridge comprising a deck including an upper surface and a lower surface
US11931038B2 (en) 2022-10-03 2024-03-19 Cilag Gmbh International Cartridge assemblies for surgical staplers

Also Published As

Publication number Publication date
AU2003303309A1 (en) 2004-08-10
CN1742094A (en) 2006-03-01
US8298677B2 (en) 2012-10-30
EP1604031B1 (en) 2017-05-03
WO2004063387A3 (en) 2005-09-22
JP2014133893A (en) 2014-07-24
WO2004063387A2 (en) 2004-07-29
JP2006517985A (en) 2006-08-03
ES2709398T3 (en) 2019-04-16
CN101387639A (en) 2009-03-18
EP1604031A4 (en) 2008-08-20
WO2004074504A2 (en) 2004-09-02
EP2369342A2 (en) 2011-09-28
EP1604031A2 (en) 2005-12-14
EP2369342B1 (en) 2019-08-28
JP2010070768A (en) 2010-04-02
JP2006514708A (en) 2006-05-11
AU2003303309B2 (en) 2009-04-23
CN1767941A (en) 2006-05-03
JP2011052228A (en) 2011-03-17
EP1572445B1 (en) 2019-01-09
AU2003303290A1 (en) 2004-09-09
KR20050109455A (en) 2005-11-21
WO2004074504A3 (en) 2004-12-02
KR20050103186A (en) 2005-10-27
JP4965804B2 (en) 2012-07-04
CN100443295C (en) 2008-12-17
US20100035365A1 (en) 2010-02-11
US8409876B2 (en) 2013-04-02
US20060183246A1 (en) 2006-08-17
EP2369342A3 (en) 2011-10-19
EP1572445A4 (en) 2008-10-22
ES2753144T3 (en) 2020-04-07
EP1572445A2 (en) 2005-09-14
EP2364840A1 (en) 2011-09-14

Similar Documents

Publication Publication Date Title
US8409876B2 (en) Fluorescent silica-based nanoparticles
US10548997B2 (en) Fluorescent silica-based nanoparticles
Jazayeri et al. Various methods of gold nanoparticles (GNPs) conjugation to antibodies
Jung et al. Fabrication of silica nanotubes by using self-assembled gels and their applications in environmental and biological fields
AU2006249323B2 (en) Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US20110060269A1 (en) Method for killing cells using photocatalytic titanium dioxide particles
Parracino et al. State-of-the-art strategies for the biofunctionalization of photoactive inorganic nanoparticles for nanomedicine
JP2023500677A (en) Ultra-small nanoparticles and methods for their production, use and analysis
JP2010083803A (en) Gold fine particle, method for producing the same and use thereof
JP3826402B2 (en) Dispersion containing photocatalytic titanium dioxide composite fine particles
AU2014221249B2 (en) Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
Shringirishi et al. Gold nanoparticles: Promising and potential nanomaterial
Amirthalingam Multi-functionalization of micro-and nanoparticles for cancer theranostics
AU2012211421B2 (en) Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
Auwalu et al. Fluorescent Nanomaterials for Detection and Discrimination of Amino Acids
Penon Esteva Synthesis and functionalization of nano-and micro-particles for sensing and therapy in living cells
Ghosh Surface functionalized hybrid nanomaterials: Implications in biosensing and therapeutics
Nakamura Approaches to the biofunctionalization of spherical silica nanomaterials
Yapar Novel Gold Nanoparticles for Dipeptide Recognition in Water
Kapur Peptide Mediated Delivery of Inorganic Nanomaterials
Lodeiro et al. Bioinspired Functionalized Nanoparticles as Tools for Detection, Quantification and Targeting of Biomolecules
Yang Functionalised silica coated nanoparticle hybrids for drug delivery and imaging

Legal Events

Date Code Title Description
AS Assignment

Owner name: CORNELL RESEARCH FOUNDATION, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WIESNER, ULRICH;OW, HOOISWENG;REEL/FRAME:013844/0627;SIGNING DATES FROM 20030129 TO 20030130

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION